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Background: Emergency calls are frequently made to ambulance services for older people who have
fallen, but ambulance crews often leave patients at the scene without any ongoing care. We evaluated a
new clinical protocol which allowed paramedics to assess older people who had fallen and, if appropriate,
refer them to community-based falls services.
Objectives: To compare outcomes, processes and costs of care between intervention and control groups;
and to understand factors which facilitate or hinder use.
Design: Cluster randomised controlled trial.
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Participants: Participating paramedics at three ambulance services in England and Wales were based at
stations randomised to intervention or control arms. Participants were aged 65 years and over, attended by
a study paramedic for a fall-related emergency service call, and resident in the trial catchment areas.
Interventions: Intervention paramedics received a clinical protocol with referral pathway, training and
support to change practice. Control paramedics continued practice as normal.
Outcomes: The primary outcome comprised subsequent emergency health-care contacts (emergency
admissions, emergency department attendances, emergency service calls) or death at 1 month and
6 months. Secondary outcomes included pathway of care, ambulance service operational indicators,
self-reported outcomes and costs of care. Those assessing outcomes remained blinded to group allocation.
Results: Across sites, 3073 eligible patients attended by 105 paramedics from 14 ambulance stations were
randomly allocated to the intervention group, and 2841 eligible patients attended by 110 paramedics from
11 stations were randomly allocated to the control group. After excluding dissenting and unmatched
patients, 2391 intervention group patients and 2264 control group patients were included in primary
outcome analyses. We did not find an effect on our overall primary outcome at 1 month or 6 months.
However, further emergency service calls were reduced at both 1 month and 6 months; a smaller
proportion of patients had made further emergency service calls at 1 month (18.5% vs. 21.8%) and the
rate per patient-day at risk at 6 months was lower in the intervention group (0.013 vs. 0.017). Rate of
conveyance to emergency department at index incident was similar between groups. Eight per cent of trial
eligible patients in the intervention arm were referred to falls services by attending paramedics, compared
with 1% in the control arm. The proportion of patients left at scene without further care was lower in the
intervention group than in the control group (22.6% vs. 30.3%). We found no differences in duration of
episode of care or job cycle. No adverse events were reported. Mean cost of the intervention was £17.30
per patient. There were no significant differences in mean resource utilisation, utilities at 1 month or
6 months or quality-adjusted life-years. In total, 58 patients, 25 paramedics and 31 stakeholders
participated in focus groups or interviews. Patients were very satisfied with assessments carried out by
paramedics. Paramedics reported that the intervention had increased their confidence to leave patients at
home, but barriers to referral included patients’ social situations and autonomy.
Conclusions: Findings indicate that this new pathway may be introduced by ambulance services at modest
cost, without risk of harm and with some reductions in further emergency calls. However, we did not find
evidence of improved health outcomes or reductions in overall NHS emergency workload. Further research
is necessary to understand issues in implementation, the costs and benefits of e-trials and the performance
of the modified Falls Efficacy Scale.
Trial registration: Current Controlled Trials ISRCTN60481756 and PROSPERO CRD42013006418.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 21, No. 13.
See the NIHR Journals Library website for further project information.
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Plain English summary
The Support and Assessment for Fall Emergency Referrals (SAFER) 2 study aimed to assess the costs andbenefits of new protocols for paramedics to assess older people following a fall, with an option to leave
them at home with a referral to a community falls service. In three UK ambulance services, we compared
what happened to patients attended by paramedics with the new protocols (intervention group) with what
happened to patients attended by paramedics delivering usual care (control group). We interviewed a small
sample of patients, paramedics and other staff about their experiences of the new model of care.
A total of 4655 patients were included in the trial. There were no differences in the number of further
emergency health-care contacts or deaths between groups, but patients in the intervention group were
less likely to make further emergency service calls. Although only 8% of patients were referred directly to
falls services by paramedics, overall this meant that fewer patients were left at home without further care.
The intervention was as safe as usual practice, and we did not find any differences in how long paramedics
spent on each job or in patients’ health and quality of life. Patients were generally happy with the care
they received and paramedics found that the protocol increased their confidence.
The SAFER 2 study findings indicate that ambulance services may introduce this new pathway safely and at
low cost, and expect reductions in further emergency service calls. However, we did not find any evidence
of improved quality of life for patients or reductions in overall NHS emergency workload.
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Scientific summary
Background
Emergency calls to ambulance services are frequently made for older people who have fallen, but
ambulance crews often leave patients at the scene without any ongoing care. Subsequent falls and
emergency episodes of care are common in this group. In the Support and Assessment for Fall Emergency
Referrals (SAFER) 2 trial, we evaluated a new clinical protocol that allows paramedics to assess older people
who had fallen and refer those who do not need to be taken to the emergency department (ED) to
community-based falls services for continuing care.
Aim and objectives
Aim
To assess the benefits and costs of a complex intervention comprising training and clinical protocols
enabling paramedics to assess older people who have fallen and refer them to falls services
when appropriate.
Objectives
l To compare outcomes, processes and costs of care between intervention and control groups:
¢ patient outcomes: rate and pattern of subsequent emergency health-care contacts or deaths;
health-related quality of life; falls efficacy (fear of falling); and change in place of residence
¢ processes of care: pathway from index incident; subsequent health-care contacts; ambulance
service operational indicators and protocol compliance including clinical documentation
¢ costs of care to the NHS.
l To understand how patients experience the new intervention.
l To identify factors which facilitate or hinder the use of the intervention.
l To inform the development of methods for falls research.
Methods
We undertook a systematic review of published evidence related to the effectiveness of emergency care
interventions by ambulance crews for older people who had fallen. We searched the following electronic
databases: The Cochrane Library, Allied and Complementary Medicine Database (AMED), Applied Social
Sciences Index and Abstracts (ASSIA), British Nursing Index (BNI), Cumulative Index to Nursing and Allied
Health Literature (CINAHL) Plus, Internurse, MEDLINE, PsycINFO, PubMed, Scopus, The British Library, UK
Institutional Library Search, GreyNet, Conference Proceedings Citation Index (Web of Science), OpenGrey
and The British Library’s Electronic Table of Contents (Zetoc) between 1990 and July 2013.
The SAFER 2 study was a multicentre, cluster randomised controlled trial with economic evaluation and
qualitative component. We undertook the trial in defined areas within three ambulance services in which
falls services were set up but direct referral from the ambulance service did not take place. We allocated
ambulance stations, and the paramedics who volunteered to take part, to intervention and control groups.
We included patients in the trial if they were aged ≥ 65 years, resident in the catchment area of
participating falls services, and attended by a study paramedic following an emergency call to the
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ambulance service that was coded by a dispatcher as a fall without priority symptoms. Patients were
recruited for their first incident within the trial period.
The complex intervention that we evaluated comprised assessment protocol, referral pathway, falls service,
and training, clinical and operational support to paramedics. We asked paramedics at control stations
to continue their usual practice, comprising routine assessment, initial care, assistance in moving and
conveyance to ED unless the patient refused.
The primary outcome comprised subsequent emergency health-care contacts (death, emergency
admissions, ED attendances and emergency service calls) at 1 month and 6 months.
Secondary outcomes from routine data:
l referral to falls service or other provider
l compliance with clinical documentation guidelines
l durations of ambulance service job cycle and episode of care
l duration of subsequent inpatient episodes
l subsequent fractures
l costs of care.
Secondary outcomes from patient questionnaires:
l health-related quality of life [Short Form questionnaire-12 items (SF-12)]
l patient satisfaction (Quality of Care Monitor, at 1 month only)
l ‘fear of falling’ [modified Falls Efficacy Scale (mFES)]
l self-reported falls.
Routine outcomes were retrieved from the ambulance services and matched to central NHS registers by the
National Welsh Informatics Service and the Health and Social Care Information Centre (HSCIC) in to link
them to NHS and Office for National Statistics data sets. We linked self-reported outcomes from postal
questionnaires to the routine data by trial identifiers and analysed them in the Secure Anonymised
Information Linkage (SAIL) databank without identifiers.
We collected qualitative data from patients attended by intervention paramedics concerning their
experience and satisfaction, and from ambulance service paramedics and managers on their views of
implementation of the intervention.
We analysed quantitative data by treatment allocated except for those describing uptake of the
intervention. Qualitative data were analysed using a framework approach.
We obtained ethical approvals from the Research Ethics Committee for Wales, the National Information
Governance Board and each participating health board, NHS trust and primary care trust. We followed all
patients who did not actively decline consent (dissent) through the anonymised route.
Results
Systematic review
Of 5355 papers identified by searches, 138 appeared potentially eligible from title and abstract; we included
13 papers (12 studies) after detailed reading of full text. Studies from the USA, the UK, Australia and New
Zealand comprised two randomised controlled trials, nine cohort studies and one qualitative study. These
yielded limited and weak evidence of the most effective ways to deliver alternative treatments to older people
who fall. A minority identified benefits – reductions in subsequent emergency calls and hospital admissions –
SCIENTIFIC SUMMARY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xxiv
for patients referred to a falls prevention service or attended by a paramedic with additional skills. However,
several studies did not explore such outcomes and the quality of most of the studies was low. We concluded
that robust evidence from well-designed and rigorous research is needed to inform service delivery.
Support and Assessment for Fall Emergency Referrals 2 cluster randomised
controlled trial
Recruitment
Between March 2011 and June 2012, across the three study sites, 3073 eligible patients were attended by
105 paramedics based at 14 ambulance stations randomly allocated to the intervention group, and 2841
eligible patients were attended by 110 paramedics based at 11 stations allocated to the control group.
After excluding dissenting and unmatched patients, we included 2391 from the intervention group and
2264 from the control group in primary outcome analyses at 1 and 6 months.
Baseline data
Recruitment of patients was higher at site 1 than at the other sites. There was little difference in age, sex,
time of call, distance to ED or time to recruitment between trial arms. There was one more intervention
station at each site, but fewer paramedics per station.
Missing data
We retrieved a number of routine data for all 4704 eligible patients who did not dissent. However, neither
the SAIL database nor HSCIC enabled us to match 49 of these, or to retrieve data on their ED attendances,
hospital admissions and death. Questionnaire response rates at 1 month varied between sites from
30% to 51%, with 1307 questionnaires returned; and at 6 months from 53% to 74%, with 678
questionnaires returned.
Outcomes and estimation
Clinical effectiveness
One-third of patients had suffered a further emergency episode or death by 1 month [870 out of 2391
(36.4%) intervention group patients and 843 out of 2264 (37.2%) control group patients; odds ratio (OR)
0.96, 95% confidence interval (CI) 0.85 to 1.08]. By 6 months this had risen to two-thirds [1701 out of
2391 (71.1%) intervention group patients and 1592 out of 2264 (70.3%) control group patients; OR 1.02,
95% CI 0.89 to 1.16].
We found evidence of fewer emergency service calls by 1 month [442 out of 2391 (18.5%) intervention
group patients called vs. 493 out of 2264 (21.8%) control group patients; OR 0.82, 95% CI 0.70 to 0.94];
thus, the mean number of further calls per patient per day at risk was 0.020 and 0.025, respectively
(difference –0.004, 95% CI –0.008 to 0.000). By 6 months, 1046 out of 2391 (43.7%) intervention group
patients had called the emergency services, compared with 1046 out of 2264 (46.2%) control group
patients (OR 0.90, 95% CI 0.80 to 1.01); the mean number of further calls per patient per day at risk was
0.013 and 0.017, respectively (difference –0.005, 95% CI –0.007 to –0.002). These differences were
largely consistent across sites, and there was some evidence of fewer ED attendances at 6 months
(mean number of further attendances per patient: intervention group, 0.84; control group, 0.91; event
ratio 0.81, 95% CI 0.72 to 0.91).
The proportion of patients transported to the ED at the time of index incident was similar in the two
groups [1579 out of 2420 (65.2%) patients in the intervention group compared with 1431 out of 2284
(62.7%) patients in the control group; OR 1.08, 95% CI 0.96 to 1.22]. However, this proportion varied
considerably by site, from < 60% at site 1 to nearly 80% at site 2. Intervention paramedics referred 8% of
patients to falls services, ranging from 7.5% at site 1 to 9.7% at site 3. Control paramedics referred only
1.1% of patients to falls services, with some variation between sites. The number of patients left at the
DOI: 10.3310/hta21130 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 13
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Snooks et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xxv
scene without any referral for further care was lower in the intervention group (547 out of 2420; 22.6%)
than in the control group (692 out of 2284; 30.3%) (OR 0.69, 95% CI 0.60 to 0.78).
Completion of clinical documentation was high (> 90% on all key physiological indicators recorded
on-scene) across sites, with no clear difference between trial groups. We also found no differences in
operational indicators [the mean duration of episodes of care, from emergency service call until patient’s
emergency episode was complete, was 196.8 minutes in the intervention group and 192.8 minutes
in the control group (difference 2.05 minutes, 95% CI –6.68 to 10.77 minutes); and the mean duration
of the job cycle, from emergency service call until the ambulance was free, was 99.9 minutes in the
intervention group and 97.8 minutes in the control group (difference 1.69 minutes, 95% CI –0.75 to
4.12 minutes)].
We did not find differences in the following measures:
Duration (mean) of inpatient stay, which at 1 month was 2.25 days in the intervention group versus
2.10 days in the control group (difference 0.14 days, 95% CI –0.21 to 0.49 days) and at 6 months was
11.18 days in the intervention group versus 11.62 days in the control group (difference –0.56 days,
95% CI –1.88 to 0.76 days).
SF-12 mental health component (mean score), which at 1 month was 39.80 in the intervention group
versus 38.89 in the control group (difference 0.90, 95% CI –0.74 to 2.55) and at 6 months was 43.21 in
the intervention group versus 42.82 in the control group (difference 0.46, 95% CI –1.72 to 2.64).
SF-12 physical health component (mean score), which at at 1 month was 29.07 in the intervention group
versus 29.40 in the control group (difference –0.50, 95% CI –1.85 to 0.86) and at 6 months was 30.44 in
the intervention group versus 31.88 in the control group (difference –1.30, 95% CI –3.28 to 0.68).
Fall-specific mFES (mean score), which at 1 month was 3.71 in the intervention group versus 3.82 in
the control group (adjusted difference –0.06, 95% CI –0.39 to 0.28) and at 6 months was 4.55 in the
intervention group versus 4.79 in the control group (adjusted difference –0.23, 95% CI –0.73 to 0.27).
Satisfaction with care: technical mean scores at 1 month were 62.82 in the intervention group versus
63.21 in the control group (adjusted difference –0.32, 95% CI –1.27 to 0.63); in contrast, interpersonal
mean scores were significantly higher, that is 68.92 in the intervention group versus 68.04 in the control
group (adjusted difference 3.13, 95% CI 1.59 to 4.68).
Fewer intervention patients reported further falls by 1 month: 413 out of 621 (66.5%) in the intervention
group versus 409 out of 589 (69.4%) in the control group (OR 0.72, 95% CI 0.54 to 0.96). However,
there was no significant difference in subsequent fractures by 1 month, being reported by 98 out of
2391 patients in the intervention group (4.1%) versus 91 out of 2264 (4.0%) patients in the control group
(OR 1.00, 95% CI 0.74 to 1.35). By 6 months, however, significant interactions between intervention and
site masked any generic effect on further falls or subsequent fractures.
Sixty per cent of intervention group paramedics used their protocols to refer patients to falls services
(i.e. between one and 11 times). Patients’ age, sex and distance to ED did not influence these referrals.
However, only 19 of 40 paramedics (48%) at site 3 referred patients to falls services, compared with 26 of
39 (67%) at site 1 and 19 of 26 (73%) at site 2.
Cost-effectiveness
We estimated the mean cost of the SAFER 2 study intervention across the three ambulance services as
£17.30 per patient, including generic and local set-up costs such as training package development,
training delivery and clinical support for implementation.
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We estimated mean resource use by 1 month to be £3740.00 in the intervention group and £3514.00 in
the control group (adjusted difference £190.24, 95% CI –£13.83 to £394.31), with the cost of initial
hospital stays (£2523.27 and £2329.79, respectively) a major cost driver. Estimated mean resource use by
6 months was £8816.41 in the intervention group and £8661.77 in the control group (adjusted difference
£24.20, 95% CI –£468.01 to £516.40), with the cost of subsequent hospital stays (£3982.21 and
£4111.10, respectively) a major cost driver.
The imputed Short Form questionnaire-6 Dimensions (health and quality-of-life outcomes) scores showed
that mean utilities over 6 months were slightly higher in the control group; however, the adjusted
difference of –0.0026 was not statistically significant (95% CI 0.0066 to 0.0014).
Qualitative findings
Almost all of the 58 patients interviewed were very satisfied with the processes of assessment and
examination carried out by paramedics. Most of those able to compare their SAFER 2 study encounter with
the ambulance service with a previous contact after a fall could see little difference in the assessment and
care delivered. Many patients were already accessing a complex network of community-based services,
from a range of providers (NHS, social services, third sector).
Twenty-four paramedics participated in focus groups or interviews before implementation, and
25 paramedics and 31 other stakeholders, including ambulance service managers, trainers and falls services
staff, participated in focus groups or interviews after the trial.
Before the trial, paramedics reported that they expected making significant use of the intervention.
Post trial, paramedics in all sites reported that the intervention had increased their confidence in leaving
patients at home. The structured training on the SAFER 2 study was felt to be more helpful than previous
and more informal approaches to introducing innovations. They suggested that a ‘simpler’ intervention
would have sufficed, with a less detailed flow chart. Reported barriers to referral included, in all sites,
issues relating to patients’ social situation and autonomy, and, in one site, a lack of knowledge of the role
of the falls team. Some paramedics were concerned about increased times on-scene, but managers did not
see this as an issue.
Methodological findings
We compared the performance of the generic SF-12 outcome measure with the falls-specific outcome
measure, the mFES, in the study population and found the moderate correlation between them
(r = 0.55 to 0.63), with significant floor and ceiling effects for the condition-specific measure.
Conclusions
The SAFER 2 study intervention to facilitate referral to community-based falls services was inexpensive and
safe. The number of referrals made to falls services was lower than expected, and there was considerable
variation between paramedics. The intervention reduced the number of patients left at the scene by
attending ambulance crews without ongoing care, but had little effect on other processes of care.
Although the numbers of further emergency health-care contacts and deaths were unchanged overall,
subsequent emergency service calls were significantly reduced by 1 and 6 months. There was little
evidence of impact on self-reported health outcomes or satisfaction.
Retrieval of anonymised linked data outcomes was highly successful in this ‘e-trial’, and ensured that
findings were generalisable to the whole study population. We plan further analysis trial findings to
describe fully the benefits and risks of this new approach.
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The SAFER 2 trial has shown that ambulance services can introduce this new clinical pathway for patients
without risk of harm, at modest cost and with some reductions in further emergency contacts. However,
we did not find evidence of improved health outcomes for patients.
Future work recommendations
Further research is necessary to understand ambulance service implementation and paramedic uptake
issues related to the falls intervention tested in the SAFER 2 study; costs and benefits of using anonymised
linked data outcomes in trials; and performance of the mFES in this population.
Trial registration
This trial is registered as ISRCTN60481756 and as PROSPERO number CRD42013006418.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.
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Chapter 1 Introduction
Structure of this report
This study was a cluster randomised controlled trial (C-RCT) of a protocol for emergency ambulance
paramedics to assess, and to refer to community-based care, older adults who had fallen and incorporated
an economic evaluation and qualitative research.
The report begins with an overview of the literature and policy relating to older adults falling, avoidable
conveyances to hospital, current paramedic practice, community falls services and the use of protocols for
paramedics. We describe the underpinning theoretical framework for the intervention, clinical effectiveness
and cost-effectiveness results and the qualitative findings.
We report a systematic review of the literature relating to interventions in the ambulance setting with older
people who fall, and then describe the methods used to conduct the main C-RCT. We report the results of
the trial, followed by results from the economic analysis and the qualitative components.
In the final chapter, we summarise and synthesise the findings from all three components of the study,
the systematic review, C-RCT and qualitative study, providing interpretation in the light of other studies.
We discuss the strengths and limitations of the research and generalisability to the NHS. The conclusions
are followed by recommendations for future research.
Background
Falls in older people
Falls in older people are recognised as an important issue internationally,1,2 with high human costs, for the
individual and their carers, and high organisational costs. It is estimated that around 30% of home-dwelling
people aged ≥ 65 years fall every year,3–8 and the rate of falls is even higher among care home residents.9
Studies suggest that falls in older people are the cause of 20–30% of mild to severe injuries and 10–15%
of emergency department (ED) attendances in this group.10,11 Falls in older people are often due to more
than one underlying cause or risk factor; as the number of risk factors rises, so does the risk of falling.12
Risk factors include muscle weakness, balance and gait, low blood pressure (or drop in blood pressure on
assuming upright posture) and cognitive decline. The severity of fall-related complications increases with
age.13,14 Falls are a cause of substantial rates of mortality and morbidity, as well as considerable contributors
to immobility.8 Reduction in quality of life and physical activity leads to social isolation and functional
deterioration with a high risk of resultant dependency and nursing home institutionalisation.15–18 Recovery
from fall injury is often delayed in older people, which increases the risk of subsequent falls.8 Recurrent falls
are associated with greater physician contact and functional decline.19–21 An additional complication is
post-fall anxiety, leading to a fear of falling, which in turn can further contribute to deconditioning and
weakness and in the long run may actually increase risk of falls.8
The About the National Health Interview Survey22 indicates that falls are the largest single cause of
restricted activity days among older adults. Most people who fall do not seek any medical advice, and
those who do are more likely to report to their general practitioner (GP).23,24 The combination of high falls
with a high susceptibility to injury makes a relatively mild fall dangerous. This is because of a high
prevalence of clinical diseases such as osteoporosis and age-related changes, that is slowed protective
reflexes.8 In the UK, it has been estimated that falls account for 3% of total NHS service expenditure,10
with additional costs incurred by social care providers.25 The prevention of falls in older people has been
highlighted as a priority.11,26
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Although prevention appears effective,11 reducing falls and associated morbidity depends on early
identification of people at high risk and delivery of interventions across traditional service boundaries;27
these priorities are now reflected in national and international guidelines.28–30
Emergency department overcrowding and potentially avoidable attendances
Population growth, the increasing burden of chronic disease and population ageing, and the shortage of
health-care workers are affecting health-care systems in many countries.31 EDs are under considerable
pressure and overcrowding is a significant international problem, with a negative impact on both patient
care and providers.32 Department of Health data33 show that from 2003/4 to 2012/3 the number of
attendances in English NHS ED units increased by nearly 32% (from 16.5 million to 21.7 million), although
the majority of the increase was in minor injuries units and walk-in centres. Many of the older people
presenting to EDs have had a fall.34 One study showed that older people presenting to EDs after a fall
represented 20% of all attendances and 14% of all hospitalisations in people aged > 65 years,35 and the
size of the problem is likely to be underestimated as falls are poorly defined, coded and recorded.36
Older people can be kept for a longer time in the ED than younger adults because of difficulties in
assessment and management, that is, they undergo more tests than younger adults, they are more likely
to have cognitive limitations37 and potential underlying diseases or, if they have common diseases, atypical
symptoms,38 and they are also more likely to be admitted than younger adults.39 Pressures on acute
services to discharge patients as soon as possible may mean that there is little focus on fall prevention
interventions.36 Older people taken to EDs following a fall are at high risk of falling again in the next year,
with a 30% chance of sustaining fracture or dislocation.35
It has been argued that many admissions of older people are avoidable, and that the demands placed on
the hospital system may be relieved if alternatives can be found.40 The 2006 White Paper Our Health,
Our Care, Our Say set the direction on ‘improving patient experience and significantly reducing
unnecessary admissions to hospital’,41 with paramedics and enhanced/senior paramedics to play a role in
providing care at the scene. The National Medical Director of NHS England recently proposed key areas of
change in the 2013 Keogh report Transforming Urgent and Emergency Care Services in England 2013.42
The reports look at developing the ambulance service into a mobile urgent treatment service capable of
treating more patients at the scene so they do not need to be conveyed to hospital to initiate care. The
report highlights opportunities to shift care closer to home, stating that 40% of ED patients are discharged
requiring no treatment, up to 1 million emergency admissions were avoidable in 2012 and up to 50% of
calls could be managed at the scene.
Conveyance rate of older adults who fall
Although demand on UK ambulance services continues to increase steadily, a recent study found that only
10% of calls are life-threatening, and an estimated half of all emergency calls relate to patients who could
be treated at home.43
People aged ≥ 65 years commonly call an emergency ambulance (through the emergency services)
following a fall. In London (UK), this group accounts for about 60,000 attendances (8% of emergency
ambulance attendances) each year.44 This is very similar to the proportion reported in an urban emergency
medical services (EMS) system in the USA.43
Non-conveyance to EDs is high in this group, at close to 40% in London,44 elsewhere in the UK45,46 and the
USA.43 In most cases (90%), patients who fall and are not conveyed to an ED have fallen in the home.46
Non-conveyance of patients is recognised internationally as a safety and litigation risk.47 In some UK
ambulance services, performance targets are set for individual enhanced paramedics and paramedics
regarding the percentage of patients they should leave at home, and the enhanced paramedic or
paramedic decides who can be safely left at home. In 2011/12, the Department of Health, in conjunction
with the College of Emergency Medicine, introduced eight accident and emergency (A&E) clinical quality
indicators as part of the NHS Outcomes Framework. These became mandatory from 1 April 2011.
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Indicator 1 (ambulatory care) measures the proportion of patients who are able to be treated at home by
improved pathways of care for patients to avoid hospital admission.48
Little is known about how, in the absence of specific guidelines or training to leave older people who fall
at home, paramedics make these decisions. A study acknowledged the pragmatic nature of negotiation
with patients whether or not to go to hospital.49 A UK study identified that the non-clinical factors
affecting these decisions include experience and confidence of ambulance staff, time into the shift,
presence of carers, quality of the accommodation, waiting times at the local ED and prior knowledge of
the patient.50
Ambulance services, with key stakeholders, have been required to develop alternative care pathways, some
of which involve the direct referral of older patients who have fallen to primary51 or community services.52
This is particularly relevant at a time when pressures on EDs give rise to safety concerns and challenges to
demand management;53 general practice and wider community services are being required to support the
ED directly in order to avoid secondary care, in a time of major system reorganisation.54 Alternative care
pathways (avoiding use of the ED) for ambulance clinicians have been incentivised through local targets in
the Commissioning for Quality and Innovation payment framework.55 This emphasis is likely to continue
given the pressure on EDs.
The National Service Framework for Older People26 advocates that ambulance staff/clinicians refer to
community-based care older people who have fallen, although this reflects consensus rather than research
evidence. Previous studies in this setting have found that change in practice is difficult to achieve and new
pathways of care are difficult to exploit.56
Service models: community falls services
A range of different types of trial performed in community-dwelling individuals (someone who lives among
the general population and is not living in an institution),57 care home residents and hospital patients has
established the evidence base for falls interventions.11 Recent clinical guidelines from the American
Geriatrics Society, British Geriatrics Society and American Academy of Orthopaedic Surgeons panel on
falls prevention29 have strongly advocated preventative approaches based on multidimensional risk
factor assessment, exercise programmes (which include balance, strength and endurance training) and
environmental assessment and modification. A 2004 meta-analysis demonstrated a 37% risk reduction
in the monthly rate of falling for community-dwelling individuals when multifactorial intervention was
implemented.58 Falls clinics are one approach by which falls and injuries can be managed multifactorially.59
A falls clinic is a space where older adults prone to falling can receive holistic support and treatment from
nurses, physiotherapists and other health professionals. A recent randomised controlled trial (RCT) showed
that the Chaos Falls Clinic in Finland is effective in preventing falls in home-dwelling people over 70 years
of age at high risk of falling.60 Patients in this trial were guided towards the falls clinic by regional
health-care professionals (physicians, nurses or GPs), but relatives of patients could also contact the clinic
for an assessment for eligibility.
A recent study found that referral to a community-based falls prevention of older people who had fallen
and been left at home by their attending ambulance clinicians, service reduced further falls and improved
clinical outcomes,61 and achieved cost-effectiveness.62 Recent policy changes in the UK have encouraged
the development and implementation of alternative models of care for the delivery by the ambulance
service. The literature points to the development of extended skills paramedics in line with government
policies and supported by protocols. The use of enhanced paramedics has the potential to reduce running
costs of the service considerably, while improving quality and focus, although significant ‘one-off’ costs
associated with training are also necessary. However, Newman63 noted, the ‘emphasis on the national
standards plus local flexibility appeared to reflect supposed shifts in the role of state’ but more particularly
presented a range of models which resulted in ‘confusing messages about the relationship between
government, the professionals and the public’.
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Theoretical underpinning for intervention
Explicit definition of the theoretical underpinning for an intervention to be evaluated is a necessary step in
the process for developing both the intervention to be tested as well as the methods for its evaluation.
The theoretical basis for the Support and Assessment for Fall Emergency Referrals (SAFER) 2 study
intervention – the protocol for emergency ambulance paramedics to assess older patients attended
for a fall, and allowing referral for those not needing immediate care at ED to a falls service for
community-based care (see Appendix 1) – was built on work carried out previously by the research team
and other published research in the two areas of emergency prehospital care paramedic practice and
service delivery, and care of older people who fall.
The intervention is hypothesised to work by improving the decision-making of paramedics in terms of safe
non-conveyance and referral to appropriate community-based services of older people who have had a fall.
Through the protocol, pathway, training, support and feedback, the intervention provided a formalised
framework for decision-making and referral for this patient group. This is hypothesised to make a
difference by one or more of the following four mechanisms:
l increasing paramedics’ clinical knowledge of how to make appropriate non-conveyance decisions
l increasing paramedics’ knowledge of falls services and pathways for referral
l increasing paramedics’ confidence about making a non-conveyance decision and reducing anxiety
about risk
l increasing awareness and likelihood that paramedics will consider non-conveyance and referral
pathways as an option in appropriate cases.
For the intervention to make a difference to practice and to patient outcomes, a number of factors needed
to be in place, including:
l effective referral pathways, and sufficient capacity in falls teams to respond to referrals
l training and support provided to paramedics that is appropriate and effective
l motivation on the part of paramedics to use the new protocol and referral pathway, including them
not finding it too onerous or time-consuming.
If improved decision-making can be achieved, based on our best knowledge, we can expect the following
beneficial effects:61,62,64–66
l better outcomes (fewer subsequent falls and emergency episodes; higher satisfaction with care) for
patients, in particular for those who would have been left at home with no further care but who are
now referred to falls services, and also for those who may have been taken to the ED unnecessarily,
with related risks of inpatient admission and hospital-related adverse events (AEs)
l reduced costs to the NHS and patients because of fewer initial ED episodes, inpatient admissions and
subsequent falls and related care
l improved paramedic skill sets, level of professionalisation and practitioner morale.
Uncertainties lie at the certain points on the required causal pathway in terms of the feasibility of
implementation and uptake by paramedics; acceptability to patients of non-conveyance/referral;
improvements to processes of care for patients; of any wider impact on the operation of the ambulance
service, such as increased job cycle times; and of patient health outcomes, including their perception of
their own health.
We designed the SAFER 2 trial to gather data about each of these elements of the pathway in order to
assess not only outcomes but also processes that may lead to improved outcomes. Study objectives and
outcomes reflect the theoretical underpinning and hypothesised causal pathway.
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Research aim and objectives
Aim
To assess the benefits and costs to patients and the NHS of a complex intervention comprising education,
clinical protocols and pathways enabling paramedics to assess older people who have fallen and refer
them to community-based falls services when appropriate.
Objectives
l To compare outcomes, processes and costs of care between intervention and control groups:
¢ patient outcomes: rate and pattern of subsequent emergency health-care contacts or deaths, for
any reason; health-related quality of life; psychological status, especially fear of falling; and change
in place of residence
¢ processes of care: pathway of care at index incident; subsequent health-care contacts; ambulance
service operational indicators; and protocol compliance including clinical documentation
¢ costs of care: provided by NHS and personal social services (PSS); incurred by patients or carers in
seeking care.
l To estimate wider system effects of the introduction of the intervention on ambulance service
performance and costs.
l To understand how patients experience the new health technology.
l To identify factors which facilitate or hinder the use of the intervention.
l To inform the development of methods for falls research especially outcome measures recommended
for trials of interventions for older people who fall.59
l To carry out a systematic review on the implementation and impact of interventions by emergency
medical staff who care for older people who fall.
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Chapter 2 Systematic review of literature on
effects of interventions by emergency medical staff
for older people who fall
Abstract
Background
Since the publication of the National Service Framework for Older People 2001,26 the NHS has prioritised
older people who fall. As the overall use of EDs increases, policy is shifting to encourage ambulances to
convey fewer patients and refer them to other services, when appropriate.
Objective
To review evidence about effects of interventions within EMSs for older people who fall, which aim to
reduce demand for EDs.
Method
We undertook a systematic search of 18 electronic databases. Studies were eligible for inclusion if they
included empirical data on novel interventions by EMS in the community for older people who fall. We
extracted outcomes, assessed studies for methodological quality and used narrative synthesis to analyse results.
Results
Of the 5355 articles identified, we selected 12 studies reported in 13 papers. Identified studies were
excluded for the following main reasons: not English language, not EMS, not falls, no or entirely insufficient
empirical data, no intervention or the outcomes of falls were not differentiated. The 13 papers reported data
from 7411 participants: 7399 patients and 12 paramedics. Interventions fell into two groups: prospective
screening on-scene or at the time of the emergency call and retrospective screening and referral to
falls prevention.
Up to half of patients screened on-scene were conveyed to hospital, and referrals to falls services were low
except when automatic (retrospectively). The majority of studies were judged to be of poor quality and
data were heterogeneous, limiting opportunities for comparison and meta-analysis. Of the higher-quality
studies, one trial reported a reduction in ED attendance and hospital admission and increased patient
satisfaction; the other reported a reduction in ambulance calls over 12 months, with patients reporting
fewer falls and increased confidence.
Discussion
Despite national policy to prevent falls and reduce use of emergency services, studies were few and
evidence was mainly weak on effective ways to provide emergency care to older people who fall. When
high-quality trial data were available, positive impact on patient and service outcomes was reported.
Study registration
This systematic review is registered on PROSPERO number CRD42013006418.
Introduction
This chapter presents a systematic review of the literature on the effects of novel interventions by EMSs
for older people who fall. It describes the background and rationale for the review in the context of the
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SAFER 2 study, defines the methods used and presents findings to identify existing evidence and topics for
further research.
Background and rationale for the review
Since the publication of the National Service Framework for Older People 2001,26 the NHS has prioritised older
people who fall. These people have reduced quality of life and levels of physical activity, leading to social
isolation and functional deterioration with high risk of increased dependency and institutionalisation.15–17
Treatment of falls is a major and rising cost for health systems internationally. In the UK, falls cost the NHS
more than £2.3B per annum,67 about 3% of total expenditure.10 In the USA, costs will increase by almost 75%
between 2010 and 202068 and in Australia by more than double between 2004 and 2021.69 Older people
who fall and need emergency attention make up a substantial part of the EMS workload. In London, for
example, they generate over 60,000 attendances, about 8% of the workload.44,51 International proportions are
similar.70 Standard paramedic practice is to assess injury and immediate care needs, move patients from where
they have fallen and convey them to an ED unless they refuse.71 In the face of rising ED attendances,
policy is shifting to encourage emergency ambulance services to convey fewer patients to EDs in the UK
and internationally.40,72
Research has highlighted opportunities for alternative treatment for older people who fall that reflect
their health status and risk.43,46,73,74 Some older people who fall and call the emergency services can be
identified in the ambulance call centre, allowing rapid and targeted alternative responses.75 The cost of
EMS attendance to older people who fall is high.76 Innovative approaches are necessary and feasible,77,78
but evidence about cost-effectiveness of alternative treatment is needed.76
A Cochrane review11 of 159 randomised trials of interventions to reduce incidence of falls among older
people living in the community reported that exercise interventions reduce risk and rate of falls. However,
very few studies reported interventions by EMS staff.61,62,71,79 Gates et al.65 found limited evidence
supporting fall prevention programmes in EDs, primary care or the community but did not evaluate of any
initiatives delivered by EMS. More recently a systematic review by Mikolaizak et al.74 reported that one
study found that 49% of non-transported patients who had fallen had unplanned health contact within
14 days;44 another study reported that 33% of such patients were admitted to hospital within 28 days;80
and two studies that found that attendance by specially trained paramedics reduced subsequent falls,
hospital attendance and other AEs.61,66,74 However, this review did not assess the quality of included studies
or observe Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) reporting
guidelines,81 thus limiting interpretation of findings. None of these reviews considered issues affecting
implementation of interventions for older people who fall, notably the views of EMS staff delivering care.
Methods
Protocol and registration
We registered this review with PROSPERO and the All Wales Systematic Review Register. We adhered to
the guidance for reviews of health care by the Centre for Reviews and Dissemination82 and PRISMA.81
Eligibility criteria
We defined inclusion and exclusion criteria in terms of the population, intervention, comparator,
outcomes, context and study design (PICOCS) of included studies, which is an adaption of population,
intervention, comparator, outcomes (PICO). The additional ‘C’ in the acronym recognises the importance of
the context within which the intervention is delivered.82,83
We included studies that evaluated interventions by EMS staff in the community to older people who had
fallen and generated an emergency service call. We considered any treatment above the care routinely
provided by a paramedic or other EMS staff. Table 1 shows our inclusion and exclusion criteria.
SYSTEMATIC REVIEW
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Sources and search strategy
We searched published and grey literature and reference lists of included studies. We searched the
electronic databases listed in Table 2 during the first week of July 2013 using a search strategy focusing
mainly on the target population and the setting of the intervention. We used medical subject headings
(MeSHs) and keywords when available. Table 3 shows the search strategy for MEDLINE, the Allied and
Complementary Medicine Database and Cumulative Index to Nursing and Allied Health Literature Plus.
Our search strategy focused on two elements of PICOCS:
1. population, using terms such as ‘aged’, ‘health services for the aged’, ‘frail elderly’, ‘age’, ‘accidental
falls’, ‘trip’ and ‘slip’
2. context, using terms such as ‘emergency medical services’, ‘ambulatory care’, ‘ambulances’, ‘emergency
medical technicians’, ‘urgent care’, ‘emergency care’ and ‘prehospital’.
TABLE 1 Inclusion and exclusion criteria
PICOCS and limits Inclusion Exclusion
Population l Older people (aged ≥ 60 years) who fall
at home or in the community and call for
an emergency ambulance
l ≥ 80% of participants recruited sustained
a fall
l Patients who fall from higher than standing
l Patients who sustain falls in sports
l Patients whose fall is identified by home-based
technology (e.g. motion sensors), which
alerts EMSs
l > 20% of participants recruited sustained an
injury other than a fall
Intervention l Enhanced practice delivered to older
people attended by EMS following falls in
the community – at the time of treatment
or to follow up the fall
l Normal practice – patient is treated at home
by an ambulance technician or paramedic with
standard skills using standard procedures
(viz. usual care within the ambulance service in
which the study takes place)
l Referral to a falls service by ED or health-care
professional
l Care delivered by helicopter EMSs
Comparator No comparator required since any study design included
Outcome l Referrals to other services
l ED conveyance
l Any outcome affecting patient care
l Subsequent falls
l Subsequent emergency calls for falls
l Costs
l Acceptability to patients
l Use of screening tool usage
l Views of staff on acceptability and
implementation of intervention
l Strategies to increase referral rates
l Mere description of demography, geographical
location of patient or presenting injuries
l Outcomes of decisions to transport to
specialist treatment centres
Context l Prehospital emergency care l ED
l Primary and community care
l Secondary care
Study design and
reporting format
l Full papers reporting empirical data from
any study design
l Letters, comments, conference abstracts or
opinion pieces
l Papers presenting no empirical data
Limits l English language
l Publications between 1990 and 2013
l UK and international research
l Reports published before 1990
DOI: 10.3310/hta21130 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 13
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Snooks et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
9
The terms for each database varied slightly according to MeSH or other indexed terms. The key terms were
included, as well as keywords in title, abstract or text.
The search strategy used in three of the databases (MEDLINE, EMBASE and PubMed) can be summarised
as follows:
l population, using the MeSH terms of ‘Aged’, ‘Health Services for the Aged’, Frail Elderly’, ‘Accidental
Falls’ and the keywords of ‘age*’, ‘trip’ and ‘slip’
l context, using the MeSH terms of ‘Emergency Medical Services’, ‘Ambulatory care’, ‘Ambulances’,
‘Emergency Medical Technicians’ and the keywords of ‘urgent care’, ‘emergency care’, ‘prehospital’,
‘pre-hospital’ and ‘emergency medical service*’
l combination of elements, combining each of the population terms and each of the context terms with
‘OR’; and combing the population and the context terms with ‘AND’.
TABLE 2 Sources of literature used
Type of literature Data sources
Reviews The Cochrane Library (Cochrane Database of Systematic Reviews, Database of Abstracts of
Reviews of Effects, NHS Economic Evaluation Database, Cochrane Central Register of Controlled
Trials and Cochrane Register of Methodological Reviews)
Reference lists of included articles
General journal articles AMED
ASSIA
BNI
CINAHL Plus
EMBASE
Internurse
MEDLINE
PsycINFO
PubMed
Scopus
Reference lists of included articles
Grey literature The British Library
UK Institutional Repository Search
GreyNet
Conference Proceedings Citation Index (Web of Science)
OpenGrey
Zetoc
Reference lists of included articles
Journal citation reports Web of Science
AMED, Allied and Complementary Medicine Database; ASSIA, Applied Social Sciences Index and Abstracts; BNI, British
Nursing Index; CINAHL, Cumulative Index to Nursing and Allied Health Literature.
SYSTEMATIC REVIEW
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TABLE 3 Search carried out in MEDLINE, the Allied and Complementary Medicine Database, and Cumulative Index
to Nursing and Allied Health Literature Plus
Search identification Search terms
Search options
Limiters – English language
S22 S4 AND S11 AND S20 Search modes – Boolean/Phrase
S21 S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 Search modes – Boolean/Phrase
S20 (MH ‘Ambulatory Care’) Search modes – Boolean/Phrase
S19 (MH ‘Ambulances’) Search modes – Boolean/Phrase
S18 (MH ‘Emergency Medical Services’) OR (MH ‘Emergency
Medical Technicians’)
Search modes – Boolean/Phrase
S17 urgent care Search modes – Boolean/Phrase
S16 emergency care Search modes – Boolean/Phrase
S15 pre hospital Search modes – Boolean/Phrase
S14 pre-hospital Search modes – Boolean/Phrase
S13 ambulance Search modes – Boolean/Phrase
S12 S6 OR S7 OR S8 OR S9 OR S10 Search modes – Boolean/Phrase
S11 age* Search modes – Boolean/Phrase
S10 (MH ‘Aged’) Search modes – Boolean/Phrase
S9 (MH ‘Health Services for the Aged’) Search modes – Boolean/Phrase
S8 (MH ‘Frail Elderly’) Search modes – Boolean/Phrase
S7 old* Search modes – Boolean/Phrase
S6 elder* Search modes – Boolean/Phrase
S5 S1 OR S2 OR S3 Search modes – Boolean/Phrase
S4 (MH ‘Accidental Falls’) Search modes – Boolean/Phrase
S3 trip* Search modes – Boolean/Phrase
S2 slip* Search modes – Boolean/Phrase
S1 fall* Search modes – Boolean/Phrase
Study selection
We downloaded electronic search results into the EndNote bibliographic software (Thomson Reuters, CA,
USA). One researcher (RC, MH or MK) screened the title, abstract and keywords of each study using the
inclusion and exclusion criteria in Table 1. A second researcher, blind to the first researcher’s decision,
screened 1 in 10 references, to ensure consistent decision-making. We resolved differences in discussion
with the third researcher. We retrieved the full text of papers whose abstract met the inclusion criteria.
We compared final recommendations and again achieved consensus on eligible studies in discussion with
the third researcher.
Data extraction
We developed and piloted a data extraction framework reflecting the objectives of the review in line with
guidance.82 Two researchers independently extracted the following items:
l year of publication, country of origin, setting, study design
l aim or research question, outcome measure(s), method(s), study population, sample size
l description of intervention
l key findings.
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When possible, we used the taxonomy developed by the Prevention of Falls Network Europe (ProFaNE),84
from the work of Hauer et al.,85 to describe these data, thus increasing consistency of extraction across the
included studies and opportunity for synthesis. The full data extraction table can be found in Appendix 2.
We compared completed forms and agreed on content in discussion with the third researcher.
Assessment of the risk of bias (quality)
We assessed quality of included studies using checklists recommended by Centre for Reviews and
Dissemination82 to inform comparisons and guide interpretation.85 We identified these checklists as
potentially suitable in the Centre for Reviews and Dissemination guidance. We used the Scottish
Intercollegiate Guidelines Network checklist86 for all study methods except qualitative reports, for which we
used the summary criteria of Walsh and Downe.87 We assessed general methodological quality as high,
acceptable or low, defined by Scottish Intercollegiate Guidelines Network86 thus:
l high: almost all criteria met; low risk of bias; conclusions unlikely to change after further research
l acceptable: most criteria met; some flaws with an associated risk of bias; conclusions may change after
further research
l low: either most criteria not met or clear flaws in study design; conclusions likely to change after
further research.
Data synthesis
We assessed quantitative results for their potential to contribute to a meta-analysis. We used narrative
synthesis to synthesise heterogeneous data.88 We explored relationships within and between studies,
seeking to explain similarities and differences between study findings.
Findings
Inclusion
We identified a total of 5355 references. Our review of titles and abstracts suggested that 138 articles
might be eligible. After studying full texts, we confirmed that 13 papers61,62,66,80,89–97 reporting 12 studies
met our inclusion criteria, as detailed in Figure 1. Table 4 summarises the 12 included studies; Tables 5
and 6 describe them in more detail and Table 7 assesses their quality. Appendix 3 lists excluded studies
(at full-text screening stage) with reasons for exclusion.
Study characteristics
Of the 12 studies, six61,62,66,80,89,94 came from the UK, four90–93 came from the USA, one97 came from
Australia and one95 came from New Zealand. Study designs comprised two RCTs61,66 (one of which61
published a separate paper evaluating cost-effectiveness element of the study),62 nine cohort studies
(of which six did not include a comparator arm89,91–93,95,97 and three included intervention and control
arms80,90,96) and one qualitative study.94 Of the nine cohort studies, three were retrospective,92,95,96 five
were prospective80,89–91,97 and one had both prospective (screening) and retrospective (referral) elements.93
These study characteristics are summarised in Table 4.
The one-armed nature of six89,91–93,95,97 of the studies restricted them to reporting descriptive outcomes.
All but Logan et al.61 reported outcomes at the time of the intervention or soon after. The most common
outcome measures were referrals made to a receiving unit or service,66,89,91–93,97 acceptance of referral by
the patient66,89,91,92,97 and patient conveyance following attendance by EMSs.66,80,95 Five studies reported
follow-up outcomes for patients receiving a novel intervention (see Table 6).61,66,80,90,97 Three66,80,90 used
short follow-up periods (14 and 28 days) with limited inclusion of outcome measures in two,80,90 whereas
another collected physical health, quality-of-life and mortality outcomes.66 One written as two research
papers reported outcomes over 12 months;61,62 but one did not report the period of follow-up.97
SYSTEMATIC REVIEW
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Ten61,66,80,89,90,92,93,95–97 of these studies included a total of 7399 patients and the qualitative study interviewed
12 paramedics.94 However, one study did not specify its sample size.91
Methodological quality
The methodological quality of the studies was variable, but was generally weak (see Table 7). The
controlled trials,61,66,90 economic evaluation62 and qualitative study94 were considered acceptable or high
quality and scored highly for internal validity. The cohort studies were mostly of weak quality and did not
report sufficient information to determine if their methods minimised risk of bias or confounding. Seven
out of eight of the cohort studies80,89,90,92,93,96,97 failed to identify potential confounders in study design and
analysis. Shah et al.93 and Metcalfe89 did not provide a focused research question. Gray and Walker80
scored fairly low using the quality assessment tool, but reviewers defined this study as of acceptable
quality as, compared with the other studies included in this review, it included a control arm, a clearly
focused aim and clearly written methods and results sections. Kue et al.92 did not define outcomes or
reliably assess exposure. However, reviewers considered all studies that reported data that were directly
relevant to this review, and all were included.98 The full quality assessment for each included study is
presented in Appendix 2, with a brief summary of the internal validity score, risk of bias and noted
limitations given in Table 7.
Study findings
Interventions within ambulance services to treat older people who fall
The 12 evaluated interventions fell broadly into two main types; 10 encouraged EMS staff on-scene
to adopt a new approach when making their initial assessment of the older person who had
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FIGURE 1 The PRISMA flow chart.
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fallen;66,80,89–92,94,95,97 two did so retrospectively61,96 and one study93 did both through intervention on-scene
by EMS staff and retrospective action by other staff. Of the others in the first group, eight used
paramedics/paramedic practitioners to intervene at the time of attendance66,80,90–92,94,95,97 whereas the other
did so within the despatch centre, also known as ambulance control.96 The two other studies used
individuals not participating in the initial EMS care retrospectively to screen patients for referral.61,89
TABLE 7 Summary of quality of included studies
Study
Internal validity
score/total possible
score (n n/a)
How well was
the study done
to minimise bias?
Particular limitations noted during quality
appraisal
Controlled trials
Shah et al., 200690 4/5 (5 n/a) Moderate quality Potential bias from choosing intervention
cluster from two without randomisation;
cofounding not controlled for
Mason et al., 200766 8/9 (1 n/a) High quality Participants could not be blinded; as some
outcomes were self-reported, there was
potential for reporting bias; high level of
attrition (50%)
aLogan et al., 201061 7/9 (1 n/a) High quality Participants could not be blinded
aSach et al., 201262 7/8 (1 n/a) High quality As outcomes were self-reported, there was
potential for reporting bias
Qualitative study
Halter et al., 201194 10/12 (0 n/a) High quality Lacks detail about ethics, researchers and
analysis
Cohort studies
Kue et al., 200992 3/7 (7 n/a) Low quality Data not presented clearly; limited by small
study numbers and being in one site
Comans et al., 201397 5/11 (3 n/a) Low quality Very high attrition (75%); limited data used as
the basis for evaluation
Hoyle et al., 201295 3/6 (8 n/a) Low quality Subjective assessment and possibly bias in
dispatch, disparity in transportation rates;
uncontrolled evaluation with limited
follow-up data
Gray and Walker, 200880 3/10 (4 n/a) Low quality Nominally controlled but collected different
data from intervention and control groups,
limiting comparison
Studnek et al., 201296 4/8 (6 n/a) Low quality Nominally controlled but study sites changed
between phases without relevant comparator/
baseline data; very limited in terms of outcomes
measured
Shandro et al., 200791 4/8 (6 n/a) Low quality Uncontrolled evaluation; very limited
presentation of EMS-specific data and
outcomes of care; number of exposed patients
not stated
Shah et al., 201093 2/9 (5 n/a) Low quality Feasibility study without controls or patient
outcome measures
Metcalfe, 200689 2/9 (5 n/a) Low quality Uncontrolled evaluation with poorly reported
methods; authors’ conclusions do not match
results
n/a, not applicable.
a These papers report the same study.
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Seven interventions screened patients on-scene with a predefined tool to decide whether or not to make a
referral with the option of referring to a community-based service,89–94,97 one used the expertise of health
professionals other than paramedics to decide upon conveyance,96 three used paramedic practitioners trained
to provide community-based clinical assessment for patients aged > 60 years,66,80,95 and one referred all
eligible patients who were not conveyed following attendance by EMSs.61 Screening tools ranged from a
single question about the patient’s risk of falling,90 through several questions about eligibility for referral90–93,97
to a flow chart to guide the EMS staff through decision-making.94 One study screened the patients off-scene,
with a nurse who retrospectively screened ambulance service records to decide whether or not to refer
patients to a community service.89 Once the patient was successfully screened and a decision was made to
refer the patient, the studies referred them to a falls prevention service,61,91,97 social services,66,92 the patient’s
GP,66,90,94 district nurse,66 a rapid response service89 or a case management service.93
Of the four66,80,95,96 studies not using predefined screening tools, but using the expertise of paramedic
practitioners or health professionals other than paramedics, three assessed patients to decide whether to
convey patients to hospital or to leave them at home;66,80,95 Mason et al.66 used paramedic practitioners,
and Gray and Walker80 and Hoyle et al.95 both used emergency care practitioners (ECPs) on-scene,
paramedics with extended skills but without specific screening questions or falls service referral routes.
Studnek et al.96 transferred patients with medical problems deemed of ‘low acuity’ to a nurse-led advice
line while an ambulance was travelling to their location. The nurse provided advice on alternative modes of
care or transportation. The ambulance response was stopped only if the patient requested it.
Effect of interventions by emergency medical services for older people who fall
The outcomes measures assessed by the included studies were heterogeneous. Only a minority of the
studies followed up patient outcomes: five89,91–93,95 collected outcomes only from the initial contact with the
patient, relating to the emergency service call itself or the ambulance service’s care of the patient on-scene;
the remaining five reported outcomes after initial contact with the patient; and four66,80,90,97 studies reported
both initial and subsequent outcomes. Among those reporting later outcomes, follow-up intervals were
varied. Comans et al.97 did not report this interval; two studies used periods of ≤ 1 month80,90 and the
randomised trial assessed effectiveness and cost-effectiveness over 1 year.61,62 To try to synthesise the effect
of the novel interventions on patients, we stratify the findings of the included studies by the time point at
which the outcome was collected.
Outcomes pertaining to initial patient contact
Referrals
The most widely reported outcome measure was numbers of patient referrals to a community service
following screening prompted by a fall, as reported by five studies89,91–93,97 (Table 8). Referral rates were
generally low (between 1% and 15% of screened patients). However, Metcalfe89 reported that 53 (60%)
out of 89 patients screened by an experienced nurse within 24 hours of their fall were referred to a rapid
response team or another appropriate service.
Three studies89,91,97 reported numbers of patients accepting referrals (Table 9). The acceptance rate was
high, reported by Comans et al.97 and Shandro et al.91 to be 76% and 65%, respectively. Metcalfe89
reported that just two patients (3.8%) refused the referral generated by the rapid response team, giving a
96% acceptance rate. Although we have presented these data together, it should be noted that these
studies measured referral acceptance at different time points in the referral process, with Comans et al.97
reporting patients who consented to the study and underwent initial assessments, Shandro et al.91
assessing the number of patients enrolling on the programme, and Metcalfe89 assessing the number of
patients who accepted referrals.
Referral mechanisms that required on-scene referrals by EMS staff91,92,97 were undertaken less frequently
and had lower patient acceptance rate than retrospective referrals, which had high patient acceptance.89
As all these studies were of low quality, however, findings are not robust.
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Conveyance to emergency department
In three studies,66,80,95 ECPs or PPs (paramedics with enhanced training) took the decision to convey a
patient to ED. ECPs or PPs did not use any additional decision-making tool above clinical judgement.
Conveyance to the ED can only be reported here for two of the studies80,95 as the third study combined
reporting of conveyance at the time (0 days) with conveyance at 28 days66 and was varied (Table 10).
Admission to hospital
Two studies80,96 assessed whether or not patients who received a novel EMS intervention after making the
emergency service call experienced reduced hospital admissions. Studnek et al.96 found that hospital
admissions fell from 35% (n = 56) to 25.7% (n = 26) when emergency service callers who had sustained a
fall were screened to receive nurse-led telephone advice, in addition to a standard EMS attendance.
Studnek et al.96 did not calculate individual significant values for patients who had fallen, but found that,
for all patients (with all possible medical complaints), there was a statistically significant difference in the
proportion of patients discharged home following attendance at the ED (i.e. not admitted to hospital)
compared with the control period (p = 0.03; CIs not reported). Gray and Walker80 assessed hospital
admittance at 72 hours post EMS attendance. Admission rates decreased from 51% (n = 396) during the
control period to 26% (n = 62) during the intervention period (significance levels not reported).
TABLE 8 Studies reporting number of referrals made to a community service
Referral
component
Study
Kue et al.,
200992
Comans et al.,
201397
Shandro et al.,
200791
Shah et al.,
201093 Metcalfe, 200689
Intervention Referral pathway from EMS to community service
Outcome Number of
referrals
Number
attempted to
refer
Number of
referrals
Number of patients
referred because of
falls
Number of referrals
made for patients
experiencing a fall
Number of referrals 7 21 17 124 53
Sample size (patients
screened for referral)
721 638 Unknown 814 89
Percentage referred 1 3 Unknown 15 60
TABLE 9 Studies reporting patient acceptance of referrals to a community service
Referral
component
Study
Comans et al., 201397 Shandro et al., 200791 Metcalfe, 200689
Intervention Referral pathway from EMS to community service Provision of screening tool with
referral to community service
Outcome Consented to study and
underwent initial assessment
Number of enrolments on falls
prevention programme from
EMS referrals
Number patients accepting
referrals
Data 13 11 51
Sample size (number
of patients referred)
17 17 53
Percentage
consented/accepted
76.5 64.7 96.2
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Outcomes collected following initial contact with patients
Five studies, written as six research papers,61,62,66,80,90,97 reported follow-up outcomes. Five reported the impact
on subsequent falls and health service utilisation61,66,80,90,97 and one reported the impact on costs to the NHS.62
Subsequent falls and use of health care
Logan et al.61 reported that patients referred to a falls prevention team experienced 55% fewer falls over
12 months than the control group [95% confidence interval (CI) 0.35 to 0.58; p < 0.001]. Patients also
had reduced fear of falling (assessed by the falls efficacy scale, mean difference –16.5, 95% CI –23.2 to
–9.8; p < 0.001), were more active [assessed by the Barthel Activities of Daily Living Index, odds ratio (OR)
2.91, 95% CI 1.18 to 7.20]. There was also a significant reduction in emergency ambulance calls for falls
over 12 months (effect size 0.60, 95% CI 0.40 to 0.92; p = 0.018).
Mason et al.66 reported several patient outcomes with a significant difference for the intervention group
(those attended by a paramedic practitioner): a 25% decrease in attendance at an emergency department
at 0 and 28 days following the incident (relative risk 0.72, 95% CI 0.68 to 0.75; p< 0.001), a 6.1%
decrease in hospital admission during the same period (relative risk 0.87, 95% CI 0.81 to 0.94; p< 0.001),
an increase in subsequent unplanned contact with secondary care services (relative risk 0.1.21, 95% CI
1.06 to 1.38; p< 0.001), and an 11.7% increase in those reporting being ‘very satisfied with their care’
(relative risk 1.16, 95% CI 1.09 to 1.23; p< 0.001).
The other three studies80,90,97 reporting follow-up outcomes were cohort studies collecting outcome
measures associated with specific aspects of the novel intervention. Shah et al.90 assessed whether or not
patients had discussed their risk of falls with their doctor and if they had received changes to their home
environment. Although increased numbers of patients had these attributes in the intervention arm,
the difference was not significant.
Gray and Walker80 reported a 17% reduction in admissions at 28 days following EMS attendance during
the intervention period than in the control period when patients were attended by paramedics with usual
training (reduction from 52% to 44%, n = 1005, df = 1; p = 0.05).
Comans et al.97 reported the number of patients who completed the referral programme, with five patients
who were referred to a falls prevention service completing the programme, out of the eight patients who
initially enrolled on the programme.
Effect on cost
One paper62 found that the referral of patients who had been attended and left at home by EMS to a falls
prevention service, carried out within a randomised trial,60 was cost-effective. The mean difference in NHS
and PSS costs between the intervention and control groups was –£1551.00 per patient over 1 year
(95% CI –£5932.00 to £2829.00). The mean difference in quality-adjusted life-years (QALYs) was 0.070
(95% CI −0.010 to 0.150) in favour of the intervention group.
TABLE 10 Studies reporting number of patients conveyed to the ED as an outcome
Referral component
Study
Hoyle et al., 201295
Gray and Walker,
200880
Intervention Paramedics with extended training (with no referral pathway)
Outcome Percentage of patients transported to ED Patients attending ED
Data 44 62
Sample size (number of patients screened/attended) 131 233
Percentage of patients transported to ED 34 27
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What is the impact on and views of emergency medical services staff of interventions
designed to improve the care of and outcomes for older people who fall?
Staff appeared reluctant to use new interventions to treat older people who fall, according to two
studies.94,97 Halter et al.94 reported variable use of a clinical assessment tool to review whether to safely
leave a patient at home or convey him or her to the ED. This qualitative study reported that paramedics
were reluctant to use a systematic decision-making tool but instead relied on informal processes, showing
the need for a consistent message and support for ambulance staff. Comans et al.97 identified that
repeated education sessions, good relations and regular contact between falls services and paramedics
raised referral rates, but these were not sustained when awareness-raising ended.
Discussion
This systematic review identified limited and mainly weak evidence regarding the most effective ways to
deliver alternative treatments to older people who fall. The 12 studies that were included in this review
implemented variable novel interventions, limiting comparisons that can be made between studies.
We classified the interventions within two groups: (1) on-scene screening during patient assessment or
triage during the emergency service call to refer them to a community health service or hospital
conveyance; or (2) retrospective screening and referral to a community health service.
The studies included in this review are heterogeneous in terms of interventions and outcomes, and, while
this is a finding in itself, we have considered the studies to be similar enough, in a small research field, to
analyse as a group because of the similarity of the context and patient group included in all the studies.
We have not attempted meta-analysis for this reason, and it is the heterogeneity of outcome measures,
and a lack of follow-up outcomes to assess the long-term effect of the novel interventions on patients,
that means it is difficult to assess the impact of these interventions. The majority of outcome measures
were descriptive, detailing the number of referrals that were made and the acceptance of these referrals to
patients. Studies utilising these descriptive outcome measures identified that a low percentage of the
overall number of screened patients were referred, except where the referral was made retrospectively
externally to the ambulance service. Similarly, acceptance of the referral by patients increased when the
referral was undertaken externally to the ambulance service. Although these outcome measures are useful
for understanding the paramedics’ and patients’ adoption of the intervention, they do not allow
understanding of the effect of the novel intervention on the patient.
Five studies, written as six research papers, undertook follow-up of patients beyond the initial contact with
EMS,61,66,80,90,96 five of which undertook between-group analyses. They identified that, compared with the
control groups, patients who were treated for a fall by EMS had fewer future falls, called the EMS less
often and received cost-effective care when referred to a fall prevention service;61 were less likely to be
admitted to hospital when being treated by a paramedic practitioner66 or ECP;80 and were more likely to
discuss fall risk with their doctor when a referral was made.90 The study not undertaking between-group
analyses found that five out of eight patients who enrolled in a fall prevention programme completed it.97
Emergency medical services staff’s views of the novel interventions were seldom reported; the one
qualitative study included in this review concluded that EMS staff were reluctant to use formalised
assessment techniques, instead relying on their usual decision-making process.94 One study did not directly
report paramedics’ views, but did suggest that use of the intervention increased with regular contact and
good relations.97 Although other included studies did not directly assess EMS staffs views of the novel
interventions, the studies that reported referral rates reported a low percentage of referrals taking place.
These findings highlight the difficultly of changing practice with EMS.
Assessment of study quality, using recommended tools, identified that the included papers were mostly
poorly reported and overall quality of the evidence was not high. Most of the studies were single-arm
cohort studies and many had methodological drawbacks leaving them open to bias. The majority of the
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included studies were single-group cohorts and only one RCT was identified. Seven of the included papers
were deemed to be of low quality, two of acceptable quality and three of high quality.
Previous systematic reviews undertaken to assess the effect of referral mechanisms on patients who fall
have found varying level of benefits for patients. A review looking to assess the effect of multidisciplinary
falls prevention service treatment on patients referred from community settings found limited evidence to
support a reduction in falls or fall- related injuries for referred patients.65 Another review, undertaken
to identify evidence regarding patients who are not conveyed following a fall, found that appropriate
interventions can benefit patients who have fallen, including reducing AE and EMS calls.74
The current review identified benefits within a minority of the included studies – one study reported
significant decreases to future EMS attendances and hospital admissions when patients are referred
retrospectively to a falls prevention service, while two studies described a reduction in admission to
hospitals when patients are attended by an ECP. These positive findings on patient and service outcomes
are, however, set in the context of the number of studies for which such outcomes are not explored and
the low quality of the majority of the included studies.
High-quality evidence from well-designed and rigorously conducted research is needed to understand how
effective services can be adopted and delivered which will provide appropriate and safe care for patients.
Future research should focus on the ability of paramedics to make decisions regarding a patients’
conveyance, paramedics’ views of the intervention and the long-term health consequences for patients of
such interventions.
Strengths and limitations of this review
We used a systematic process in line with good practice82,99 to identify international research and review
reported data. In undertaking this review, we were unable either to consider papers in languages other
than English or to request original data from study authors because of time constraints.
Heterogeneity of interventions and outcomes and low study quality mean data should be interpreted with
caution. It also limits ability to generalise findings.
The quality assessment tools that were utilised were not tailored to single-group cohort studies. Therefore,
many of the questions were not relevant to the majority of studies that were included in this review.
Nevertheless, the inability to answer a question was regarded as a sign of low quality.
Review findings as context for Support and Assessment for Fall Emergency
Referrals 2
The SAFER 2 trial selected the age of 65 years and older as its cut-off point for inclusion, as both the
National Service Framework for Older People 200126 and the National Institute for Health and Care
Excellence (NICE) guidelines for falls67 use this cut-off point, although they recognise this as an arbitrary
point that varies in relevance to individual health and disability.
In the systematic review, however, we chose to also include studies that stated their lower age for
inclusion to be 60 years, as we were aware from our reading on the topic that two61,66 UK trials had used
this slightly lower age breakpoint.
Although we recognise that this might suggest that the cut-off point of ≥ 60 years of age could or should
have been used for the SAFER 2 trial, we are reassured that our results are comparable when we look at
the mean age of participants in the 10 of the 12 studies that provide us with this demographic information
about participants:61,66,89–93,95–97 7 of these 10 studies report mean ages of participants in the ‘frail older
people’ group, ranging from 77 to 83 years61,66,90–93,97 and one of the most common age group of
participants as 80–89 years.89 The two studies of exception were those where fall was one condition only
amongst a range studied, and these reported average ages of 4796 and 62 years.95 We therefore feel
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confident that the different lower age parameter for the systematic review and the trial did not impact on
relevance of one to the other.
We suggest that the fact that this review found limited evidence on the topic of support and assessment
for older people who fall and are attended by the emergency ambulance service, and even more limited
evidence of high quality, is the context and justification for the SAFER 2 trial, the findings of which are
now reported.
SYSTEMATIC REVIEW
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Chapter 3 Methods
Overview
The SAFER 2 study design comprised a C-RCT, with economic evaluation and qualitative component.
Aim
To assess the benefits and costs to patients and the NHS of a complex intervention comprising education,
clinical protocols and pathways enabling paramedics to assess older people who have fallen and refer
them to community-based falls services when appropriate.
Objectives
l To compare outcomes, processes and costs of care between intervention and control groups:
¢ patient outcomes: rate and pattern of subsequent emergency health-care contacts or deaths;
health-related quality of life; falls efficacy (fear of falling); and change in place of residence
¢ processes of care: pathway of care at index incident; subsequent health-care contacts; ambulance
service operational indicators and protocol compliance including clinical documentation
¢ costs of care.
l To understand how patients experience the new health technology.
l To identify factors which facilitate or hinder the use of the intervention.
l To inform the development of methods for falls research.
Cluster randomised controlled trial
Trial design
The trial was conducted in geographically defined sites within three UK ambulance services. The unit of
clustering at each site was an ambulance station. The clusters comprised the paramedics based at eligible
stations who volunteered to participate in the trial. Once stations had been randomly allocated to
intervention or control groups, participating paramedics based at those stations were asked to deliver care
according to their group allocation, irrespective of their location on any particular shift.
We chose a cluster design, as opposed to a patient-level RCT, as the intervention included training and
new assessment skills, and it would be impossible to switch on and off as would be required in a patient-
level RCT. Other units of randomisation have been used in trials based in prehospital emergency care,
with limited success.100 We chose to randomly allocate stations in order to allow the hosting ambulance
services to support change in practice for paramedics based at intervention stations while minimising
contamination to practice by paramedics based at control stations.
Trial management
Following the Medical Research Council guidelines for good practice in clinical trials,101 the management
structure for the trial (see Appendix 4) included an independent Trial Steering Committee (TSC) and Data
Monitoring and Ethics Committee (DMEC), with an internal Trial Management Group (TMG), local
implementation team (LIT) in each area, core research team, and task and finish groups for specific aspects
of the trial such as data management. The TSC provided external oversight and advice to the chief
investigator, the Health Technology Assessment (HTA) programme and the sponsor on all aspects.
The DMEC had access to unblinded comparative data to monitor the data and make recommendations to
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the TSC if there were ethical or safety reasons why the trial should not continue. The TMG managed the
trial at an overarching level. The LITs dealt with operational issues at each site and provided liaison
opportunities between participating services. The core team that managed the trial at a day-to-day
operational level was smaller and included the chief investigator, site principal investigators and researchers.
Setting
We undertook the trial in prehospital emergency care, with paramedics delivering the intervention in
partnership with community-based falls services (known as falls prevention services). We selected sites
within three ambulance services in England and Wales in which a falls service was available, but no process
was in place for paramedics to make direct referrals from the scene of emergency service call attendances.
Appendix 5 maps stations and hospitals with ED departments at each site.
Participants
Ambulance stations were eligible for inclusion in the study as a cluster if they were situated within a
participating ambulance service and were a base for paramedics who regularly attended patients within a
participating falls prevention service’s catchment area.
We invited paramedics based at selected ambulance stations to participate in the trial before allocating
those stations randomly between intervention and control groups. Paramedics were approached via e-mail,
letter and station posters and were asked to return a reply slip if they were interested in participating.
Paramedics who volunteered to participate were given a £50.00 voucher.
Patients received either intervention or control group care, depending on the group allocation of the
attending paramedic. During training, intervention paramedics were instructed to lead on care if there was
also a control group paramedic on-scene, and these patients were included in the intervention group
for analysis.
Inclusion criteria:
l aged ≥ 65 years
l resident in the catchment area of participating falls services
l attended by a study paramedic following an emergency call to the ambulance service which was coded
by a dispatcher as a fall without priority symptoms (Advanced Medical Priority Dispatch System
Code 17)
l first eligible call during the trial period.
Randomisation
Randomisation of stations to groups was carried out in accordance with principles related to cluster
randomisation and blinding of analysis team, as outlined in the West Wales Organisation for Rigorous
Trials in Health and social care (WWORTH) standard operating procedure (SOP) on randomisation.102
The trial statistician (WYC) and manager (JP) undertook randomisation after recruitment of paramedics had
closed, to avoid selection bias, using trial site, volume of calls, falls service and the number of participating
paramedics as stratification variables.
Recruitment
Patients were identified as being potentially eligible for study inclusion from routine emergency service
dispatch records through standardised queries written for each site. Site researchers confirmed eligibility of
individual patients by retrieving corresponding patient report forms (PRFs), which are routinely completed
by paramedics when they attend a patient. PRFs include patient identifiers and demographics; and
operational, clinical assessment and treatment information.
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In this cluster trial we did not ask paramedics to approach patients for consent to participate in the trial
during the emergency episode. Instead, following identification of eligible patients as detailed in
Participants, we sought consent from patients for follow-up through routine medical records and by postal
questionnaire. Following considerable discussion with the Research Ethics Committee, our consent process
included contacting patients by post and then, if necessary, by telephone or a home visit. Patients then
had the opportunity to actively ‘consent’ or ‘decline consent’ (dissent). However, we were unable to
contact some patients at all (no response by post or telephone). We had Health Research Authority
Confidentiality Advisory Group (HRA CAG) permission to follow up this group anonymously (but they
neither ‘consented’ nor ‘declined consent’). The group we analysed consisted of those who had consented
and those who we could not contact (follow-up was through an anonymised route). Only those who
had actively declined consent (dissented) were excluded from this group. The postal consent pack
(see Appendix 6) included:
l covering letter
l consent form
l patient information sheet
l 1-month questionnaire (see Appendix 7)
l Freepost return envelope
l £5.00 voucher, to thank participants for their time.
Interventions
Experimental: intervention group care
The core of the health technology we evaluated was a clinical protocol for the care of older people who
have fallen, enabling emergency ambulance paramedics to assess and refer them to community-based falls
services (see Appendix 1). During a workshop held to define the intervention, participants from across
specialties and sites agreed common minimum standards for each component of the intervention, with
flexibility allowed for local differences in processes such as referral and documentation. The complex
intervention comprised the assessment protocol (the health technology being trialled) and six other
components, as shown in Table 11. Local variations are shown in detail in Appendix 8.
Control group care
Control group paramedics did not receive training in the intervention. We asked paramedics based
at control stations to continue their usual practice. Although we know that conveyance rates vary
considerably among services, stations and paramedics, we did not seek to standardise practice, as we
were unable to identify best practice. Current practice in the control group was therefore care as usual
comprising assessment of injury or other condition requiring immediate care, assistance in moving and
conveyance to ED unless the patient refused.
Outcomes
Outcome measures at 1 month and 6 months after the patient’s index incident were consistent with
recommendations of ProFaNE.103
Primary outcome
A composite outcome of subsequent emergency health-care contacts (in order of severity, i.e. death,
emergency admissions, ED attendances or emergency service calls), summarised by:
l proportion of patients who suffer these events
l interval to first event
l event rate.
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Secondary outcomes
At index incident:
l onward pathway of care (conveyed to the ED; referred to falls service; referred to other provider)
l compliance with guidelines for ambulance service clinical documentation
l durations of: ambulance service job cycle (from receipt of emergency service call to time that
ambulance reports being free for next call); episode of care (from receipt of emergency service call
to end of emergency episode, i.e. the patient is left at home, discharged from ED or admitted to
hospital); or time to falls service response.
At 1 month and 6 months after patient’s index incident:
l duration of subsequent inpatient episodes
l subsequent reported fractures
l health-related quality of life, as measured by the Short Form questionnaire-12 items (SF-12)104
l patient satisfaction as measured by the Quality of Care Monitor105 and ‘fear of falling’ as measured by
the modified Falls Efficacy Scale (mFES)106
l self-reported further falls
TABLE 11 Definition of the SAFER 2 trial intervention
Component Core minimum standard Local variation permitted
Assessment protocol Clinical protocol to guide paramedic through the
decision-making process and assess the patient’s
risk of further falls and safety for non-conveyance
Consent process for patient agreement
to be referred to falls service
Protocol may be used as aide memoire or
as a specific additional form to the PRF
Training One full day, with training package including
programme, written materials and DVD
(see Appendix 9)
Background and role of trainers,
including members of falls teams when
possible
Referral pathway A pathway to allow intervention paramedics to
refer patients to a falls prevention service, including
a system to allow auditing of receipt of referral
forms
Method and process of referral, to
minimise any delays on-scene
Participation of GP practices across falls
servicea catchment area
Referral tool A form recording information to be passed to
the falls prevention service, including basic
demographic, clinical and contact details
Other information included in referral
form
Falls service response to
referral
Telephone contact with patient, by professional
with ability to recognise cases where urgent input is
needed
Time frame for initial patient contact and
assessment
Initial face-to-face multifactorial assessment;
multidisciplinary assessment if appropriate
Falls service provision NICE guidance-adherent service: multidisciplinary
treatment delivered by team of appropriately
qualified professionals (may include, e.g.
equipment, balance training, medical review)
Details of service and patient intervention
Clinical and operational
support
Clinical support debrief with ED every 2–4 weeks
plus feedback on outcomes for individual patients
referred to falls service
Exact method and means of clinical
support and feedback
DVD, digital versatile disc.
a At site 1 not all GP practices within the trial catchment area were linked to the participating falls services. Intervention
paramedics needed to consult a list of participating GP practices before offering referrals to patients. These patients
were trial eligible, but were not eligible for the full intervention. Numbers recruited are noted in Chapter 4.
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l costs of care to NHS and PSS
l self-reported costs incurred by patients and carers.
Qualitative:
l views of ambulance service paramedics, managers and partners on implementation of the intervention
l experience and satisfaction of patients receiving the intervention.
Data collection
l Ambulance service: routine clinical and operational management information about index and
subsequent contacts from despatch records (completed by emergency service call takers) and PRFs
completed by paramedics during or immediately after patient attendance.
l Falls services: information about referrals and falls service response.
l Participants (or their carers): questionnaire data, sent by post to eligible patients at 1 month (see
Appendix 7) and those who consented to a further questionnaire at 6 months (see Appendix 10).
l Health and Social Care Information Centre (HSCIC) (England) and National Welsh Informatics Service
(Wales): routine data about ED attendances, hospital admissions and deaths for all matched study
patients over the study period.
At all three sites, patients who dissented by any means were excluded from all data collection. For all
other patients, we collected anonymised data on index and subsequent health-care contacts. Identifying
information collected at ambulance and falls services was split from clinical information by our trial
partners within the three ambulance services. In order to improve the matching rate achieved by National
Welsh Informatics Service and HSCIC, our ambulance service partners used imperfect emergency service
call information such as name, address and date of birth to look up NHS numbers. Once patients were
matched, clinical outcome data were retrieved and transferred for analysis into the Secure Anonymised
Information Linkage (SAIL) gateway when it was joined up with questionnaire data.
Data entry
The method of data entry varied by source and site. Ambulance service despatch data were downloaded
electronically to study databases. There were two types of PRF: paper and electronic. Sites 2 and 3 used
only paper forms and site 1 used a mix of paper and electronic forms. Paper forms were input into study
databases manually by the study team, whereas electronic forms were input automatically after they
were downloaded from a central server. Questionnaires were input into study databases using Teleform
software version 10 (Cardiff Software, Sunnyvale, CA, USA). A quality assurance check was carried out on
all manually entered data.
Blinding
Blinding was carried out when possible. Paramedics, trial managers and site researchers were not blinded,
as they needed to know the allocation of participating ambulance stations for operational reasons. The
trial statistician and all other TMG members were kept blind to allocations in order to eliminate reporting
bias. This was undertaken by coding the allocated groups in order to prevent group identification. Blinding
statisticians is a technique recognised, both by statisticians in general and by the WWORTH SOP on
statistics,107 as best practice in statistical analysis. Even though the WWORTH SOP also requires that trials
agree statistical analysis plans before starting analysis, these cannot cover all eventualities, with the result
that unblinded statisticians could unconsciously take analytical decisions that favour intervention over
control or vice versa. Unblinding occurred after completion of primary analyses.
Sample size and power
We estimated our trial sample size from our principal outcome: the proportion of participants who, within
6 months, die or contact emergency services. From previous trials of interventions for older people who
have sustained a fall and presented for emergency treatment, summarised in a recent systematic review,108
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we made the conservative estimate that trial patients had about a 50% chance of making another
emergency contact or dying within 6 months. We judged that a change of 5% in this proportion could
be clinically and economically important. In the absence of clustering, a sample size of 4190 evaluable
participants would have yielded 90% power to detect a change of at least 5% (from 50% to ≤ 45% or
≥ 55%) when using a two-sided 5% significance level. As participants came from 25 clusters, we needed
to adjust this sample size to allow for intracluster correlation (ICC). We estimated this ICC from the
findings of the SAFER 1 trial,79 which evaluated the clinical effectiveness and cost-effectiveness of
computerised clinical decision support software for use by paramedics when attending older adults who
had a fall. The SAFER 1 trial estimated the ICC for the same outcome, but over 1 month rather than
6 months, as 0 when clustering participants by station (as in the SAFER 2 trial), but 0.005 when clustering
participants by paramedic (as in the SAFER 1 trial).79 To be conservative, we allowed for an ICC of 0.002 by
increasing the target evaluable sample to 6290, namely 25 clusters × 251.6 participants per cluster. This
sample would have more than 90% power to detect a change of 0.18 in the number of emergency
contacts of 1.8 over 6 months, given a standard deviation (SD) of 1.5. Hence, the SAFER 2 trial was able to
detect a difference of 1 emergency contact in 10 avoided (or induced) by the intervention.
We had originally postulated that patients recruited to the study would have a 40% chance of making an
emergency contact or dying within 6 months and that the ICC could be as high as 0.03. Under those
assumptions our target sample of 6290 would have yielded 80% power to detect a change of at least
10% (i.e. from 40% to ≤ 30% or ≥ 50%) when using a two-sided 5% significance level. When the SAFER 1
trial showed that the assumed ICC was unduly pessimistic, recruitment was progressing well. Therefore,
rather than finish the trial early, we decided, with the approval of both TSC and DMEC, to be less
conservative in assuming a worst ICC of 0.02, thus yielding enough power to detect a change of only 5%
in the emergency contact rate, still a clinically important difference in the view of our advisers.
Statistical methods
The full analysis plan can be found in Appendix 11. Primary analysis was by ‘treatment allocated’. Analyses
included logistic regression for binary outcomes; cross-tabulations and risk ratios for categorical outcomes;
and survival analysis including Cox’s proportional hazards models for times to events. We used multilevel
modelling to estimate (random) station effects and (fixed) group effects and analysed repeated
observations as such.
Our principal outcome is made up of a hierarchy of events. We therefore undertook analysis incrementally:
first, deaths; second, emergency admissions plus deaths; third, ED attendances plus admissions and deaths;
and, finally, emergency service calls plus attendances, admissions and deaths. Although we originally
planned to undertake analysis for all events and for those coded as a fall, in practice data quality across
the levels precluded analysis of falls only. We have presented results as follows: the proportion of patients
who called the emergency services, attended ED, were admitted or died; survival analysis of the time to
the first subsequent emergency contact; the mean number of further emergency contacts adjusted for
time at risk, excluding days in hospital or after death; and recurrent event analysis when feasible. We also
examined the effect of the intervention on patient satisfaction, health-related quality of life and costs
(as described under Economic evaluation).
Potential predictors of triage decisions include the distance between the site of the index event and the
ED; patients’ age, sex and history of previous falls; type of presentation [specifically, a seasonality term
capturing when, during the calendar year, the call was made, and an indicator of whether or not it was
made out of (GP) hours]; and time since recruitment started (recruitment point). The list of adjusting
factors (covariates) includes those suggested by the TSC and may be divided into three subsets:
(1) group and site interactions, reflecting study design; (2) participant characteristics (age and gender);
and (3) characteristics related to the timing and location of the index incident. We used the covariates in
the analysis. It is possible that patients in the catchment area of one station may receive care for a
subsequent event from a paramedic based at another station participating in the study but allocated to
a different group. Nevertheless, analysis was still by treatment allocated. We have identified referrals made
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to falls services at subsequent emergency service call attendances and are able to use this for censored
analysis in order to minimise contamination, but this is not included in the current report.
We proposed to identify any wider system effects, by comparing response times during the trial period
across the study catchment area and surrounding areas with pretrial response times and response times
elsewhere. This analysis would only be necessary if effects were found on ambulance operational
performance indicators – job cycle time within the trial population.
To inform the development of outcome measures for falls research as recommended by ProFaNE,103 we
compared SF-12 and derived Short Form questionnaire-6 Dimensions (SF-6D) scores with mFES scores to
establish their construct validity. We also assessed their predictive validity by comparing scores with the
number of further events and the time to the first subsequent event.
Missing data
We adopt a consistent approach to missing data relating to both clinical effectiveness and cost-effectiveness,
except when individual outcome measures require some variation in that approach. For each variable, we
consider the frequency of missing data; if there is no reason to suspect that data are not missing completely
at random, we use appropriate imputation methods to mitigate the problem of missing data. Specifically, in
addition to taking the SF-6D score as 0 when a participant is dead at the data collection point, we imputed
missing values by regression (thus adjusting for other covariates) from all available values of that score at
other data points.
Adverse events
As the study population had high mortality and morbidity, we did not routinely record or report AEs that
were neither serious nor adverse reactions (ARs) in the sense of possibly being caused by the new clinical
protocol for referring to falls services. The main potential AR is misdiagnosis, which could lead to an
inappropriate pathway of care. As misdiagnosis is reliably identifiable only through patient complaints or
coroner’s inquest, we focus on these, and treat them as serious ARs. Any patient complaint or coroner’s
inquest at which the ambulance service was asked to supply information related to non-conveyance of
a trial participant from the index incident triggered was investigated by the local principal investigator and
chief investigator. We also investigated suspected ARs brought to our attention in any other way.
Death or emergency hospital admissions are serious adverse events (SAEs). As these form the primary
outcome of this trial, and are not unusual or unexpected in the study population, we report them at the
end of the trial. In particular, the imbalance between intervention and control groups in the occurrence of
SAEs or serious ARs was the subject of statistical analysis at the end of the trial.
Economic evaluation
Aim
We undertook an economic evaluation alongside the RCT from the perspective of the UK NHS and PSS, in
line with the approach recommended by NICE. Economic analysis estimated the costs of providing the
intervention and the consequences of the scheme for the NHS and PSS in terms of inpatient admissions,
ED attendances, GP consultations, out-of-hours GP contacts, NHS Direct contacts and use of social services.
Method
We estimated the costs of providing the new intervention by utilising data collected from financial reports
and documents, relevant information logged as a part of routine practice and from resource utilisation
recording sheets, together with reference to patient records and discussions with relevant finance staff.
We collected data on participants’ use of health service and social services resources from paramedic
records, routine hospital records and patient-completed questionnaires. We estimated NHS resource use
from routine data including duration of ambulance job cycles and episodes of care; records of resource
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use; and patient records. We also estimated social services resource costs from discussion with relevant
social services departments. Costs were then calculated using published unit costs such as the Personal
Social Services Research Unit (PSSRU) Unit Costs of Health and Social Care 2013123 and NHS Reference
Costs 2011–12.109
Health-related quality-of-life outcome
The SF-6D scores (derived from SF-12 scores) were used to estimate the QALYs gained from the
intervention and an incremental cost per QALY, applying appropriate threshold incremental
cost-effectiveness ratios, such as the £20,000.00 and £30,000.00 per QALY thresholds used by NICE.
These ratios were presented along with their associated cost-effectiveness acceptability curve.
Lost to follow-up/missing data
If a participant was dead at the data collection point, the SF-6D score was taken as 0. To avoid outliers,
SF-6D and mFES scores were taken to be the minimum value observed for that measure in the relevant
treatment group. The problem of missing data was addressed using an appropriate regression-based
imputation approach, as reported earlier.
Discounting
As the outcomes were assessed at 1 month and 6 months, no discounting was employed.
Uncertainty
We addressed uncertainty by applying bootstrapping for cost-effectiveness acceptability curves and CIs.
Sensitivity analyses were undertaken to assess the robustness of results to changes in the configuration of
the intervention and other health service costs.
Qualitative methods
Aim
The qualitative component of the trial was designed to address the following two of the study objectives:
1. Gain an in-depth understanding of how the intervention is experienced by patients.
2. Understand how the intervention is delivered in practice, identifying factors which enable or hinder
its use.
Participants
Patients
We undertook qualitative interviews with a sample of trial patients who had experienced a fall, were seen
by an intervention paramedic and agreed to the interview. Patients were selected from all three study sites,
with a target number of 20 from each site. A mix of patients was identified for interview: those who had
been taken to ED; those who had been referred to a falls service; and those who were neither taken to
the ED nor referred to a falls service.
All eligible patients who had been referred to a falls service were selected for interview. The other two
patient groups (taken to ED and left at home without referral) were much larger; sampling was therefore
carried out so that only every 10th sequential patient was selected for interview. The selected patients
were then telephoned to arrange an interview. Whenever possible, this occurred 6–8 weeks after the index
incident, although in practice some interviews took place up to 4 months after the index incident. A log
of the interviews undertaken and the characteristics of the patient’s index incident (i.e. location, disposal,
patient sex and patient age) was kept in order to ensure that all patient groups were interviewed.
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Paramedics
We invited all intervention paramedics who volunteered to take part in the study to discuss their
expectations and experiences of the intervention. Whenever possible, paramedics were invited to take part
in a focus group,110 bringing together between four and eight of their peer group in a local venue within
their ambulance service area. When paramedics were not available to take part in a focus group, we
invited them to take part in a face-to-face interview.
We carried out interviews with paramedics before they started to carry out the intervention (pre trial but
after having received the training) and after the patient recruitment phase (post trial).
Other stakeholders
In each study site, data were gathered after the end of the trial period from other relevant staff involved in
delivering the intervention: training staff and management staff from the ambulance service, and those
involved in managing and delivering the falls service. Participants were selected purposively and were
invited to take part in focus groups; those who were not able to attend a focus group were invited to take
part in an interview instead.
In each of site 2 and 3, one focus group was held of staff involved in delivering the falls service, and one
of staff in the ambulance service with a training or supervisory role. In addition to this, in site 3 two
one-to-one interviews were conducted with stakeholders who were not able to attend a focus group.
In site 1, stakeholders took part in four one-to-one interviews, but no focus group.
Data collection
We interviewed patients and paramedics only in the intervention arm (not in the control group) because
we were interested in how the intervention was used and experienced in practice, and the mechanisms by
which it may or may not have worked.
Patient interviews
A schedule (see Appendix 12) for face-to-face, semistructured patient interviews was developed by the
research team, drawing on the aims and objectives of the study, in order to explore:
l patients’ experience of the ambulance service
l patients’ experience of those seen by a falls service
l patients’ health since fall
l patients’ satisfaction with treatment.
Face-to-face semistructured interviews were conducted by experienced researchers from the study team
(RA, RC, MK, LW). In some cases, a carer or other person who had been present at time of fall also took
part in the interview or was present to support the participant. Interviews took place in patients’ own
homes, and were recorded and later transcribed in full.
Paramedic focus groups and interviews
Data collection with paramedics took place at two points in the study:
1. at baseline, after paramedics had been trained in the SAFER 2 trial intervention but before they started
using it in practice (see Appendix 13)
2. after the end of the patient recruitment period (see Appendix 14).
Separate topic guides were developed by the research team for each phase of data collection, drawing on
the aims and objectives of the study. The topic guides were reviewed by members of the LITs, which
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included ambulance service personnel at different clinical, operational and management levels. The focus
group topic guides were adapted for use in one-to-one interviews. The topic guide covered:
l paramedics’ views and attitudes towards the new intervention
l any preconceptions about the new way of working
l factors which enabled the use of the new referral pathway
l factors which hindered the use of the new referral pathway.
Each focus group was led by one researcher, with a second member of the team acting as support and
taking notes to enable the linkage of texts to speakers, and noting other details, such as points of
consensus or disagreement, issues that drew strong emotional responses such as anger, fear or anxiety.
All focus groups and interviews, with the permission of participants, were recorded and transcribed in full.
Stakeholder focus groups and interviews
Topic guides (see Appendix 15) were developed by the research team for use with ambulance service
personnel and wider stakeholders, and covered:
l perception of how well the intervention worked
l impact on the stakeholder’s organisation
l cross-organisational working
l views on the process of implementing the intervention.
Stakeholder focus groups took place before the main results of the trial were known. Each was led by one
researcher, with a second member of the team acting as support and taking notes to enable the linkage of
texts to speakers, and noting other details, such as points of consensus or disagreement, issues that drew
strong emotional responses such as anger, fear or anxiety. Each interview was carried out face to face, and
was conducted by one member of the research team. All focus groups and interviews, with the permission
of participants, were recorded and transcribed in full.
Qualitative data management
As this was a team-based project involving collection of data in multiple sites, maintaining consistency in
data collection and transcription was crucial. The co-ordinator set up a data management system
consisting of instructions on converting raw data to computer files (in the form of a transcription protocol),
on organising data storage and on data archiving steps and a data management checklist. The
transcription protocol ensured that standard conventions were adopted throughout the transcription
process, and that a standard presentation format was used. All transcripts were anonymised and stored
securely. Transcripts of interviews with stakeholders were sent back to the participant for checking, to
ensure that they were accurate.
Qualitative data analysis
The data were analysed thematically using a modified version of the framework analysis approach for
applied policy research.111 This is a systematic, dynamic and transparent method of analysis, which
generates themes from the original accounts of participants.112
Two separate analysis tasks were carried out: data from patient interviews were analysed to address
objective 3; and data from focus groups and interviews with paramedics and stakeholders were analysed
to address objective 4. Each task consisted of the following stages:
l The transcripts were distributed for reading among members of the research team (RA, RC, SG, MK,
AP, LW and AT, the patient representative) so that each had at least five to read, with each transcript
being read by two people.
l Each member of the research team made notes on themes and ideas, guided by the relevant
study objective.
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l The research team met to discuss and agree a coding frame.
l Two researchers independently coded up two transcripts each using the coding frame, discussed how
well it worked, and then revised the coding frame. The final coding frames are shown in Appendix 16.
l RA, RC, MK and AP used the revised coding frame on one transcript, then compared coding to
check consistency.
l Transcripts were then shared among RA, RC, MK and AP for coding. RA then entered all codes into an
NVivo database (QSR International, Warrington, UK) (one database relating to objective 3 and one
relating to objective 4).
l RC, MK and AP met to discuss overall themes and findings relating to each objective, drawing on the
NVivo database and the coding frame.
The qualitative findings in Chapter 6 present anonymised quotations from participants. In line with the
guidance from Corden and Sainsbury,113 quotations have been used to present evidence, to support
explanation of complex ideas, to provide illustration, and to deepen understanding, particularly when
respondents had an emotional response. Although many quotations were selected to illustrate the majority
view, some show exceptional viewpoints, as noted. In some cases, quotations were selected to illustrate
complexity or ambiguity of perspective, as noted.
Involvement of service users
Involving service users in research is encouraged to improve relevance, quality and accountability of
research.114–117 The SAFER 2 trial followed the principles and procedures outlined in the WWORTH SOP for
user inclusion118 to ensure that members of the public were actively involved throughout the research
process. This SOP provided a starting point for developing a model of user involvement in the SAFER
2 trial. Moreover, the SAFER 2 trial aimed to address the challenges of involving older people, who are
often in poor health because of their falls history or falls risk. The model took into account the multiple
layers of a multisite trial and proposed three tiers of involvement in different forums at the strategic, site
and local levels where overall or specific input could be made. We followed best practice guidance by
involving two service users in each of the strategic trial committees.114,119,120 We also involved service users
at site (n = 3) and local levels (n = 18) of the trial to provide a range of forums and opportunities for
involvement by older people with risk of falling. Our involvement model received the Involving People
Award in 2014 as an example of best practice.
Strategic level
Two service user members were sought for each of the TMG, TSC and DMEC. These strategic level
meetings involved trial co-applicants and independent members. They were responsible for trial oversight
and took strategic level decisions.
Site level
Local implementation team meetings took place at each site to oversee the delivery of the trial, and service
users were sought to participate in these. In addition, in each of the three sites a Service User Reference
Group was formed to provide forums for service users to discuss and contribute to the study. They were
co-ordinated by the site researchers and held meetings at universities and community venues. Membership,
meeting arrangements and frequency varied, reflecting local interest and individual needs.
Local level
Service user representatives took part in task-and-finish groups to develop the patient questionnaire and
associated paperwork and to find ways to improve questionnaire response rates. Finally, towards the end
of the study period, service users took part in qualitative analysis meetings.
Service users were recruited by various routes:
l previous experience of participating in research studies or membership of a standing user involvement
group connected to a university
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l membership of a third-sector organisation bringing together members of the target population
(e.g. the Princess Royal Trust for Carers)
l Involving People Network providing links to service users
l personal contact from the research team.
All service users contributing to the trial were provided with training and support (including expenses
payments) in line with guidelines set by the public involvement organisation INVOLVE.114
Through the methods adopted by the trial, service users were involved in a range of trial processes,
including developing and planning research; overseeing the management of the trial; refining data
collection methods; and contributing to analysis, particularly of the qualitative data. Appendix 17 is a case
study from one of our service users about his involvement in the SAFER 2 trial.
Support and Assessment for Fall Emergency Referrals 2
trial progress
This section details the ‘story’ of the study, charting progress from the awarding of funding to the
completion of the project, highlighting the main events leading to the successful completion of the study
and events that led to unforeseen setbacks to the project timetable.
The SAFER 2 study received confirmation of funding from the HTA programme in January 2009. The trial
ethics application was submitted to the Multicentre Research Ethics Committee for Wales in April 2009.
This highlighted the proposed consent process (the same used in the SAFER 1 trial), in which patients were
invited to ‘opt out’ if they did not wish to take part in the study. The committee approved this process
subject to permission from the then National Information Governance Board Ethics and Confidentiality
Committee (now the HRA CAG), as it would involve accessing patient information without their explicit
written consent. The Ethics and Confidentiality Committee did not give approval on the basis an active
opt-in consent process should be used. This decision had implications for the trial as it required potential
participants to return signed consent forms, which would be likely to lead to a low inclusion rate with the
more elderly, frail and vulnerable patients under-represented. After consultation with our research team
members, we proposed an alternative process for recruitment, combining both informed consent (gained
either postally or via telephone) and anonymous follow-up, initially via the SAIL system in Wales. Ethical
approval was gained in February 2010, 11 months behind schedule. In 2012, a further application to the
HRA CAG for anonymised follow-up of patients from England who had not declined consent (dissented)
through the HSCIC was approved.
Alongside this, the study team needed to confirm the participation of ambulance and falls services;
negotiation was required with service providers to agree arrangements for participation.
l In site 1, two of the six falls prevention services declined to participate in the trial because of concerns
with capacity.
l In site 2, one of the two health boards implemented a ‘Frailty Programme’ during the same time period
the trial was scheduled to run. Under the Frailty Programme, all older people who fell and called the
emergency services were referred on to be seen at home immediately. This compromised the trial
methods, as there would be no control group. Negotiations were ongoing for several months as to the
best way to run the two programmes alongside each other, but the health board eventually decided to
not participate in the study because of this conflict with local service developments.
l Owing to delays setting up the study, the commencement of the SAFER 2 trial coincided with the
ambulance service that contained site 3 introducing a financial reimbursement for referrals to GPs of
people who had fallen. This was incompatible with the RCT design because of the elimination of the
control group, which would lead to significant issues at this site. Following the chief investigator’s
attendance at a senior-level strategic meeting, site 3 reaffirmed its commitment to full participation in the
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trial, with the GP referral programme introduced across the service except in the trial catchment area.
Research and development (R&D) permissions were signed off, with a collaborator’s agreement in place.
Owing to risks around the participation of site 3 and falls services in the site 1 and site 2, in August 2010
we held discussions with a fourth ambulance service that expressed an interest in joining the trial. After a
period of negotiation and consideration across local partner services, it decided that it could not participate
in the trial at this time.
By early 2010, participating services were confirmed. In total, the study involved three ambulance services,
with 26 NHS partners based within five comprehensive local research networks (CLRNs) and NHS trusts.
Research governance processes commenced across the three trial sites, later than scheduled, in March
2010. Although English ambulance services, which each span several CLRNs, had a lead CLRN identified,
at the time it was not clear how this process (i.e. research processes, cost attribution and support to carry
out studies) worked for the participating acute trusts and primary care trusts (PCTs) in the trial areas. On
advice from these organisations, principal investigators were identified and approached for sign-up at
the 26 NHS organisations. Site-specific information forms were prepared, but these could neither be
completed nor a formal sign-up of NHS organisations be achieved without agreement of the attribution of
costs across the trial. Although NHS costs had been estimated at the outset of the planning process, these
were affected by changes to the study design (in particular the recruitment and data retrieval processes)
and lack of clarity about cost attribution. Discrepancies between CLRN and NHS research site views on cost
attribution led to the set-up of a meeting with the Department of Health in May 2010, in which the
attribution of costs was finally agreed.
Alongside the processing of research governance approvals, the study team were developing the SAFER 2
trial intervention. Undertaken using the Medical Research Council guidance,64 the intervention was
established through the use of previous literature, a stakeholder workshop, modelling and patient
involvement (see Appendix 8).
It was very difficult to predict how long it would take to complete R&D processes at global and local levels
across the research sites. R&D approvals for all three sites (with the exception of some acute trusts in site 3,
where full R&D approvals were not gained until March 2012) were finally gained in October 2010, allowing
the trial to commence.
The delays outlined above had a knock-on effect on the overall timescale of the project. In mid-2010, we
revised the project timetable, proposing that the full pilot with recruitment of patients for the study started
in January 2011 followed by the main trial in February. Owing to the study team receiving additional data
regarding the number of older fallers seen by paramedics, we reassessed the expected recruitment rate in
order to meet recruitment targets, resulting in a proposed extension to the recruitment phase of 2 months
(until the end of October 2011 instead of the end of August 2011).
As the trial gained momentum, we looked to recruit two new research support officers, funded through
service support costs (CLRN/National Institute for Social Care and Health Research) to undertake
administrative tasks associated with patient recruitment. These ambulance service-based roles (which were
undertaken by paramedics in site 2 and site 3 and an administrative assistant within site 1) were key to
paramedic recruitment, as our researchers had restricted access to ambulance stations and identifiable
data. Full funding agreements had to be in place before the ambulance services would proceed with
recruitment to these posts, which led to delays in advertising and filling them. Further delays occurred in
site 3 because of issues releasing paramedic staff to undertake these roles. Inevitably, this had a knock-on
effect on the paramedic recruitment schedule.
Paramedic recruitment to the trial commenced in November 2010 at the three trial sites. Recruitment of
paramedics was initially slow; some showed unwillingness to be involved in the trial when there was a
50% chance of being randomly allocated to the control group. In December 2010, we received approval
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from the ethics committee to provide a £50.00 voucher to paramedics for taking part (in London the
money was pooled into a station training budget); this allowed paramedic recruitment to increase.
Paramedic training was undertaken once stations (clusters) were randomly allocated to either control or
intervention arms of the trial. Paramedics based at intervention stations underwent training delivered by
ambulance service trainers, falls service representatives and the study team, using a cascade method
originating with the training team who developed the clinical protocol. In early 2011, following the
successful completion of paramedic training, patient recruitment commenced. Site 1 was first to start in
March 2011, with sites 2 and 3 following in April and July, respectively.
Identification of eligible patients required a high level of resources. In two of the trial sites (1 and 2), PRFs
containing patient details needed to confirm eligibility into the trial were particularly difficult to locate.
These forms were completed by paramedics on-scene and were stored at ambulance stations before being
centrally collated. Considerable effort was put into locating the forms, which were often difficult to locate
because of the issues with data reliability. Ambulance service senior managers were aware of the issue and
were helpful in terms of supporting the location and retrieval of the outstanding forms.
The study team wrote to patients to gain informed consent once study eligibility had been confirmed.
Informed consent is particularly challenging in prehospital care research and in the SAFER 2 trial this was even
more so as the participants were frail and elderly. Initially, patient consent rates were low, at around 10%.
In August 2011, following a review of the consent procedures, the study team proposed an alteration to
the consent process, including simplification of the consent form, sending of the questionnaire with the initial
patient letter and inclusion of a £5.00 voucher to thank patients for their time spent considering the study.
A substantial amendment was submitted to and approved by the Multicentre Research Ethics Committee,
allowing the process to be altered. The consent rate to identifiable data follow-up increased to 30%. In early
2012, a front cover was added to the existing questionnaire to improve response rates.
In October 2011, the trial was temporarily suspended at site 1, because of internal governance concerns
regarding the processes of verbal consent of patients over the telephone. As a consequence, we revised
the way in which verbal consent was recorded across the trial. From the start of the patient recruitment
phase, it was clear that fewer eligible patients were being attended by study paramedics within sites 2 and
3 than estimated from the pilot data received at the start of the study: this was mainly because of
paramedics working outside the study catchment area. This, coupled with the previously mentioned issues
around ethical approvals, information governance and R&D permissions, meant the study fell behind its
recruitment schedule. Originally, patient recruitment was scheduled to finish in December 2011. In early
2012, the HTA funded an extension to the study, allowing patient recruitment to carry on until the end of
June 2012.
Summary of changes to the project protocol
The following changes were made to the original protocol after it was funded:
l The process for recruiting patients to the trial was amended following ethical approval from an opt-out
process to an active opt-in consent process including follow-up telephone call.
l Participating ambulance stations at the London site were changed from South to North Central London
stations, following set-up of a falls service in the original proposed study area.
l The paramedic recruitment process was amended to include a £50.00 voucher for those who volunteered.
l The number of paramedics recruited at each site was updated to reflect actual numbers recruited,
which were greater than originally stated.
l The European Quality of Health-5 Dimensions (EQ-5D) was not used. In order to be consistent with
outcome measures used on the SAFER 1 trial, we instead used the derived SF-6D.
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l Patient recruitment was further amended after the trial commenced to include a simpler process and
the addition of a £5.00 voucher with the invitation pack. This was in order to improve response rates.
l An anonymised data follow-up process for the two English sites was added.
l We originally planned to compare test–retest reliability and responsiveness of the instruments, by
sending a retest questionnaire to 100 randomly selected patients from each site. We did not proceed
with this because of the evident difficulties our frail and elderly patients were experiencing completing
essential study documentation.
l Administration of the Patient Generated Index was also originally included as part of the qualitative
patient interviews. Owing to time and resource pressures this was not carried out.
l The study received two extensions. The first extended the study by 15 months, from 30 June 2012 to
30 September 2013. Owing to difficulties in gaining ethical permission at the commencement of the
study, there had been a delay to the start, which had a knock-on effect to the rest of the trial.
Recruitment was also slower than expected, and the extension allowed for us to reach our projected
recruitment target. The second (unfunded) extension was for a further 4 months, to 31 January 2014.
This was to allow time for full analysis of the data, following difficulties in retrieving anonymised
outcome data.
Ethics and research governance
Ethical approval was obtained from the Research Ethics Committee for Wales, Information Governance
approval from the National Information Governance Board, and NHS R&D approval from each participating
health board, NHS trust and PCT.
Trial registration
The trial is registered as Current Controlled Trials ISRCTN60481756 and UKCRN 6801. The trial protocol
has been published.71
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Chapter 4 Clinical effectiveness results
Participant flow
Between March 2011 and June 2012 a total of 5914 eligible patients were attended by 215 paramedics
based at 25 ambulance stations across the three study sites [Consolidated Standards of Reporting Trials
(CONSORT) flow chart in Figure 2; site CONSORT flow charts in Appendix 18]. Six of 31 eligible stations
withdrew after randomisation but before the start of patient recruitment because of a conflicting ‘Frailty
Programme’ intervention being introduced throughout one participating health board area at site 2.
Participating paramedics based at 14 stations were randomly allocated to the intervention group and those
based at the remaining 11 stations were randomly allocated to the control group. After 1210 (20%)
dissenting patients were excluded, 4704 (80%) were available for follow-up: 2420 in the intervention
group and 2284 in the control group. As all but 49 patients were subsequently matched at SAIL or HSCIC,
we included 4655 patients in analysis of anonymised linked data primary outcome.
Recruitment
Patients were recruited to the trial between 14 March 2011 and 30 June 2012. Start dates varied between
March and July, as sites were ready to begin recruiting patients. All sites finished recruitment at the same
time point (Table 12).
We followed up patients for 6 months after the index incident.
Baseline characteristics
Individual patient level
Although we expected recruitment of patients to be similar across ambulance service sites, and similar
numbers of ambulance stations participated in the trial at each site, recruitment of patients was much
higher at site 1 as a result of several factors including:
l longer recruitment period at site 1
l operational practice which took paramedics out of the trial catchment area, particularly in site 3
l loss of six stations and related paramedics at site 2.
There was also variation in recruitment between trial arms across sites, with a higher proportion of control
group patients recruited at site 1 than at either site 2 or 3. There was very little difference between groups
in age, overall or at any site. There were more women than men recruited to the trial, although the
proportion of men was slightly higher in the intervention group than the control group, with about 3%
more at each site and overall. There was little difference between trial arms in the proportion of calls made
outside usual GP operating hours was similar between trial arms, distance to ED or time to recruitment
(Table 13). There were some differences between sites, for example site 3 had a lower proportion of
female patients, a lower proportion of calls made ‘out of hours’ and shorter distances to ED. This was our
most urban site, which may have accounted for these differences in study population.
Cluster level
We randomly allocated one more station to the intervention group than the control group at each site.
However, we recruited fewer paramedics recruited per station in the intervention arm than in the control
arm at each site.
DOI: 10.3310/hta21130 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 13
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Snooks et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
41
Number of eligible stations
(N = 31)
En
ro
lm
en
t
A
llo
ca
ti
o
n
Fo
llo
w
-u
p
A
n
al
ys
is
Intervention
Paramedics
(N = 249)
Stations
(N = 17)
Stations delivering intervention
(N = 14)
• Stations withdrawn after randomisation, n = 3
• Paramedics withdrawn after
   randomisation, n = 33
• Paramedics who did not volunteer, n = 111
Paramedics delivering intervention
(N = 105)
• Did not meet eligibility criteria, n = 2497
• Unable to confirm eligibility, n = 300
• Dead on scene, n = 2
• Dissented, n = 653
Patients screened as potentially eligible 
attended by intervention paramedics
(N = 5872)
Number of stations, n = 14; average per station,
7.5; range per station = 1–19
Eligible patients attended by 
intervention paramedics
(N = 3073)
Number of stations, n = 14; average per 
station, 219.43
Stations available for follow-up
(N = 14)
Paramedics available for follow-up
(N = 105)
Number of stations, n = 14; average per station, 
7.5; range per station = 1–19
Patients available for follow-up
(N = 2420)
Number of stations, n = 14; average per 
station, 172.86; range per station = 14–447
• Patients not matched at HSCIC/SAIL, n = 29
Station clusters analysed
(N = 14)
Paramedics analysed
(N = 105)
Number of stations, n = 14; average per station,
7.5; range per station = 1–19; coefficient of 
variation = 69.1%
Patients analysed at 1 and 6 months
(N = 2391)
Number of stations, n = 14; average per station, 
168; range per station = 14–428; coefficient 
of variation = 78.9%
• Patients not eligible for Falls Service 
   referral, n = 230
Patients eligible for Falls Service referral
(N = 2161)
Number of stations, n = 14; average per station,
151.6; range per station = 14–378; coefficient 
of variation = 73.5%
Control
Paramedics
(N = 202)
Stations
(N = 14)
Stations delivering control
(N = 11)
• Stations withdrawn after randomisation, n = 3
• Paramedics withdrawn after 
   randomisation, n = 16
• Paramedics who did not volunteer, n = 76
Paramedics delivering control
(N = 110)
• Did not meet eligibility criteria, n = 1914
• Unable to confirm eligibility, n = 275
• Dead on scene, n = 3
• Dissented, n = 557
Patients screened as potentially eligible 
attended by control paramedics
(N = 5033)
Number of stations, n = 11; average per station,
10; range per station = 4–28
Eligible patients attended by 
control paramedics
(N = 2841)
Number of stations, n = 11; average per 
station, 258.27
Stations available for follow-up
(N = 11)
Paramedics follow-up
(N = 110)
Number of stations, n = 11; average per station, 
10; range per station = 4–28
Patients available for follow-up
(N = 2284)
Number of stations, n = 11; average per station,
207.64; range per station = 14–518
• Patients not matched at HSCIC/SAIL, n = 20
Station clusters analysed
(N = 11)
Paramedics analysed
(N = 110)
Number of stations, n = 11; average per station, 
10; range per station = 4–28; coefficient of 
variation = 67.1%
Patients analysed at 1 and 6 months
(N = 2264)
Number of stations, n = 11; average per station, 
202; range per station = 12–457; coefficient 
of variation = 80.6%
• Patients not eligible for Falls Service 
   referral, n = 282
Patients eligible for Falls Service referral
(N = 1982)
Number of stations, n = 11; average per station, 
176.6; range per station = 12–383; coefficient 
of variation = 69.0%
Stations randomly allocated
(N = 31)
Paramedics available at 
randomly allocated stations
(N = 451)
• Stations which did not take part, n = 0
FIGURE 2 Flow of clusters and individuals through RCT for all participants. Adapted from Snooks et al.121
with permission from the American College of Emergency Physicians. Copyright © 2017 American College of
Emergency Physicians. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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TABLE 12 Periods of recruitment
Site
Recruitment period
Start End Length in days
Site 1 14 March 2011 30 June 2012 475
Site 2 4 April 2011 30 June 2012 454
Site 3 6 July 2011 30 June 2012 361
TABLE 13 Baseline individual and cluster characteristics by treatment allocated
Variables
Group
Intervention Control
Individual variables
Number of participants
All sites 2420 2284
Site 1 1329 1352
Site 2 544 436
Site 3 547 496
Age (years), mean (SD) [n]
All sites 82.54 (7.97) [2414] 82.14 (8.11) [2275]
Site 1 82.99 (7.81) [1329] 82.57 (7.91) [1352]
Site 2 82.79 (7.97) [538] 81.79 (8.60) [427]
Site 3 81.20 (8.21) [547] 81.28 (8.16) [496]
Female, proportion (%)
All sites 1480/2419 (61.2) 1477/2284 (64.7)
Site 1 816/1329 (61.4) 882/1352 (65.2)
Site 2 351/543 (64.6) 292/436 (67.0)
Site 3 313/547 (57.2) 303/496 (61.1)
Emergency service index call out of hours, proportion (%)
All sites 1012/2419 (41.8) 954/2282 (41.8)
Site 1 624/1328 (47.0) 626/1352 (46.3)
Site 2 221/544 (40.5) 174/436 (39.9)
Site 3 167/547 (30.5) 154/494 (31.2)
Distance to ED (miles), mean (SD) [n]
All sites 4.77 (3.43) [2406] 4.65 (3.08) [2270]
Site 1 5.03 (3.09) [1329] 5.04 (2.61) [1352]
Site 2 7.33 (3.38) [542] 6.75 (3.65) [434]
Site 3 1.55 (0.74) [535] 1.71 (0.72) [484]
continued
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Numbers analysed
Table 14 shows questionnaire response rates for all 4704 eligible patients who did not dissent and for
whom we sought to retrieve linked data outcomes. However, SAIL and HSCIC could not match the
demographic data for 29 intervention patients (18 in site 1, 4 in site 2 and 7 in site 3) and 20 control
patients (15 in site 1, 3 in site 2 and 2 in site 3). Therefore, we could not retrieve data on ED attendances,
hospital admissions or death for these 49 patients.
Accounting for people who did not consent to questionnaires and those who died within 1 month, the
overall response rate was 36.5%. Although there was little difference between intervention and control
groups, response rates ranged from 30.0% at site 3 to 49.5% at site 2.
At 6 months the overall response rate was 58.7% (60.1% in the intervention group and 57.2% in the
control group). Again there was variation in response rate between sites from 54.1% at site 1 to 67.4% at
site 3. Furthermore, in site 3, 73.8% of the intervention group returned a 6-month questionnaire
compared with 60.3% of the control group.
Outcomes and estimation
We did not find any significant differences between groups in our composite primary outcome at 1 month
or 6 months. One-third of patients had suffered a further emergency episode or death by 1 month, rising
to over two-thirds by 6 months. When primary outcome components were analysed separately we found
TABLE 13 Baseline individual and cluster characteristics by treatment allocated (continued )
Variables
Group
Intervention Control
Recruitment point (days), mean (SD) [n]
All sites 221.8 (129.0) [2420] 220.8 (129.2) [2284]
Site 1 239.4 (136.4) [1329] 238.1 (132.9) [1352]
Site 2 217.4 (128.8) [544] 227.0 (128.7) [436]
Site 3 183.4 (98.6) [547] 168.3 (102.9) [496]
Cluster variables
Number of stations (number of paramedics)
All sites 14 (105) 11 (110)
Site 1 5 (39) 4 (38)
Site 2 5 (26) 4 (26)
Site 3 4 (40) 3 (46)
Recruited paramedics per station, mean (SD)
All sites 7.5 (5.185) 10 (6.708)
Site 1 7.8 (4.97) 9.5 (4.203)
Site 2 5.2 (3.033) 6.5 (2.082)
Site 3 10 (7.348) 15.33 (11.15)
Reprinted from Snooks et al.121 with permission from the American College of Emergency Physicians. Copyright © 2017
American College of Emergency Physicians. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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evidence of significantly lower demand in the intervention group. Tables 15 and 16 show fewer further
emergency service calls at both 1 and 6 months, with differences largely consistent across sites, and some
indication of fewer ED attendances at 6 months, albeit with significant variations across the three sites
(Tables 17 and 18).
Table 19 shows that rate of conveyance to ED at the index incident was similar between groups overall
and at each site, although the proportion conveyed varied considerably by site, from < 60% at site 1 to
nearly 80% at site 2. Eight per cent of trial eligible patients were referred to falls services by their
attending paramedic in the intervention arm, varying from 7.5% at site 1 to 9.7% at site 3. Very few
patients were referred to falls services in the control group; the rate was 1% overall, but higher at site 3,
where there was a service-wide initiative to increase referrals of this patient group. More patients were left
at scene without referral for further care in the control group than in the intervention group, 30% versus
23% overall; a proportion which varied widely by site and was highest in the control group at site 1
(37%). Completion of clinical documentation was high across groups and sites with no clear difference
between trial arms. We also found no differences in the operational indicators of duration of episode of
care (time from emergency service call until patient’s emergency episode was complete) or job cycle
(time from emergency service call until ambulance free).
No differences were found in the secondary outcomes of duration of inpatient stay, or self-reported quality
of life or fall-related self-efficacy (fear of falling) at 1 month or 6 months (Tables 20 and 21). There was
evidence of differences between groups in the proportion reporting further falls at 1 and 6 months: lower in
the intervention group at 1 month, but higher at 6 months amid significant variations across sites. There were
also significant differences between groups in the interpersonal aspect of patient satisfaction at 1 month
TABLE 14 Questionnaire response rates by treatment allocated
Variable
Group
Total
Intervention Control
Site 1 Site 2 Site 3 Total Site 1 Site 2 Site 3 Total
Total number of eligible participants 1329 544 547 2420 1352 436 496 2284 4704
No consent to 1-month questionnaire
(before new consent process), n
330 117 n/a 447 301 93 n/a 394 841
Died within 1 month, n 86 31 30 147 79 26 32 137 284
Participants sent 1-month
questionnaire, n
913 396 517 1826 972 317 464 1753 3579
Valid 1-month questionnaires
returned, n
322 191 155 668 337 162 140 639 1307
1-month questionnaire response
rate, %
35.3 48.2 30.0 36.6 34.7 51.1 30.2 36.5 36.5
No consent to 6-month
questionnaire, n
759 299 313 1371 743 261 295 1299 2670
Died within 6 months, n 249 116 93 458 270 75 75 420 878
Participants sent 6-month
questionnaire, n
321 129 141 591 339 100 126 565 1156
Valid 6-month questionnaires
returned, n
172 79 104 355 185 62 76 323 678
6-month questionnaire response
rate, %
53.6 61.2 73.8 60.1 54.6 62.0 60.3 57.2 58.7
n/a, not applicable.
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TABLE 15 Primary outcome and components at 1 month analysed by treatment allocated
Primary outcome
Raw data Adjusted comparisona,b ICC
Intervention Control
Estimate,
p-value 95% CI Estimate 95% CI
Overall composite outcome
Proportion of patients with
further emergency service call,
ED attendance, emergency
admission or death,c n/N (%)
870/2391
(36.4)
843/2264
(37.2)
OR = 0.956;
p= 0.461
0.848 to
1.077
0.0009 0 to 0.0048
Primary outcome components
Proportion of patients dying
(any cause),d n/N (%)
147/2391
(6.1)
136/2264
(6.0)
OR = 0.994;
p= 0.960
0.780 to
1.266
0 n/a
Proportion with further
emergency admission,e n/N (%)
517/2391
(21.6)
475/2264
(21.0)
OR = 1.039;
p= 0.595
0.903 to
1.196
0.0019 0.0002 to
0.0060
Proportion of patients with
further ED attendance,f n/N (%)
463/2391
(19.4)
418/2264
(18.5)
OR = 1.067;
p= 0.392
0.920 to
1.237
0.0070 0.0021 to
0.0151
Further ED attendances per
patient,g mean (SD) [n]
0.2631
(0.6162)
[2197]
0.2609
(0.7954)
[2093]
Λ= 1.104
(p= 0.219)
0.943 to
1.293
0.0058 0.0017 to
0.0128
Further ED attendances/patient/
day at risk,h mean (SD) [n]
0.0236
(0.1018)
[2197]
0.0223
(0.0833)
[2093]
Δ= 0.0011;
p= 0.710
–0.0045 to
0.0066
0.0068 0.0020 to
0.0150
ΔL = 0.0436;
p= 0.413
–0.0609 to
0.1481
0.0100 0.0035 to
0.0204
Proportion of patients with
further emergency service call,i
n/N (%)
442/2391
(18.5)
493/2264
(21.8)
OR = 0.815;
p= 0.006
0.705 to
0.943
0.0056 0.0018 to
0.0119
Further emergency service calls
per patient,j mean (SD) [n]
0.2981
(0.7758)
[2197]
0.3378
(0.7823)
[2093]
Λ= 0.883;
p= 0.049
0.780 to
1.000
0.0038 0.0011 to
0.0086
Further emergency service calls/
patient/day at risk,k mean (SD) [n]
0.0204
(0.0641)
[2197]
0.0245
(0.0814)
[2093]
Δ= –0.0040;
p= 0.071
–0.0083 to
0.0003
0.0043 0.0011 to
0.0101
ΔL = –0.1354;
p= 0.013
–0.2418 to
–0.0290
0.0046 0.0013 to
0.0103
n/a, not applicable.
a As well as indicators for group, site, and their interaction, ‘core’ covariates considered are age (in years) and its square;
distance to ED (in miles); recruitment point (based on days since start of study); seasonality; indicators of gender; and
whether or not the index call was made out of (GP) hours.
b The comparison between groups reflects the variable under consideration; specifically, we report an OR from logistic
regression models for binary variables; a multiplicative event ratio (Λ) from negative binomial regression models for count
data; and an additive group effect [Δ, in the same units as the dependent variable; ΔL refers to log-transformed data,
using ln(y + 0.001) in place of y] from linear models for measurement variables. Statistically significant covariates are
listed in further footnotes.
c Gender (p< 0.001); seasonality (p = 0.002); out of hours (p= 0.008).
d Gender (p< 0.001); age (p < 0.001); seasonality (p= 0.038).
e Site 3 (p= 0.001); out of hours (p = 0.010).
f Site 1 (p= 0.003); site 3 (p< 0.001); age (p= 0.036); age2 (p= 0.020); seasonality (p= 0.002).
g Site 1 (p= 0.006); site 3 (p< 0.001); interaction between site 3 and group (p= 0.031); age (p< 0.001); age2 (p = 0.001);
seasonality (p= 0.004); days at risk (p< 0.001).
h For Δ: site 3 (p< 0.001); for ΔL: site 1 (p= 0.013), site 3 (p< 0.001); seasonality (p = 0.003).
i Site 1 (p< 0.001); site 3 (p = 0.002); age (p< 0.001); seasonality (p = 0.004); out of hours (p< 0.001); recruitment
point (p< 0.001).
j Site 1 (p< 0.001); age (p= 0.029); distance to ED (p = 0.001); recruitment point (p< 0.001); out of hours (p< 0.001);
days at risk (p< 0.001).
k For Δ: age (p< 0.001); distance to ED (p= 0.004); recruitment point (p= 0.012); out of hours (p= 0.025); for ΔL: site 1
(p= 0.001); site 3 (p= 0.009); age (p< 0.001); recruitment point (p< 0.001); out of hours (p< 0.001); seasonality (p= 0.008).
Adapted from Snooks et al.121 with permission from the American College of Emergency Physicians. Copyright © 2017
American College of Emergency Physicians. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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TABLE 16 Primary outcome and components at 6 months analysed by treatment allocated
Primary outcome
Raw data Adjusted comparisona,b ICC
Intervention Control
Estimate,
p-value 95% CI Estimate 95% CI
Overall composite outcome
Proportion of patients with
further emergency service call,
ED attendance, emergency
admission or death,c n/N (%)
1701/2391
(71.1)
1592/2264
(70.3)
OR = 1.018;
p= 0.789
0.895 to
1.157
0 n/a
Primary outcome components
Proportion of patients dying
(any cause),d n/N (%)
458/2391
(19.2)
419/2264
(18.5)
OR = 1.187;
p= 0.094
0.971 to
1.451
0 n/a
Proportion with further
emergency admission,e n/N (%)
1153/2391
(48.2)
1084/2264
(47.9)
OR = 1.001;
p= 0.984
0.891 to
1.125
0.0052 0.0016 to
0.0113
Proportion of patients with
further ED attendance,f n/N (%)
1079/2391
(45.1)
1021/2264
(45.1)
OR = 0.999;
p= 0.986
0.888 to
1.123
0.0191 0.0085 to
0.0342
Further ED attendances per
patient,g mean (SD) [n]
0.844 (1.392)
[2380]
0.913 (2.738)
[2257]
Λ= 0.810;
p< 0.001
0.722 to
0.909
0.0144 0.0062 to
0.0261
Further ED attendances/patient/
day at risk,h mean (SD) [n]
0.0169
(0.0907) [2380]
0.0144
(0.0686) [2257]
Δ= 0.0025;
p= 0.292
–0.0021 to
0.0071
0.0041 0.0011 to
0.0098
ΔL= –0.0163;
p= 0.711
–0.1024 to
0.0699
0.0264 0.0127 to
0.0451
Proportion of patients with
further emergency service call,i
n/N (%)
1046/2391
(43.7)
1046/2264
(46.2)
OR = 0.899;
p= 0.076
0.799 to
1.011
0.0030 0.0006 to
0.0079
Further emergency service calls
per patient,j mean (SD) [n]
1.136 (2.506)
[2380]
1.251 (2.672)
[2257]
Λ= 0.931;
p= 0.076
0.860 to
1.007
0.0040 0.0012 to
0.0090
Further emergency service calls/
patient/day at risk,k mean (SD) [n]
0.0125
(0.0363) [2380]
0.0172
(0.0599) [2257]
Δ= –0.0045;
p= 0.002
–0.0073 to
-0.0017
0.0029 0.0004 to
0.0069
ΔL= –0.1183;
p= 0.010
–0.2079
to –0.0286
0.0036 0.0009 to
0.0086
n/a, not applicable.
a As well as indicators for group, site, and their interaction, ‘core’ covariates considered are age (in years) and its square;
distance to ED (in miles); recruitment point (in days since start of study); Seasonality; indicators of gender; and whether
or not the index call was made during out of (GP) hours.
b The comparison between groups reflects the variable under consideration; specifically, we report an OR from logistic
regression models for binary variables; a multiplicative event ratio (Λ) from negative binomial regression models for count
data; and an additive group effect [Δ, in the same units as the dependent variable; ΔL refers to log-transformed data,
using ln(y+ 0.001) in place of y] from linear models for measurement variables. Statistically significant covariates are
listed in further footnotes.
c Age (p< 0.001); gender (p < 0.001); out of hours (p< 0.001); recruitment point (p= 0.001); seasonality (p= 0.022).
d Age (p< 0.001); gender (p < 0.001); out of hours (p= 0.001); site 3 (p= 0.003); interaction between site 1 and group
(p= 0.023); distance to ED (p= 0.037).
e Site 1 (p= 0.019); gender (p = 0.003); age (p= 0.015); recruitment point (p= 0.031); distance to ED (p< 0.001).
f Site 1 (p= 0.009); site 3 (p < 0.001); out of hours (p= 0.020); distance to ED (p= 0.003); age2 (p < 0.001);
seasonality (p= 0.019).
g Site 3 (p< 0.001); interaction between site 1 and group (p< 0.001); gender (p< 0.001); seasonality (p < 0.001);
recruitment point (p= 0.033); distance to ED (p < 0.001); days at risk (p< 0.001).
h For Δ: seasonality (p= 0.012); recruitment point (p= 0.018); site 3 (p = 0.037). For ΔL: site 1 (p = 0.036); site 3
(p< 0.001); age (p< 0.001); distance to ED (p = 0.001); out of hours (p= 0.023); seasonality (p = 0.003).
i Site 1 (p= 0.016); site 3 (p = 0.035); age (p< 0.001); recruitment point (p< 0.001); out of hours (p < 0.001).
j Site 1 (p< 0.001); site 3 (p = 0.031); recruitment point (p< 0.001); out of hours (p< 0.001); distance to ED (p= 0.001).
k For Δ: out of hours (p< 0.001); seasonality (p= 0.003); age (p= 0.006); recruitment point (p= 0.020). For ΔL: out of
hours (p< 0.001); distance to ED (p= 0.002); age (p< 0.001); recruitment point (p< 0.001).
Adapted from Snooks et al.121 with permission from the American College of Emergency Physicians. Copyright © 2017
American College of Emergency Physicians. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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TABLE 17 Primary outcome and components at 1 month at each site analysed by treatment allocated
Primary outcomes Site
Raw data Site effectsa,b
Intervention Control Main Interaction
Proportion of patients with
further emergency service call,
ED attendance, emergency
admission or death, n/N (%)
Site 1 481/1311 (36.7) 509/1337 (38.1) OR = 1.136;
p= 0.268
OR = 1.091;
p= 0.583
Site 2 172/540 (31.9) 152/433 (35.1) n/a OR = 0.864;
p= 0.285
Site 3 217/540 (40.2) 182/494 (36.8) OR= 1.078;
p= 0.582
OR = 1.333;
p= 0.125
Proportion of patients dying
(any cause), n/N (%)
Site 1 86/1311 (6.6) 79/1337 (5.9) OR= 0.983;
p= 0.941
OR = 1.173;
p= 0.616
Site 2 31/540 (5.7) 26/433 (6.0) n/a OR = 0.953;
p= 0.862
Site 3 30/540 (5.6) 31/494 (6.3) OR = 1.048;
p= 0.864
OR = 0.922;
p= 0.830
Proportion with further
emergency admission, n/N (%)
Site 1 271/1311 (20.7) 272/1337 (20.3) OR = 1.001;
p= 0.993
OR = 1.091;
p= 0.644
Site 2 104/540 (19.3) 88/433 (20.3) n/a OR = 0.935;
p= 0.679
Site 3 142/540 (26.3) 115/494 (23.3) OR= 1.190;
p= 0.278
OR = 1.257;
p= 0.291
Proportion of patients with
further ED attendance, n/N (%)
Site 1 256/1311 (19.5) 244/1337 (18.2) OR = 1.311;
p= 0.078
OR = 1.080;
p= 0.711
Site 2 79/540 (14.5) 63/433 (14.5) n/a OR = 1.006;
p= 0.972
Site 3 128/540 (23.7) 111/494 (22.5) OR= 1.702;
p= 0.002
OR = 1.065;
p= 0.788
Further ED attendances per
patient, mean (SD) [n]
Site 1 0.2642 (0.6574)
[1230]
0.2337 (0.5449)
[1258]
Λ= 1.224; p= 0.161 Λ= 1.103;
p= 0.613
Site 2 0.2017 (0.5017)
[466]
0.1901 (0.4824)
[384]
n/a Λ= 1.014;
p= 0.938
Site 3 0.3174 (0.6042)
[501]
0.3969 (1.374)
[451]
Λ= 2.050; p< 0.001 Λ= 0.777;
p= 0.240
Further ED attendances/patient/
day at risk, mean (SD) [n]
Site 1 0.0217 (0.0775)
[1230]
0.0201 (0.0753)
[1258]
Δ= 0.0063;
p= 0.245
Δ= –0.0018;
p= 0.811
ΔL = 0.1933;
p= 0.058
ΔL = –0.2631;
p= 0.851
Site 2 0.0172 (0.0611)
[466]
0.0138 (0.0661)
[384]
n/a Δ= 0.0034;
p= 0.600
n/a ΔL = 0.0803;
p= 0.504
Site 3 0.0341 (0.1648)
[501]
0.0357 (0.1115)
[451]
Δ= 0.0219;
p= 0.001
Δ= –0.0050;
p= 0.572
ΔL = 0.4744;
p< 0.001
ΔL = –0.0955;
p= 0.563
Proportion of patients with
further emergency service call,
n/N (%)
Site 1 257/1311
(19.6)
320/1337
(23.9)
OR = 1.689;
p< 0.001
OR = 0.855;
p= 0.442
Site 2 78/540 (14.4) 68/433 (15.7) n/a OR = 0.906;
p= 0.585
Site 3 107/540
(19.8)
105/494
(21.3)
OR = 1.449;
p= 0.031
OR = 1.010;
p= 0.966
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TABLE 17 Primary outcome and components at 1 month at each site analysed by treatment allocated (continued )
Primary outcomes Site
Raw data Site effectsa,b
Intervention Control Main Interaction
Further emergency service calls
per patient, mean (SD) [n]
Site 1 0.3130 (0.8111)
[1230]
0.3831 (0.8763)
[1258]
Λ= 1.682; p< 0.001 Λ= 0.824;
p= 0.278
Site 2 0.2318 (0.6508)
[466]
0.2292 (0.5686)
[384]
n/a Λ= 0.987;
p= 0.933
Site 3 0.3234 (0.7920)
[501]
0.3034 (0.6384)
[451]
Λ= 1.311; p= 0.078 Λ= 1.077;
p= 0.721
Further emergency service calls/
patient/day at risk, mean (SD) [n]
Site 1 0.0196 (0.0595)
[1230]
0.0247 (0.0728)
[1258]
Δ= 0.0073;
p= 0.088
Δ= –0.0068;
p= 0.241
ΔL = 0.3538;
p= 0.001
ΔL= –0.2094;
p= 0.142
Site 2 0.0191 (0.0642)
[466]
0.0174 (0.0733)
[384]
n/a Δ= 0.0017;
p= 0.736
n/a ΔL= 0.0196;
p= 0.873
Site 3 0.0238 (0.0743)
[501]
0.0301 (0.1067)
[450]
Δ= 0.0127;
p= 0.012
Δ= –0.0080;
p= 0.248
ΔL = 0.2877;
p= 0.020
ΔL= –0.1077;
p= 0.525
n/a, not applicable.
a Site effects are calculated using a base model which includes only indicators for group, site and interactions from the list
of ‘core’ covariates, and are not adjusted for other covariates in that list. Main effects use site 2 as the reference category.
b The main and interaction effects reflect the variable under consideration; specifically, we report OR from logistic
regression models for binary variables; a multiplicative event ratio (Λ) from negative binomial regression models for count
data; and additive effects [Δ, in the same units as the dependent variable; ΔL refers to log-transformed data, using
ln(y + 0.001) in place of y] from linear models for measurement variables.
TABLE 18 Primary outcome and components at 6 months at each site analysed by treatment allocated
Primary outcomes Site
Raw data Site effectsa,b
Intervention Control Main Interaction
Proportion of patients with
further emergency service
call, ED attendance,
emergency admission or
death, n/N (%)
Site 1 933/1310 (71.2) 948/1337 (70.9) OR = 1.214; p= 0.101 OR = 0.918;
p= 0.598
Site 2 372/540 (68.9) 289/433 (66.7) n/a OR = 1.103;
p= 0.476
Site 3 396/540 (73.3) 355/494 (71.9) OR= 1.273; p= 0.092 OR = 0.976;
p= 0.901
Proportion of patients dying
(any cause), n/N (%)
Site 1 249/1311 (19.0) 270/1337 (20.2) OR = 1.208; p= 0.190 OR = 0.710;
p= 0.073
Site 2 116/540 (21.5) 75/433 (17.3) n/a OR = 1.306;
p= 0.105
Site 3 93/540 (17.2) 74/494 (15.0) OR = 0.841; p= 0.333 OR = 0.904;
p= 0.671
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TABLE 18 Primary outcome and components at 6 months at each site analysed by treatment allocated (continued )
Primary outcomes Site
Raw data Site effectsa,b
Intervention Control Main Interaction
Proportion with further
emergency admission,
n/N (%)
Site 1 597/1311 (45.5) 620/1337 (46.4) OR = 0.953; p= 0.663 OR = 0.959;
p= 0.782
Site 2 258/540 (47.8) 206/433 (47.6) n/a OR = 1.008;
p= 0.950
Site 3 298/540 (55.2) 258/494 (52.2) OR= 1.205; p= 0.158 OR = 1.117;
p= 0.537
Proportion of patients with
further ED attendance,
n/N (%)
Site 1 592/1311 (45.2) 584/1337 (43.7) OR = 1.235; p= 0.062 OR = 1.170;
p= 0.310
Site 2 196/540 (36.3) 167/433 (38.6) n/a OR = 0.908;
p= 0.467
Site 3 291/540 (53.9) 270/494 (54.7) OR= 1.920; p< 0.001 OR = 1.068;
p= 0.717
Further ED attendances per
patient, mean (SD) [n]
Site 1 0.813 (1.362)
[1310]
0.790 (1.355)
[1336]
Λ = 1.172; p= 0.067 Λ= 1.259;
p= 0.055
Site 2 0.561 (0.912)
[535]
0.678 (1.083)
[429]
n/a Λ= 0.820;
p= 0.058
Site 3 1.204 (1.743)
[535]
1.453 (5.296)
[492]
Λ = 2.163; p< 0.001 Λ= 1.009;
p= 0.945
Further ED attendances/
patient/day at risk, mean
(SD) [n]
Site 1 0.0155 (0.0859)
[1310]
0.0117 (0.0461)
[1336]
Δ = –0.0036; p= 0.426 Δ= 0.0046;
p= 0.455
ΔL = 0.1424; p= 0.086 ΔL = 0.0942;
p= 0.405
Site 2 0.0145 (0.1033)
[535]
0.0153 (0.1117)
[429]
n/a Δ= –0.0008;
p= 0.874
n/a ΔL = –0.0690;
p= 0.477
Site 3 0.0231 (0.0886)
[535]
0.0209 (0.0701)
[492]
Δ = 0.0056; p= 0.297 Δ= 0.0030;
p= 0.677
ΔL = 0.5620; p< 0.001 ΔL = 0.0353;
p= 0.793
Proportion of patients with
further emergency service
call, n/N (%)
Site 1 590/1311 (45.0) 635/1337 (47.5) OR = 1.413; p= 0.002 OR = 0.763;
p= 0.077
Site 2 233/540 (43.1) 169/433 (39.0) n/a OR = 1.186;
p= 0.195
Site 3 223/540 (41.3) 242/494 (49.0) OR= 1.500; p= 0.002 OR = 0.618;
p= 0.008
Further emergency service
calls per patient, mean
(SD) [n]
Site 1 1.260 (2.917)
[1310]
1.412 (3.163)
[1336]
Λ = 1.684; p< 0.001 Λ= 0.883;
p= 0.252
Site 2 0.849 (1.497)
[535]
0.839 (1.456)
[429]
n/a Λ= 1.011;
p= 0.910
Site 3 1.120 (2.183)
[535]
1.173 (1.882)
[492]
Λ = 1.398; p< 0.001 Λ= 0.944;
p= 0.656
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TABLE 18 Primary outcome and components at 6 months at each site analysed by treatment allocated (continued )
Primary outcomes Site
Raw data Site effectsa,b
Intervention Control Main Interaction
Further emergency service
calls/patient/day at risk,
mean (SD) [n]
Site 1 0.0118 (0.0308)
[1310]
0.0177 (0.0604)
[1336]
Δ = 0.0038; p= 0.165 Δ= –0.0045;
p= 0.228
ΔL = 0.2946; p= 0.001 ΔL= –0.2524;
p= 0.034
Site 2 0.0125 (0.0376)
[535]
0.0139 (0.0620)
[429]
n/a Δ= –0.0015;
p= 0.646
n/a ΔL= 0.1088;
p= 0.286
Site 3 0.0144 (0.0460)
[535]
0.0184 (0.0565)
[492]
Δ = 0.0045; p= 0.170 Δ= –0.0025;
p= 0.573
ΔL = 0.3329; p= 0.001 ΔL= –0.3508;
p= 0.013
n/a, not applicable.
a Site effects are calculated using a base model which includes only indicators for group, site and interactions from the list
of ‘core’ covariates, and are not adjusted for other covariates in that list. Main effects use site 2 as the reference category.
b The main and interaction effects reflect the variable under consideration; specifically, we report OR from logistic
regression models for binary variables; a multiplicative event ratio (Λ) from negative binomial regression models for count
data; and additive effects [Δ, in the same units as the dependent variable; ΔL refers to log-transformed data, using
ln(y + 0.001) in place of y] from linear models for measurement variables.
TABLE 19 Secondary outcomes at index incident analysed by treatment allocated
Secondary outcome Site
Raw data Adjusted comparisona,b ICC
Intervention (A) Control (B)
Estimate,
p-value 95% CI Estimate 95% CI
Conveyed to ED,c,d
n/N (%)
All 1579/2420
(65.2)
1431/2284
(62.7)
OR = 1.082;
p= 0.205
0.958 to
1.223
0.0512 0.0266 to
0.0832
Site 1 779/1329
(58.6)
755/1352
(55.8)
Site 2 426/544
(78.3)
344/436
(78.9)
Site 3 374/547
(68.4)
332/496
(66.9)
Referred to falls
service by emergency
service crew,c,e
n/N (%)
All 204/2420
(8.4)
26/2284
(1.1)
OR = 51.730;
p< 0.001
16.46 to
162.54
0.0400 0.0204 to
0.0652
Site 1 100/1329
(7.5)
3/1352 (0.2)
Site 2 51/544 (9.4) 0/436 (0)
Site 3 53/547 (9.7) 23/496 (4.6)
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TABLE 19 Secondary outcomes at index incident analysed by treatment allocated (continued )
Secondary outcome Site
Raw data Adjusted comparisona,b ICC
Intervention (A) Control (B)
Estimate,
p-value 95% CI Estimate 95% CI
Left at scene without
referral,f n/N (%)
All 547/2420
(22.6)
692/2284
(30.3)
OR = 0.686;
p < 0.001
0.600 to
0.784
0.0375 0.0195 to
0.0612
Site 1 379/1329
(28.5)
496/1352
(36.7)
Site 2 72/544
(13.2)
84/436
(19.3)
Site 3 96/547
(17.6)
112/496
(22.6)
Key physiological indicators recorded at scene
Respiratory rate,g
n/N (%)
All 2318/2420
(95.8)
2165/2284
(94.8)
OR = 1.278;
p = 0.090
0.963 to
1.695
0.0449 0.0215 to
0.0764
Site 1 1281/1329
(96.4)
1288/1352
(95.3)
Site 2 495/544
(91.0)
386/436
(88.5)
Site 3 542/547
(99.1)
491/496
(99.0)
Pulse rate,h n/N (%) All 2319/2420
(95.8)
2173/2284
(95.1)
OR = 1.216;
p = 0.186
0.910 to
1.624
0.0511 0.0254 to
0.0851
Site 1 1296/1329
(97.5)
1309/1352
(96.8)
Site 2 489/544
(89.9)
378/436
(86.5)
Site 3 534/547
(97.6)
486/496
(98.0)
Level of
consciousness,i
n/N (%)
All 2327/2420
(96.2)
2189/2284
(95.8)
OR = 1.058;
p = 0.704
0.790 to
1.418
0.0016 0.0001 to
0.0055
Site 1 1262/1329
(95.0)
1285/1352
(95.0)
Site 2 533/544
(98.0)
427/436
(97.9)
Site 3 532/547
(97.3)
477/496
(96.2)
Length of episode of
care (minutes),j mean
(SD) [n]
All 196.8 (153.9)
[2410]
192.8 (152.8)
[2273]
Δ = 2.048;
p = 0.645
–6.68 to
10.77
0.0180 0.0074 to
0.0336
Site 1 185.4 (130.9)
[1328]
181.8 (135.8)
[1352]
Site 2 205.4 (211.0)
[540]
209.1 (217.9)
[431]
Site 3 216.2 (135.5)
[542]
208.7 (122.4)
[490]
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TABLE 19 Secondary outcomes at index incident analysed by treatment allocated (continued )
Secondary outcome Site
Raw data Adjusted comparisona,b ICC
Intervention (A) Control (B)
Estimate,
p-value 95% CI Estimate 95% CI
Length of job-cycle
timek (minutes),
mean (SD) [n]
All 99.9 (41.9)
[2416]
97.8 (43.9)
[2277]
Δ= 1.685;
p= 0.174
–0.746 to
4.117
0.0167 0.0070 to
0.0308
Site 1 97.5 (41.4)
[1328]
97.2 (44.9)
[1352]
Site 2 108.8 (47.7)
[543]
102.2 (48.2)
[435]
Site 3 96.9 (35.0)
[545]
95.8 (36.3)
[490]
a As well as indicators for group, site, and their interaction, ‘core’ covariates considered are age (in years) and its square;
distance to ED (in miles); recruitment point (based on days since start of study); seasonality; indicators of gender; and
whether or not the index call was made during out of (GP) hours.
b The comparison between groups reflects the variable under consideration; specifically, we report an OR from logistic
regression models for binary variables and an additive group effect (Δ, in the same units as the dependent variable from
linear models for measurement variables.
c Some patients were conveyed and referred (intervention group n= 34, control group n= 18). Statistically significant
covariates are listed in further footnotes.
d Out of hours (p< 0.001); site 1 (p< 0.001); site 3 (p< 0.001); recruitment point (p= 0.001).
e Out of hours (p= 0.001); site 3 (p< 0.001); interaction between group and site 3 (p< 0.001); seasonality (p= 0.028);
age (p= 0.032).
f Out of hours (p< 0.001); site 1 (p< 0.001); recruitment point (p = 0.001); site 3 (p= 0.028).
g Site 1 (p< 0.001); site 3 (p < 0.001); recruitment point (p= 0.009); age (p= 0.039).
h Site 1 (p< 0.001); site 3 (p < 0.001); age (p= 0.008); age2 (p= 0.047).
i Site 1 (p< 0.001).
j Out of hours (p< 0.001); recruitment point (p< 0.001); site 1 (p < 0.001); seasonality (p= 0.002); age (p= 0.018).
k Distance to ED (p < 0.001); out of hours (p< 0.001); recruitment point (p< 0.001); seasonality (p < 0.001); site 1
(p< 0.001).
Adapted from Snooks et al.121 with permission from the American College of Emergency Physicians. Copyright © 2017
American College of Emergency Physicians. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
TABLE 20 Secondary outcomes at 1 month analysed by treatment allocated
Secondary outcome Site
Raw data Adjusted comparisona,b ICC
Intervention (A) Control (B)
Estimate,
p-value 95% CI Estimate 95% CI
Duration of
subsequent inpatient
episodes (nights in
hospital, truncated) at
30 days,c mean (SD) [n]
All 2.25 (6.14)
[2391]
2.10 (6.05)
[2264]
Δ= 0.141;
p= 0.426
–0.207
to 0.490
0.0012 0.0001 to
0.0045
Site 1 1.98 (5.64)
[1311]
1.97 (5.73)
[1337]
Site 2 2.51 (6.72)
[540]
2.42 (6.77)
[433]
Site 3 2.64 (6.67)
[540]
2.17 (6.20)
[494]
Proportion with further
reported fractures,d
n/N (%)
All 98/2391 (4.1) 91/2264 (4.0) OR= 1.002;
p= 0.987
0.744 to
1.351
0.0049 0.0013 to
0.0114
Site 1 38/1311 (2.9) 42/1337 (3.1)
Site 2 41/540 (7.6) 27/433 (6.2)
Site 3 19/540 (3.5) 22/494 (4.5)
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TABLE 20 Secondary outcomes at 1 month analysed by treatment allocated (continued )
Secondary outcome Site
Raw data Adjusted comparisona,b ICC
Intervention (A) Control (B)
Estimate,
p-value 95% CI Estimate 95% CI
Self-reported outcomes
Quality of life SF-12
MCS,e mean (SD) [n]
All 39.80 (12.47)
[447]
38.89 (12.16)
[410]
Δ= 0.902;
p= 0.282
–0.744
to 2.547
0.0080 0.0004 to
0.0306
Site 1 40.68 (12.85)
[214]
40.30 (13.04)
[217]
Site 2 37.76 (11.59)
[126]
35.63 (10.69)
[104]
Site 3 40.44 (12.53)
[107]
39.26 (10.88)
[89]
Quality of life SF-12
PCS,f mean (SD) [n]
All 29.07 (9.97)
[447]
29.40 (10.28)
[410]
Δ= –0.495;
p= 0.472
–1.847
to 0.856
0 n/a
Site 1 28.92 (9.81)
[214]
29.62 (11.47)
[217]
Site 2 28.13 (9.66)
[126]
28.39 (7.99)
[104]
Site 3 30.47 (10.55)
[107]
30.03 (9.58)
[89]
Patient satisfaction
QCM Technical,g mean
(SD) [n]
All 62.82 (7.98)
[563]
63.21 (8.16)
[551]
Δ= –0.320;
p= 0.506
–1.265
to 0.625
0.0102 0.0018 to
0.0273
Site 1 63.13 (7.45)
[274]
63.79 (7.97)
[295]
Site 2 61.37 (9.78)
[163]
61.64 (8.63)
[137]
Site 3 64.01 (6.07)
[126]
63.58 (7.91)
[119]
Patient satisfaction
QCM Interpersonal,h
mean (SD) [n]
All 68.92 (8.66)
[563]
68.04 (9.12)
[551]
Δ= 3.132;
p< 0.001
1.587 to
4.678
0.0123 0.0017 to
0.0357
Site 1 67.59 (9.63)
[274]
67.94 (9.93)
[295]
Site 2 71.18 (7.42)
[163]
68.25 (8.51)
[137]
Site 3 68.88 (7.28)
[126]
68.06 (7.68)
[119]
Fall-related
self-efficacy (fear of
falling),i mean (SD) [n]
All 3.714 (3.040)
[634]
3.815 (3.117)
[600]
Δ= –0.055;
p= 0.743
–0.385
to 0.275
0.0062 0.0004 to
0.0224
Site 1 3.836 (3.103)
[302]
4.052 (3.273)
[321]
Site 2 3.148 (2.866)
[182]
3.194 (2.666)
[151]
Site 3 4.156 (3.035)
[150]
3.955 (3.133)
[128]
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arising from higher scores from intervention patients in site 2, but not in the technical aspect of patient
satisfaction. There was evidence of a difference in the proportion of patients with further fractures at 6 months
(but not at 1 month), with pronounced differences between groups across the three sites (approximately equal
at site 1, higher in intervention patients in site 2 and lower in intervention patients at site 3).
Contamination
Table 22 shows the percentage of control patients subsequently attended within the trial period by a
paramedic from the intervention group, < 5% at 1 month rising to about 15% at 6 months, with broadly
similar rates at each site.
Patients ineligible for referral to the falls service
A subgroup of participants in site 1 were registered at GP practices without agreement for referral of
patients to falls services and were less able to benefit from the full SAFER 2 intervention. Appendix 19
therefore presents the main results after excluding these patients. Results in these tables are consistent
with those presented in the preceding sections.
Patterns of referral to the falls service
Sixty per cent of designated intervention group paramedics referred trial eligible patients to a falls service
(Table 23). Paramedics referred up to 11 patients, although most made referrals once or twice. Patient age, sex,
distance to ED did not appear to influence referral (Table 24); however, patients were more likely to be referred
to falls services out of hours and less likely to be referred at site 1 than at the other sites (Table 25).
For most patients left at the scene by intervention group paramedics without referral to a falls service, no
reason was identified. At site 1, 231 patients were not eligible for referral because, although they lived in
the study catchment area, they were not registered with participating GPs. Other reasons for non-referral
included refusal, not appropriate for referral or information that the patient was already under the care of
a falls team or other service (Table 26).
TABLE 20 Secondary outcomes at 1 month analysed by treatment allocated (continued )
Secondary outcome Site
Raw data Adjusted comparisona,b ICC
Intervention (A) Control (B)
Estimate,
p-value 95% CI Estimate 95% CI
Proportion of patients
who reported ≥ 1
further fall,
j n/N (%)
All 413/621 (66.5) 409/589 (69.4) OR= 0.723;
p= 0.025
0.544 to
0.961
0.0102 0.0016 to
0.0285
Site 1 211/296 (71.3) 215/314 (68.5)
Site 2 112/178 (62.9) 105/149 (70.5)
Site 3 90/147 (61.2) 89/126 (70.6)
MCS, mental component summary; n/a, not applicable; PCS, physical component summary; QCM, Quality of Care Monitor.
a As well as indicators for group, site, and their interaction, ‘core’ covariates considered are age (in years) and its square;
distance to ED (in miles); recruitment point (based on days since start of study); seasonality; indicators of gender and
whether or not the index call was made during out of [GP] hours.
b The comparison between groups reflects the variable under consideration; specifically, we report an OR from logistic
regression models for binary variables; an additive group effect (Δ, in the same units as the dependent variable) from
linear models for measurement variables. Statistically significant covariates are listed in further footnotes.
c Age (p= 0.004); site 1 (p = 0.014).
d Site 1 (p< 0.001); distance to ED (p= 0.001); gender (p = 0.009); age (p= 0.020).
e Site 1 (p< 0.001); site 3 (p = 0.019); age (p= 0.037); out of hours (p = 0.038).
f Age2 (p< 0.001); out of hours (p = 0.014).
g Site 1 (p< 0.001); site 3 (p < 0.001).
h Interaction between site 1 and group (p< 0.001); interaction between site 3 and group (p = 0.029).
i Age (p< 0.001); out of hours (p< 0.001); site 1 (p< 0.001); site 3 (p= 0.004).
j Interaction between site 1 and group (p= 0.016).
Adapted from Snooks et al.121 with permission from the American College of Emergency Physicians. Copyright © 2017
American College of Emergency Physicians. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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TABLE 21 Secondary outcomes at 6 months analysed by treatment allocated
Outcome Site
Raw data Adjusted comparisona,b
Estimate 95% CIIntervention (A) Control (B)
Estimate,
p-value
95% CI
significance
level
Routine data outcomes
Duration of
subsequent inpatient
episodes (nights in
hospital, truncated at
180 days),c mean (SD)
[n]
All 11.18 (22.80)
[2391]
11.62 (23.52)
[2264]
Δ= –0.563;
p= 0.403
–1.884 to
0.757
0.0065 0.0021 to
0.0138
Site 1 9.48 (19.29)
[1311]
9.95 (19.95)
[1337]
Site 2 14.48 (29.56)
[540]
14.75 (30.01)
[433]
Site 3 12.03 (22.52)
[540]
13.42 (25.53)
[494]
Proportion with
further reported
subsequent fractures,d
n/N (%)
All 228/2391 (9.5) 222/2264 (9.8) OR = 1.449;
p= 0.015
1.076 to
1.952
0.0172 0.0073 to
0.0318
Site 1 93/1311 (7.1) 107/1337 (8.0)
Site 2 92/540 (17.0) 59/433 (13.6)
Site 3 43/540 (8.0) 56/494 (11.3)
Self-reported outcomes
Quality of life SF-12
MCS,e mean (SD) [n]
All 43.21 (12.57)
[258]
42.82 (12.28)
[241]
Δ= 0.463;
p= 0.677
–1.717 to
2.643
0 n/a
Site 1 44.00 (12.50)
[127]
43.45 (12.55)
[144]
– – – –
Site 2 41.84 (12.42)
[53]
38.95 (12.77)
[43]
Site 3 42.84 (12.84)
[78]
44.24 (10.67)
[54]
Quality of life SF-12
PCS,f mean (SD) [n]
All 30.44 (11.33)
[258]
31.88 (11.67)
[241]
Δ= –1.300;
p= 0.198
–3.282 to
0.682
0 n/a
Site 1 29.83 (11.29)
[127]
32.36 (11.72)
[144]
Site 2 31.61 (12.89)
[53]
30.77 (12.79)
[43]
Site 3 30.64 (10.31)
[78]
31.49 (10.70)
[54]
Fall-related
self-efficacy (fear of
falling),g mean score
(SD) [n]
All 4.547 (3.328)
[341]
4.792 (3.393)
[310]
Δ= –0.230;
p= 0.368
–0.729 to
0.270
0.0018 0 to 0.0219
Site 1 4.643 (3.402)
[167]
5.091 (3.477)
[176]
Site 2 4.217 (3.254)
[72]
4.010 (3.423)
[60]
Site 3 4.624 (3.273)
[102]
4.716 (3.090)
[74]
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TABLE 21 Secondary outcomes at 6 months analysed by treatment allocated (continued )
Outcome Site
Raw data Adjusted comparisona,b
Estimate 95% CIIntervention (A) Control (B)
Estimate,
p-value
95% CI
significance
level
Proportion with
change in place of
residence,h n/N (%)
All 32/319 (10.0) 19/280 (6.8) OR = 1.497;
p= 0.183
0.826 to
2.713
0.0032 0 to 0.0235
Site 1 15/156 (9.6) 9/163 (5.5)
Site 2 5/73 (6.8) 4/50 (8.0)
Site 3 12/90 (13.3) 6/67 (9.0)
Proportion of patients
who reported ≥ 1
further fall,i n/N (%)
Site 1 110/159 (69.2) 105/172 (61.0) OR = 1.423;
p= 0.134
0.897 to
2.258
– –
Site 2 44/74 (59.5) 43/56 (76.8) OR = 0.365;
p= 0.019
0.157 to
0.848
– –
Site 3 74/96 (77.1) 44/68 (64.7) OR = 1.835;
p= 0.084
0.922 to
3.652
– –
MCS, mental component summary; n/a, not applicable; PCS, physical component summary; QCM, Quality of Care Monitor.
a As well as indicators for group, site, and their interaction, ‘core’ covariates considered are age (in years) and its square;
distance to ED (in miles); recruitment point (based on days since start of study); seasonality; indicators of gender and
whether or not the index call was made during out of [GP] hours.
b The comparison between groups reflects the variable under consideration; specifically, we report an OR from logistic
regression models for binary variables; a multiplicative event rate ratio (Λ, scalar) from negative binomial regression
models for count data; an additive group effect (Δ in the same units as the dependent variable), from linear models for
measurement variables. Statistically significant covariates are listed in further footnotes.
c Site 1 (p< 0.001); age (p = 0.001); age2 (p= 0.016).
d Gender (p< 0.001); site 1 (p < 0.001); interaction between site 1 and group (p= 0.022); interaction between site 3 and
group (p< 0.001).
e Age (p= 0.024).
f Age (p< 0.001).
g Age (p< 0.001); out of hours (p= 0.043).
h Age2 (p= 0.030).
i Analysis of this variable reveals not only five significant covariates [age (p= 0.004); site 1 (p= 0.010); recruitment point
(p= 0.015); distance to ED (p= 0.014); and gender (p= 0.036)] but also two major interactions [between site 3 and
group (p= 0.001); and between site 1 and group (p= 0.003)]. In these unusual circumstances, we have omitted the
misleading sub-row covering all participants and extended the three heterogeneous site-specific rows to summarise each
site separately. Significant covariates are site 1, age (p= 0.003); site 2, distance to ED (p= 0.001); and seasonality
(p= 0.021); and site 3, none.
Adapted from Snooks et al.121 with permission from the American College of Emergency Physicians. Copyright © 2017
American College of Emergency Physicians. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
TABLE 22 Numbers of control group participants subsequently attended by an intervention group paramedic
Site
Count, n/N (%)
Within 1 month Within 6 months
All 98/2264 (4.3) 356/2264 (15.7)
Site 1 59/1337 (4.4) 224/1337 (16.8)
Site 2 15/433 (3.5) 60/433 (13.9)
Site 3 24/494 (4.9) 72/494 (14.6)
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Comparison of outcome measures
To meet our methodological objective we compared the performance of the generic SF-12 with the mFES
(‘Fear of Falling’), a falls-specific outcome measure, in this population (Table 27 and Figures 3–6). The
SF-12 mental component summary (MCS) and physical component summary (PCS) scores at 1 month both
showed mean values at the lower end of the scale (lower scores indicate worse health), indicating mental
and physical scores below the population norms. Similarly, the mFES at 1 month showed a clustering of
scores at the lower end of the scale, indicating worse health. At 6 months, both scales again showed
mean score values at the lower end of the scale, indicating worse health. There was, however, a small
increase in MCS, PCS and mFES scores, indicating a slight improvement in patient-reported outcomes since
the 1-month follow-up.
TABLE 23 Falls referrals per intervention paramedic by site
Number of referrals to
falls servicea
Site 1 paramedics,
n (%)
Site 2 paramedics,
n (%)
Site 3 paramedics,
n (%)
Total paramedics,
n (%)
0 13 (33.3) 7 (26.9) 21 (52.5) 41 (39.0)
1 8 (20.5) 9 (34.6) 8 (20.0) 25 (23.8)
2 6 (15.4) 2 (7.7) 6 (15.0) 14 (13.3)
3 1 (2.6) 3 (11.5) 0 (0.0) 4 (3.8)
4 0 (0.0) 0 (0.0) 4 (10.0) 4 (3.8)
5 2 (5.1) 3 (11.5) 1 (2.5) 6 (5.7)
6 5 (12.8) 0 (0.0) 0 (0.0) 5 (4.8)
7 2 (5.1) 1 (3.8) 0 (0.0) 3 (2.9)
8 1 (2.6) 0 (0.0) 0 (0.0) 1 (0.9)
9 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
10 0 (0.0) 1 (3.8) 0 (0.0) 1 (0.9)
11 1 (2.6) 0 (0.0) 0 (0.0) 1 (0.9)
Total paramedics
recruited to study
39 26 40 105
a When there was more than one intervention paramedic attended to a patient, we classified all such paramedics as
referring the patient.
TABLE 24 Falls referrals at index call for intervention patients by personal and incident characteristics
Characteristics
Referred patientsa Not referred patients
n (%) SD n (%) SD
Mean age (years) 83.88 7.15 82.14 8.11
Men 61 (35.1) – 807 (35.3) –
Women 113 (64.9) – 1477 (64.7) –
Mean distance to nearest ED (miles) 4.57 3.27 4.65 3.08
Out of hours 91 (52.3) – 954 (41.8) –
Site 1 81(46.6) – 1352 (59.2) –
Site 2 49 (28.2) – 436 (19.1) –
Site 3 44 (25.3) – 496 (21.7) –
Total 174 – 2284 –
a Excluding two control participants.
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TABLE 25 Predictors of falls referral (full effects model)
Predictor B p-value Exp(B)
95% CI for Exp (B)
Lower Upper
Site 1 –0.448 0.015 0.639 0.446 0.917
Site 3 0.204 0.389 1.226 0.771 1.951
Gender 0.101 0.487 1.107 0.832 1.472
Age 0.079 0.025 1.082 1.010 1.160
Age2 –1.702 0.085 0.182 0.026 1.264
Distance to ED –0.041 0.137 0.960 0.910 1.013
Out of hours 0.456 0.001 1.578 1.202 2.072
Recruitment point –0.217 0.426 0.805 0.472 1.373
Seasonality 0.187 0.067 1.206 0.987 1.474
Constant –3.586 – – – –
Adapted from Snooks et al.121 with permission from the American College of Emergency Physicians. Copyright © 2017
American College of Emergency Physicians. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
TABLE 26 Reasons identified for non-referral of patients left at scene by intervention group paramedics
Reason All, n (%) Site 1, n (%) Site 2, n (%) Site 3, n (%)
No reason identified 377 (68.9) 241 (63.6) 60 (83.3) 76 (79.2)
Not registered with an eligible GP 68 (12.4) 68 (17.9) 0 (0) 0 (0)
Recorded by paramedic as
Not appropriate for referral 38 (6.9) 25 (6.6) 4 (5.6) 9 (9.4)
Refused referral 31 (5.7) 20 (5.3) 6 (8.3) 5 (5.2)
Care plan in place 13 (2.4) 6 (1.6) 2 (2.8) 5 (5.2)
Already under a falls team 20 (3.7) 19 (5.0) 0 (0) 1 (1.0)
Total 547 379 72 96
TABLE 27 Comparison of outcome measures at 1 and 6 months
Outcome measure na Mean score SD
1 month
SF-12 MCS 1160 43.84 9.36
SF-12 PCS 1160 35.03 8.01
mFES 1252 3.47 3.07
6 months
SF-12 MCS 595 44.95 9.04
SF-12 PCS 595 38.23 7.72
mFES 663 4.55 3.45
PROM, patient-reported outcome measure.
a This number represents those for whom a PROM score could be generated at each time point.
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FIGURE 3 Short Form questionnaire-12 items PCS and mFES scores at 1 month: correlation= 0.546.
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FIGURE 4 Short Form questionnaire-12 items MCS and mFES scores at 1 month: correlation = 0.553.
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FIGURE 5 Short Form questionnaire-12 items PCS and mFES scores at 6 months: correlation = 0.627.
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FIGURE 6 Short Form questionnaire-12 items MCS and mFES scores at 6 months: correlation= 0.547.
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There was moderate correlation between the SF-12 MCS and PCS scores and the mFES scores at both
1 and 6 months (range 0.55–0.63). Unusually, there were significant floor and ceiling effects for the
condition-specific measure, mFES, indicating less sensitivity to detect small changes in patient outcomes
than the SF-12 disease-specific measure.
Analysis of non-response
We have not analysed dissenters, as the National Information Governance Board withdrew consent to use
their data.
Questionnaire response rates for those who did not dissent did not vary between trial arms (Table 28).
Responders were slightly younger and the significant difference in recruitment point shows that the
response rate improved over the course of the trial.
Harms
We defined a SAE as an emergency service call, ED attendance, emergency hospital admission or death
identified as occurring within 2 days of the index incident. These are reported in Table 29. There is little
difference in the rate of occurrence of these events between the intervention group and the control group,
or in the total number of events between groups (n = 331 in intervention group vs. n = 334 in control
group). During the trial there was no serious ARs in which a SAE was reported as possibly related to use of
the intervention, including referral to a falls service.
TABLE 28 Comparison of characteristics of responders and non-responders to questionnaires at 1 month
Variables
Responders to 1-month
questionnaire
Non-responders to 1-month
questionnaire
Adjusted comparison
Estimate,
p-value 95% CI
Proportion in intervention
group, n/N (%)
668/1307 (51.1) 1752/3397 (51.6) OR = 0.982;
p = 0.775
0.864 to
1.115
Age (years), mean (SD) [n] 81.33 (8.06) [1303] 82.74 (8.00) [3384] Δ = –1.408;
p < 0.001
–1.920 to
–0.896
Proportion of females,
n/N (%)
828/1307 (63.4) 2129/3396 (62.7) OR = 1.029;
p = 0.675
0.901 to
1.174
Proportion with index call
out of hours, n/N (%)
503/1305 (38.5) 1462/3395 (43.1) OR = 0.829;
p = 0.005
0.728 to
0.945
Distance to ED (miles), mean
(SD) [n]
4.87 (3.39) [1296] 4.66 (3.22) [3380] Δ = 0.209;
p = 0.050
0.000 to
0.419
Recruitment point (days),
mean (SD) [n]
246.1 (125.1) [1306] 211.8 (129.4) [3396] Δ = 34.30;
p < 0.001
26.11 to
42.48
TABLE 29 Serious adverse events within 2 days following index incident
SAE Intervention (N= 2420), n (%) Control (N= 2284), n (%) Total (N= 4704), n (%)
Emergency service call 101 (4.2) 117 (5.1) 218 (4.6)
ED attendance 78 (3.2) 92 (4.0) 170 (3.6)
Emergency admission 133 (5.5) 109 (4.8) 242 (5.1)
Death 19 (0.8) 16 (0.7) 35 (0.7)
Total 331 (13.7) 334 (14.6) 665 (14.1)
CLINICAL EFFECTIVENESS RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
62
Chapter 5 Cost-effectiveness analysis
Results: summary of demographics
We included 4704 eligible participants in the analysis: 2681 from site 1, 980 from site 2 and 1043 from
site 3. Of these, 2420 patients were randomly allocated to the intervention group and 2284 to the control
group. Males accounted for 38.8% of the intervention group and 35.3% of the control group. The mean
age was 82.5 years in the intervention group and 82.1 years in the control group.
Costs of Support and Assessment for Fall Emergency Referrals 2
trial intervention
The costs of the SAFER 2 trial intervention amounted to £41,854.00, which translates to a mean cost
of £17.30 per eligible patient, as shown in Table 30. They include costs associated with training and
implementation of the scheme, with a distinction made between costs associated with establishing the
scheme (its ‘roll-out’ to other sites), which relate to development of the scheme and training in the
respective sites, and the costs of enabling the delivery of the scheme in each area.
Resource use
The costs of health care used by trial participants, in the care of trial paramedics, were derived by
multiplying items of resource use by the published unit costs in Table 31.
All but 49 patients were subsequently matched at SAIL or the HSCIC and, therefore, 4655 patients (2391
intervention, 2264 control) were included in the analysis of the anonymised linked data primary outcome.
We combined two types of resource use. We calculated costs relating to emergency service calls, ED
attendances and hospital stays for all matched participants, using routinely collected data for 1 month and
6 months following the index call, and then combined self-reported costs, obtained via questionnaires,
over 1 and 6 months. Table 32 shows that the main differences at 6 months are in the mean costs of
initial hospital stays (£2523.27 in the intervention group vs. £2329.79 for control), and of subsequent
hospital stays (£3982.21 for intervention vs. £4111.10 for control). At 6 months, mean total costs were
£7386.39 in the intervention group and £7301.31 in the control group. Consistent with the clinical
effectiveness analysis in Chapter 4, there are statistically significant differences in the mean costs of
subsequent emergency service calls over 1 month, and of ED attendances over 6 months. These may
warrant further investigation, although such differences are generally obscured when aggregated with
larger (but statistically non-significant) differences in other elements of resource use – notably, hospital
stays (see Table 32 and its footnotes).
As questionnaire response rates were low at both 1 month and 6 months, self-reported resource use costs
were used to impute unbiased estimates of such costs for all matched participants. Table 33 summarises all
resource costs. Again using the linear modelling method outlined in Chapter 4, the estimated intervention
effect (adjusted for statistically significant covariates) at 1 month is £190.24 (95% CI –£13.83 to £394.31;
p = 0.068), and at 6 months is £24.20 (95% CI –£468.01 to £516.40; p = 0.923); see Table 33 and
its footnotes.
DOI: 10.3310/hta21130 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 13
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Snooks et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
63
TA
B
LE
30
In
te
rv
en
ti
o
n
co
st
s
Ta
sk
Si
te
1
Si
te
2
Si
te
3
D
at
a
so
u
rc
es
To
ta
l
B
as
is
o
f
es
ti
m
at
e
A
ct
u
al
co
st
B
as
is
o
f
es
ti
m
at
e
A
ct
u
al
co
st
B
as
is
o
f
es
ti
m
at
e
A
ct
u
al
co
st
C
en
tr
al
se
t-
u
p
co
st
s
In
te
rv
en
tio
n
m
ee
tin
g
in
D
er
by
to
de
fin
e
co
m
m
on
co
re
an
d
lo
ca
lo
pt
io
na
l
co
m
po
ne
nt
s
of
in
te
rv
en
tio
n
O
ne
m
ee
tin
g
(5
ho
ur
s)
×
fiv
e
m
ed
ic
al
co
ns
ul
ta
nt
s
at
£5
0.
00
pe
r
ho
ur
;
th
re
e
fa
lls
te
am
le
ad
er
s
at
£4
0.
00
pe
r
ho
ur
;
on
e
nu
rs
e
co
ns
ul
ta
nt
at
£4
0.
00
pe
r
ho
ur
;
on
e
re
se
ar
ch
ch
am
pi
on
(p
ar
am
ed
ic
)
at
£2
6.
00
pe
r
ho
ur
;
on
e
EC
P
at
£3
2.
25
pe
r
ho
ur
;
tw
o
cl
in
ic
al
tr
ai
ne
rs
at
£3
2.
25
pe
r
ho
ur
;
on
e
cl
in
ic
al
ef
fe
ct
iv
en
es
s
m
an
ag
er
at
£3
2.
25
pe
r
ho
ur
£2
82
5.
00
–
–
–
–
A
m
bu
la
nc
e
se
rv
ic
e
£2
82
5.
00
In
te
rv
en
tio
n
tr
ai
ni
ng
su
bg
ro
up
to
de
si
gn
D
V
D
Fo
ur
m
ee
tin
gs
(1
ho
ur
ea
ch
)+
1
da
y
de
ve
lo
pm
en
t
w
or
k
(7
ho
ur
s)
×
on
e
EC
P
at
£3
2.
25
pe
r
ho
ur
;
on
e
nu
rs
e
co
ns
ul
ta
nt
at
£4
0.
00
pe
r
ho
ur
£7
95
.0
0
–
–
–
–
A
m
bu
la
nc
e
se
rv
ic
e
£7
95
.0
0
Pr
od
uc
tio
n
of
D
V
D
fo
r
pa
ra
m
ed
ic
tr
ai
ni
ng
Fa
lls
sp
ec
ia
lis
ts
in
vo
lv
em
en
t
10
ho
ur
s
at
£4
0.
00
pe
r
ho
ur
£4
00
.0
0
–
–
–
–
A
m
bu
la
nc
e
se
rv
ic
e
£4
00
.0
0
COST-EFFECTIVENESS ANALYSIS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
64
Ta
sk
Si
te
1
Si
te
2
Si
te
3
D
at
a
so
u
rc
es
To
ta
l
B
as
is
o
f
es
ti
m
at
e
A
ct
u
al
co
st
B
as
is
o
f
es
ti
m
at
e
A
ct
u
al
co
st
B
as
is
o
f
es
ti
m
at
e
A
ct
u
al
co
st
Lo
ca
l
se
t-
u
p
co
st
s
Tr
ai
ni
ng
of
cl
in
ic
al
ed
uc
at
or
s
O
ne
se
ss
io
n
(4
ho
ur
s)
×
tw
o
tr
ai
ne
rs
at
O
/T
ra
te
s
(£
32
.2
5
pe
r
ho
ur
)
£3
33
.0
0
Tw
o
se
ss
io
ns
(in
cl
ud
in
g
pr
ac
tic
e
se
ss
io
ns
)
×
on
e
tr
ai
ne
r
at
£1
87
.5
0
da
ily
ra
te
£3
75
.0
0
Tw
o
se
ss
io
ns
×
on
e
tr
ai
ne
r
at
£1
87
.2
4
da
ily
ra
te
£3
74
.0
0
A
m
bu
la
nc
e
se
rv
ic
e
£1
08
2.
00
C
lin
ic
al
ed
uc
at
or
s
pr
ov
is
io
n
of
tr
ai
ni
ng
to
pa
ra
m
ed
ic
s
Fo
ur
se
ss
io
ns
(4
ho
ur
s)
×
tw
o
cl
in
ic
al
ed
uc
at
or
s
at
O
/T
ra
te
s
(£
32
.2
5
pe
r
ho
ur
)
£1
03
2.
00
Th
re
e
se
ss
io
ns
(7
.5
ho
ur
s
ea
ch
)×
on
e
tr
ai
ne
r
at
£1
87
.5
0
da
ily
ra
te
£5
62
.5
0
Se
ve
n
se
ss
io
ns
(7
.5
ho
ur
s
ea
ch
)×
tw
o
tr
ai
ne
rs
at
£1
87
.2
4
da
ily
ra
te
£2
62
1.
00
A
m
bu
la
nc
e
se
rv
ic
e
£4
21
5.
50
O
th
er
s
pr
ov
is
io
n
of
tr
ai
ni
ng
to
pa
ra
m
ed
ic
s
Tw
o
se
ss
io
ns
(4
ho
ur
s)
×
on
e
EC
P
at
£3
2.
25
pe
r
ho
ur
;
on
e
nu
rs
e
co
ns
ul
ta
nt
at
£4
0.
00
pe
r
ho
ur
£5
78
.0
0
n/
a
–
n/
a
–
A
m
bu
la
nc
e
se
rv
ic
e
£5
78
.0
0
Tr
ai
ni
ng
of
pa
ra
m
ed
ic
s
40
pa
ra
m
ed
ic
s
×
7.
5
ho
ur
s
at
£2
6.
00
pe
r
ho
ur
(O
/T
in
cl
ud
ed
in
th
e
ra
te
)
Tr
av
el
:
10
m
ile
s
at
£0
.4
5
pe
r
m
ile
£8
17
5.
00
26
pa
ra
m
ed
ic
s
×
1
da
y
tr
ai
ni
ng
(1
2-
ho
ur
da
y)
at
da
ily
ra
te
£2
62
.0
0
(O
/T
in
cl
ud
ed
in
th
e
ra
te
)
(1
.5
×
)
£2
1.
83
Tr
av
el
co
st
s:
80
m
ile
s
at
£0
.4
5
pe
r
m
ile
£7
74
8.
00
40
pa
ra
m
ed
ic
s
×
8
ho
ur
s
se
ss
io
n
+
ex
tr
a
O
/T
pa
ym
en
t
of
4
ho
ur
s
=
12
ho
ur
s
at
£2
1.
00
pe
r
ho
ur
Tr
av
el
:
40
×
tw
o
zo
ne
1
+
tw
o
tu
be
tic
ke
t
tr
av
el
ca
rd
s
at
£8
.0
0
£1
0,
40
0.
00
A
m
bu
la
nc
e
se
rv
ic
e
£2
6,
32
3.
00
C
os
t
of
ca
te
rin
g
fo
r
pa
ra
m
ed
ic
tr
ai
ni
ng
Fo
ur
se
ss
io
ns
×
£2
5.
00
pe
r
gr
ou
p
pe
r
se
ss
io
n
£1
00
.0
0
26
pa
ra
m
ed
ic
s
at
£5
.0
0
m
ea
la
llo
w
an
ce
pe
r
he
ad
£1
30
.0
0
40
pa
ra
m
ed
ic
s
at
£8
.3
4
pe
r
he
ad
£3
34
.0
0
A
m
bu
la
nc
e
se
rv
ic
e
£5
64
.0
0
Fa
lls
se
rv
ic
e
le
ad
s
de
liv
er
in
g
tr
ai
ni
ng
to
pa
ra
m
ed
ic
s
Fo
ur
se
ss
io
ns
(2
ho
ur
s)
×
on
e
fa
lls
se
rv
ic
e
le
ad
at
£4
0.
00
pe
r
ho
ur
Tr
av
el
:
£4
.0
0
pe
r
se
ss
io
n
£3
36
.0
0
n/
a
–
Fo
ur
se
ss
io
ns
(1
ho
ur
ea
ch
)
×
on
e
fa
lls
se
rv
ic
e
le
ad
at
£1
5.
60
ho
ur
ly
ra
te
Tr
av
el
:
fo
ur
×
tw
o
zo
ne
1
+
tw
o
tu
be
tic
ke
t
tr
av
el
ca
rd
s
at
£8
.0
0
£9
4.
00
A
m
bu
la
nc
e
se
rv
ic
e
£4
30
.0
0
co
nt
in
ue
d
DOI: 10.3310/hta21130 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 13
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Snooks et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
65
TA
B
LE
30
In
te
rv
en
ti
o
n
co
st
s
(c
o
n
ti
n
u
ed
)
Ta
sk
Si
te
1
Si
te
2
Si
te
3
D
at
a
so
u
rc
es
To
ta
l
B
as
is
o
f
es
ti
m
at
e
A
ct
u
al
co
st
B
as
is
o
f
es
ti
m
at
e
A
ct
u
al
co
st
B
as
is
o
f
es
ti
m
at
e
A
ct
u
al
co
st
Pa
rt
ne
rs
an
d
fa
lls
se
rv
ic
e
se
t-
up
an
d
im
pl
em
en
ta
tio
n
m
an
ag
em
en
t
co
st
s
Si
x
am
bu
la
nc
e
se
rv
ic
e-
sp
ec
ifi
c
m
ee
tin
gs
(1
5
m
in
ut
es
ea
ch
)×
on
e
op
er
at
io
na
ls
up
po
rt
m
an
ag
er
(£
32
.2
5
pe
r
ho
ur
);
on
e
he
ad
of
au
di
t
an
d
re
se
ar
ch
(£
49
.9
0
pe
r
ho
ur
);
on
e
cl
in
ic
al
tu
to
r
(£
32
.2
5
pe
r
ho
ur
);
on
e
le
ad
nu
rs
e
(£
32
.2
5
pe
r
ho
ur
).
Tw
o
fa
lls
se
rv
ic
e
m
ee
tin
gs
(6
0
m
in
ut
es
ea
ch
)×
th
re
e
fa
lls
se
rv
ic
e
te
am
le
ad
er
(£
40
.0
0
pe
r
ho
ur
).
Tw
o
LI
T
m
ee
tin
gs
(1
5
m
in
ut
es
ea
ch
)×
A
E
co
ns
ul
ta
nt
£5
0.
00
pe
r
ho
ur
£4
38
.0
0
Si
x
LI
T
an
d
ot
he
r
m
ee
tin
gs
(1
5
m
in
ut
es
to
di
sc
us
s
re
fe
rr
al
pa
th
w
ay
)×
tw
o
cl
in
ic
al
tr
ai
ne
rs
at
£2
1.
00
pe
r
ho
ur
;
fo
ur
fa
lls
le
ad
s
at
£1
5.
60
;
on
e
em
er
ge
nc
y
be
d
se
rv
ic
e
m
an
ag
er
at
£2
1.
90
pe
r
ho
ur
;
on
e
m
ed
ic
al
di
re
ct
or
at
£4
8.
90
pe
r
ho
ur
;
on
e
ar
ea
op
er
at
io
ns
m
an
ag
er
at
£3
0.
00
pe
r
ho
ur
;
on
e
te
am
le
ad
er
at
£1
8.
30
pe
r
ho
ur
£3
35
.0
0
Si
x
LI
T
an
d
ot
he
r
m
ee
tin
gs
(1
5
m
in
ut
es
to
di
sc
us
s
re
fe
rr
al
pa
th
w
ay
)×
tw
o
cl
in
ic
al
tr
ai
ne
rs
at
£2
1.
00
pe
r
ho
ur
;f
ou
r
fa
lls
le
ad
s
at
£1
5.
60
;o
ne
em
er
ge
nc
y
be
d
se
rv
ic
e
m
an
ag
er
at
£2
1.
90
pe
r
ho
ur
;o
ne
m
ed
ic
al
di
re
ct
or
at
£4
8.
90
pe
r
ho
ur
;o
ne
ar
ea
op
er
at
io
ns
m
an
ag
er
at
£3
0.
00
pe
r
ho
ur
;o
ne
te
am
le
ad
er
at
£1
8.
30
pe
r
ho
ur
£3
35
.0
0
A
m
bu
la
nc
e
se
rv
ic
e
£1
10
8.
00
Tw
o
op
er
at
io
na
ls
up
po
rt
m
an
ag
er
s
(£
32
.2
5
pe
r
ho
ur
);
on
e
he
ad
of
au
di
t
an
d
re
se
ar
ch
;
on
e
cl
in
ic
al
tu
to
r
(£
32
.2
5
pe
r
ho
ur
);
on
e
le
ad
nu
rs
e
(£
32
.2
5
pe
r
ho
ur
);
th
re
e
fa
lls
se
rv
ic
e
te
am
le
ad
er
(£
40
.0
0
pe
r
ho
ur
)
COST-EFFECTIVENESS ANALYSIS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
66
Ta
sk
Si
te
1
Si
te
2
Si
te
3
D
at
a
so
u
rc
es
To
ta
l
B
as
is
o
f
es
ti
m
at
e
A
ct
u
al
co
st
B
as
is
o
f
es
ti
m
at
e
A
ct
u
al
co
st
B
as
is
o
f
es
ti
m
at
e
A
ct
u
al
co
st
D
el
iv
er
y
co
st
s
RS
O
/p
ar
am
ed
ic
tim
e
pr
ov
id
in
g
fe
ed
ba
ck
an
d
cl
in
ic
al
su
pp
or
t
to
pa
ra
m
ed
ic
s
2
da
ys
pe
r
w
ee
k
at
£1
4.
70
pe
r
ho
ur
£2
06
.0
0
2
da
ys
pe
r
w
ee
k
×
RS
O
da
y
ra
te
£1
87
.5
0
£3
75
.0
0
2
da
ys
pe
r
w
ee
k
at
RS
O
da
y
ra
te
£2
52
.0
0
£5
04
.0
0
A
m
bu
la
nc
e
se
rv
ic
e
£1
08
5.
00
Tr
av
el
fo
r
on
go
in
g
cl
in
ic
al
su
pp
or
t
20
m
ile
s
pe
r
w
ee
k
in
le
as
e
ca
r
£3
03
.0
0
n/
a
£0
.0
0
n/
a
–
A
m
bu
la
nc
e
se
rv
ic
e
£3
03
.0
0
Fe
ed
ba
ck
fo
rm
s
fr
om
fa
lls
se
rv
ic
e
to
pa
ra
m
ed
ic
s
91
re
fe
rr
al
s
×
30
m
in
ut
es
pe
r
re
fe
rr
al
un
de
rt
ak
en
by
on
e
fa
lls
th
er
ap
is
t
at
£3
0.
00
pe
r
ho
ur
£1
36
5.
00
n/
a
–
10
0
re
fe
rr
al
s
(n
ot
al
l
w
er
e
el
ig
ib
le
)×
30
m
in
ut
es
by
fa
lls
th
er
ap
is
t
at
£1
5.
60
pe
r
ho
ur
£7
80
.0
0
A
m
bu
la
nc
e
se
rv
ic
e
£2
14
5.
00
To
ta
l
in
te
rv
en
ti
o
n
co
st
s In
te
rv
en
tio
n
co
st
s
to
ta
l
£1
6,
88
6.
00
In
te
rv
en
tio
n
co
st
s
to
ta
l
£9
52
5.
50
In
te
rv
en
tio
n
co
st
s
to
ta
l
£1
5,
44
2.
00
–
£4
1,
85
4.
00
N
um
be
r
of
el
ig
ib
le
pa
tie
nt
s
13
29
N
um
be
r
of
el
ig
ib
le
pa
tie
nt
s
54
4
N
um
be
r
of
el
ig
ib
le
pa
tie
nt
s
54
7
–
24
20
C
os
t
pe
r
el
ig
ib
le
pa
tie
nt
£1
2.
71
C
os
t
pe
r
el
ig
ib
le
pa
tie
nt
£1
7.
51
C
os
t
pe
r
el
ig
ib
le
pa
tie
nt
£2
8.
23
–
£1
7.
30
D
V
D
,
di
gi
ta
lv
er
sa
til
e
di
sk
;
n/
a,
no
t
ap
pl
ic
ab
le
;
O
/T
,
ov
er
tim
e;
RS
O
,
re
se
ar
ch
su
pp
or
t
of
fic
er
.
DOI: 10.3310/hta21130 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 13
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Snooks et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
67
TABLE 31 Published average unit costs
Health service resource
Average
unit cost
Range of unit
costs
Range of
annualised
equipment
costs (3.5%
discount)
Average
annualised
equipment
cost (3.5%
discount) Source
Ambulance attendance (patient
conveyed)
£230.00 – – – NHS Reference
Costs 2012–13122
Ambulance attendance (patient
not conveyed)
£174.00 – – – NHS Reference
Costs 2012–13122
ED attendance cost £115.00 – – – NHS Reference
Costs 2012–13122
Non-elective inpatient long stay
(4.0 days)
£2752.00 £531.00–9657.00 – – NHS Reference
Costs 2012–13122
Non-elective inpatient long stay
(excess days)
£230.00 £67.00–556.00 – – NHS Reference
Costs 2012–13122
Non-elective inpatient short stay £521.00 £133.00 –1376.00 – – NHS Reference
Costs 2012–13122
Falls service referrals £119.00 – – – NHS Reference
Costs 2012–13
(from ‘Hospital
at Home/Early
Discharge
Schemes’)122
GP surgery visit (average
11.7 minutes)
£43.00 – – – PSSRU (2013)123
GP telephone consultation
(average 7.1 minutes)
£26.00 – – – PSSRU (2013)123
GP home visit (average
23.4 minutes)
£110.00 – – – PSSRU (2013)123
NHS Direct £25.00 – – – BMA (2011)124
Community nurse home visit
(district nursing sister, district
nurse)
£70.00 – – – PSSRU (2013)123
Outpatient attendance (same as
non-elective inpatient stay
average short stay cost)
£467.00 – – – NHS Reference
Costs 2012–13122
Nursing/residential care weekly
(private) (average weekly cost)
£758.00 – – – PSSRU (2013)123
Nursing/residential care weekly
(local authority) (average weekly
cost)
£796.00 £415.00–1331.00 – – PSSRU (2013)123
Local authority day care (average
cost)
£40.00 – – – PSSRU (2013)123
Extra care package for older
people (average weekly cost)
£428.00 – – – PSSRU (2013)123
Adjustable shower stools and
chairs
£81.00 £14.00–148.00 £1.80–18.00 £9.90 PSSRU (2013)123
Perching stool with arms or back £23.00 – £2.70 £2.70 PSSRU (2013)123
Toilet frame and seat £30.00 – £3.60 £3.60 PSSRU (2013)123
Mobile shower chair £55.00 – £6.60 £6.60 PSSRU (2013)123
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TABLE 31 Published average unit costs (continued )
Health service resource
Average
unit cost
Range of unit
costs
Range of
annualised
equipment
costs (3.5%
discount)
Average
annualised
equipment
cost (3.5%
discount) Source
Bath step £20.00 – £2.50 £2.50 PSSRU (2013)123
Standard bath lift, two types £317.00 £303.00–330.00 £36.00–40.00 £38.00 PSSRU (2013)123
Linked bed raisers, pair £32.00 – £3.80 £3.80 PSSRU (2013)123
Adjustable trolley £34.00 – £4.10 £4.10 PSSRU (2013)123
High-back chair £121.00 – £14.50 £14.50 PSSRU (2013)123
Variety of indoor and outdoor
grab rails
£47.00 £3.40–91.00 £0.40–11.00 £5.70 PSSRU (2013)123
Walking sticks £38.00 £22.00–54.00 £2.60–6.40 £4.50 PSSRU (2013)123
Commodes £57.00 £29.00–85.00 £3.40–10.30 £6.85 PSSRU (2013)123
Wheelchair (per year) £89.00 – – – PSSRU (2013)123
Home care £42.00 – – – PSSRU (2013)123
BMA, British Medical Association.
TABLE 32 Health-care resource use over 6 months by group
Index
Intervention (n= 2391) Control (n= 2264)
Observed Total cost
Mean cost
(SD) Observed Total cost
Mean cost
(SD)
Routine data
Proportion conveyed at index
emergency services call
n/N (%)
1562/2391
(65.3%)
£503,506.00 £210.58
(£26.66)
1424/2264
(62.9%)
£473,680.00 £209.22
(£27.06)
Proportion attending ED
following index call n/N (%)
1419/2391
(59.3%)
£163,185.00 £68.25
(£56.50)
1311/2264
(57.9%)
£150,765.00 £66.59
(£56.79)
Proportion admitted to
hospital following index call
n/N (%)
906/2391
(37.9%)
– – 843/2264
(37.2%)
– –
Index hospital stays (nights
in hospital, truncated at
1 month)
12735 £4,628,754.00 £1935.91
(£3096.33)
10857 £4,057,019.00 £1791.97
(£2954.50)
Index hospital stays (nights
in hospital, truncated at
6 months)
18068 £6,033,134.00 £2523.27
(£5221.25)
15703 £5,274,639.00 £2329.79
(£4981.03)
Index falls service referrals 204 £24,276.00 £10.15
(£33.25)
26 £3,094.00 £1.37
(£12.68)
1-month follow-up routine data
Subsequent emergency
service callsa
662 £133,724.00 £55.93
(£153.64)
710 £143,420.00 £63.35
(£153.06)
Subsequent ED attendancesb 591 £67,965.00 £28.43
(£68.94)
552 £63,480.00 £28.04
(£88.41)
continued
DOI: 10.3310/hta21130 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 13
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Snooks et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
69
TABLE 32 Health-care resource use over 6 months by group (continued )
Index
Intervention (n= 2391) Control (n= 2264)
Observed Total cost
Mean cost
(SD) Observed Total cost
Mean cost
(SD)
Subsequent hospital stays
(nights in hospital, truncated
at 1 month)c
5375 £2,287,737.00 £956.81
(£2208.39)
4758 £2,042,487.00 £902.16
(£2168.19)
1-month follow-up self-reported questionnaire data
GP surgery visit 331 £14,233.00 £21.50
(£53.51)
359 £15,437.00 £24.20
(£58.99)
GP telephone consultation 404 £10,504.00 £15.87
(£34.67)
408 £10,608.00 £16.63
(£37.50)
GP home visit 325 £35,750.00 £54.00
(£119.76)
355 £39,050.00 £61.21
(£139.02)
NHS Direct 169 £4,225.00 £6.38
(£26.20)
158 £3,950.00 £6.19
(£26.45)
Community nurse (district
nursing sister, district nurse)
visit
588 £41,160.00 £62.18
(£145.55)
554 £38,780.00 £60.78
(£150.56)
Outpatients 420 £196,140.00 £296.28
(£692.51)
382 £178,394.00 £279.61
(£697.57)
Social service equipment
(adjustable shower stools,
walking frames, etc.)
– £1,686.00 £2.55
(£10.48)
– £1,432.00 £2.25
(£9.29)
Further home care/carer – £588.00 £0.89
(£6.05)
– £840.00 £1.32
(£7.32)
Local authority day care/
nursing/residential care
weekly/extra care package for
older people
– £0.00 £0.00
(£0.00)
– £0 .00 £0.00
(£0.00)
1-month self-reported
sub-total
662 £304,286.00 £459.65
(£809.09)
638 £288,491.00 £452.18
(£823.77)
6-month follow-up routine data
Subsequent emergency
services callsd
2712 £547,824.00 £229.12
(£505.58)
2825 £570,650.00 £252.05
(£539.13)
Subsequent ED attendancese 2014 £231,610.00 £96.87
(£159.99)
2063 £237,245.00 £104.79
(£314.41)
Subsequent hospital stays
(nights in hospital, truncated
at 6 months)f
26739 £9,521,458.00 £3982.21
(£6840.75)
26311 £9,307,534.00 £4111.10
(£6963.00)
6-month follow-up self-reported questionnaire data
GP surgery visit 682 £29,326.00 £83.55
(£175.15)
602 £25,886.00 £80.14
(£161.92)
GP telephone consultation 700 £18,200.00 £51.85
(£106.10)
528 £13,728.00 £42.50
(£88.15)
GP home visit 493 £54,230.00 £154.50
(£372.27)
410 £45,100.00 £139.63
(£321.09)
NHS Direct 393 £9,825.00 £27.99
(£93.32)
270 £6,750.00 £20.90
(£73.78)
Community nurse (district
nursing sister, district nurse)
visit
1100 £77,000.00 £219.37
(£418.91)
1078 £75,460.00 £233.62
(£447.88)
Outpatients 864 £403,488.00 £1149.54
(£2204.78)
736 £343,712.00 £1064.12
(£2053.32)
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TABLE 32 Health-care resource use over 6 months by group (continued )
Index
Intervention (n= 2391) Control (n= 2264)
Observed Total cost
Mean cost
(SD) Observed Total cost
Mean cost
(SD)
Social service equipment
(adjustable shower stools,
walking frames, etc.)
– £1,985.00 £5.63
(£18.80)
– £1,288.00 £3.99
(£12.85)
Further home care/carer – £462.00 £1.32
(£7.33)
– £630.00 £1.95
(£8.85)
6-month self-reported subtotal 351 £594,506.20 £1693.75
(£2759.19)
323 £512,553.95 £1586.85
(£2527.89)
Intervention 2391 £41,352.00 £17.30
(£0.00)
2264 £0.00 £0.00
(£0.00)
Totals for 1 month – £8,154,797.55 £3410.62
(£3597.28)
– £7,222,436.70 £3190.12
(£3526.34)
Totals for 6 months – £17,660,863.50 £7386.39
(£8619.93)
– £16,530,160.95 £7301.31
(£8594.00)
a Estimate of the intervention effect (in £, from fitted linear model, adjusting for statistically significant covariates) is
Δ= –10.42 (95% CI –20.04 to –0.79; p= 0.034).
b Estimate of the intervention effect (in £, from fitted linear model, adjusting for statistically significant covariates) is
Δ= –4.85 (95% CI –10.81 to 1.11; p= 0.110).
c Estimate of the intervention effect (in £, from fitted linear model, adjusting for statistically significant covariates) is
Δ= 58.46 (95% CI –66.86 to 183.78; p= 0.361).
d Estimate of the intervention effect (in £, from fitted linear model, adjusting for statistically significant covariates) is
Δ= –17.02 (95% CI –47.01 to 12.97; p= 0.266).
e Estimate of the intervention effect (in £, from fitted linear model, adjusting for statistically significant covariates) is
Δ= –21.97 (95% CI –40.89 to –3.06; p= 0.023).
f Estimate of the intervention effect (in £, from fitted linear model, adjusting for statistically significant covariates) is
Δ= –183.06 (95% CI –577.72 to 211.61; p= 0.363).
Adapted from Snooks et al.121 with permission from the American College of Emergency Physicians. Copyright © 2017
American College of Emergency Physicians. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
TABLE 33 Summary of health-care resource use over 6 months by group
Index
Intervention (n= 2391) Control (n= 2264)
Total cost Mean cost Total cost Mean cost
1-month follow-up
Cost of index call up to 1 month £5,361,085 £2,242.19 £4,684,558 £2,069.15
Routine costs by 1 month £2,489,426 £1,041.17 £2,249,387 £993.55
Self-reported costs at 1 month (imputed) £1,091,880 £456.66 £1,022,581 £451.67
Total costs by 1 montha £8,942,391 £3,740.02 £7,956,526 £3,514.37
6-month follow-up
Cost of index call up to 6 months £6,765,465 £2,829.55 £5,902,178 £2,606.97
Routine costs by 6 months £10,300,892 £4,308.19 £10,115,429 £4,467.95
Self-reported costs at 6 months (imputed) £4,013,668 £1,678.66 £3,592,630 £1,586.85
Total costs by 6 monthsb £21,080,025 £8,816.41 £19,610,237 £8,661.77
a Estimate of the intervention effect (in £, from fitted linear model, adjusting for statistically significant covariates) is
Δ= 190.24 (95% CI –13.83 to 394.31; p= 0.068).
b Estimate of the intervention effect (in £, from fitted linear model, adjusting for statistically significant covariates) is
Δ= 24.20 (95% CI –468.01 to 516.40; p= 0.923).
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Health-related quality of life
We estimated SF-6D utilities from questionnaires received at 1 and 6 months. However, the average
proportion of missing data items was 5.5% at 1 month and 10.1% at 6 months; therefore, we imputed
these missing items from the predicted SF-6D utilities adjusted for the number of reported deaths. The
resulting imputed SF-6D utilities were higher in the control group at 6 months, although this did not
achieve statistical significance. As the utilities were collected at 6 months, the QALYs gained by the
intervention group was –0.0026 (95% CI –0.0066 to 0.0014), that is more QALYs were gained by the
control group (Table 34).
Cost-effectiveness analysis
In summary, as there is no difference between groups in relation to resource use, the net cost of the
intervention is £17.30. There is also no statistically significant difference in the number of QALYs
generated between the two groups.
To test the extent to which this conclusion depends on the various assumptions we made, we conducted
sensitivity analyses based on the upper and lower bounds of the 95% CI for both net cost (using the
adjusted comparisons in Table 33) and net QALY (Table 35).
The sensitivity analysis highlights that the extent to which the SAFER 2 trial intervention can be regarded
viewed as being cost-effective is inconclusive. This is further evidenced by the cost-effectiveness plane in
Figure 7, generated from bootstrapping (5000 resamples). There is a net mean cost of £17.30, some
clinically important statistically significant differences in the number of subsequent emergency service calls
(at 1 month) and ED attendances (at 6 months), but no statistically significant difference in QALYs gained.
Conclusion
The relative cost-effectiveness of the SAFER 2 trial intervention is inconclusive, and further investigation is
warranted to establish whether or not it represents value for money. It has resulted in important difference
in the number of subsequent emergency service calls at 1 month and ED attendances at 6 months, but
no difference between intervention and usual care in relation to QALYs gained.
TABLE 34 Mean SF-6D utilities over 6 months by group
Index
Group
Intervention (A) Control (B)
Adjusted
comparison 95% CI
1 month
Derived SF-6D, mean (SD) [n] 0.5565 (0.1264)
[480]
0.5547 (0.1278)
[452]
Δ= –0.0011;
p= 0.893
–0.0173 to 0.0151
6 months
Derived SF-6D, mean (SD) [n] 0.5885 (0.1377)
[280]
0.5970 (0.1391)
[257]
Δ= –0.0078;
p= 0.509
–0.0311 to 0.0155
SF-6D (imputed), mean (SD) [n] 0.4695 (0.2351)
[2376]
0.4838 (0.2376)
[2249]
Δ= –0.0107;
p= 0.114
–0.0240 to 0.0026
QALYs mean (SD) [n] 0.2093 (0.0709)
[2375]
0.2133 (0.0713)
[2245]
Δ= –0.0026;
p= 0.202
–0.0066 to 0.0014
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TABLE 35 Sensitivity analysis
Parameter
Incremental cost of
intervention Incremental QALY Cost per QALY gained
Baseline (95% CI) £17.30
(–£475.01 to £509.40)
–0.0026
(–0.0066 to 0.0014)
Usual care is dominant. North-west
quadrant of cost-effectiveness plane
Upper 95% bound of net cost £509 – £363,857. North-east quadrant of
cost-effectiveness plane
Upper 95% bound of net QALY – 0.0014
Upper 95% bound of net cost £509 – Usual care is dominant. North-west
quadrant of cost-effectiveness
Lower 5% bound of net QALY – –0.0066
Lower 5% bound of net cost –£475 – £71,971. South-west quadrant of
cost-effectiveness plane
Lower 5% bound of net QALY – –0.0066
Lower 5% bound of net cost –£475 – Intervention is dominant. South-east
quadrant of cost-effectiveness plane
Upper 5% bound of net QALY – 0.0014
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FIGURE 7 Cost-effectiveness plane for the SAFER 2 trial intervention.
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Chapter 6 Qualitative results
Introduction
The qualitative component of the study was designed to find out how the intervention was experienced
both by patients and by paramedics and other stakeholders involved in delivering it. In particular, it aimed
to identify factors which facilitate or hinder use of the protocol and referral pathway. The SAFER 2 trial
intervention was hypothesised to work by improving the decision-making of paramedics in terms of safe
non-conveyance and referral of older people who have had a fall to appropriate community-based services,
leading to better outcomes for patients, reduced costs and improved paramedic skill sets. Through the
protocol, pathway, training, support and feedback, the intervention provided a formalised framework for
decision-making and referral for this patient group, in comparison with the informal approaches that
characterise existing practice. This is hypothesised to make a difference by one or more of the following
four mechanisms:
1. increasing paramedics’ clinical knowledge of how to make appropriate non-conveyance decisions
2. increasing paramedics’ knowledge of falls services and pathways for referral
3. increasing paramedics’ confidence about making a non-conveyance decision and reducing anxiety
about risk
4. increasing awareness of and likelihood that paramedics will consider non-conveyance and referral
pathways as an option in appropriate cases.
In order for the intervention to make a difference to practice and to patient outcomes, a number of factors
needed to be in place, including:
l effective referral pathways, and sufficient capacity in falls teams to respond to referrals
l training and support provided to paramedics that is appropriate and effective
l motivation on the part of paramedics to use the new protocol and referral pathway.
The qualitative component of the study aimed to examine the perspective of paramedics and other clinical
stakeholders on these hypothesised mechanisms and necessary factors. It also aimed to gather data from
patients to assess whether or not they were satisfied with the new intervention and whether or not, if
relevant, the referral pathways were effective.
To address how the intervention was experienced by patients, we interviewed 58 patients attended by
paramedics trained in the use of the new protocol from across the three sites, of whom 36 had been
transferred to hospital, 12 were referred to a falls service and 10 remained at home without a referral
(Table 36). Full details of sampling and data collection processes are given in Chapter 4. In this chapter,
respondents are identified by identification numbers: numbers beginning with 1 are from site 1, those
beginning with 2 are from site 2, and those beginning with 3 are from site 3, then participants in each site
are numbered sequentially in the order in which they were interviewed. An ‘H’ after the number indicates
that the patient was transferred to hospital, an ‘F’ shows that the patient was referred to a falls service and
an ‘N’ indicates that the patient had neither outcome and was simply left at home. Findings from all three
sites are written up together, structured by theme, with variations between sites noted when relevant.
In the majority of cases, the respondent is the patient. In 18 cases, a family member with caring
responsibilities also took part in the interview; where relevant in the text, quotations from carers are
indicated by a ‘c’ appended to the end of the patient identification number.
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As discussed in the qualitative data analysis section of Chapter 3, evidence is presented as anonymised
quotations to support explanation of complex ideas, provide illustration and deepen understanding. Most
quotations were selected to illustrate the majority view; however, some do convey exceptional viewpoints,
as noted. In some cases, quotations were selected to illustrate complexity or ambiguity of perspective,
as noted.
To address the experience of those delivering the intervention, we carried out focus groups and interviews
with paramedics who were randomly allocated to the intervention group across the three sites at two time
points: before the implementation of the intervention (24 paramedics) and after the completion of the live
phase of the trial during which patients were recruited (25 paramedics). After the completion of the
patient recruitment phase, we carried out focus groups and interviews with 31 stakeholders who had a
role in delivering the intervention (e.g. ambulance service managers, training officers and staff of falls
services). This chapter has been structured around themes related to the research questions and has been
informed by the theoretical underpinning for the study. It brings together findings from the different staff
groups and different sites, noting differences between sites when relevant. Table 37 summarises the
paramedic and stakeholder focus groups and interviews that took place.
How the intervention was experienced by patients
The fall in context
Every patient we interviewed described having a fall. Fifty-one respondents talked about the circumstances
of the index incident and what they felt caused it. The majority (28) of the falls were described as taking
place within the home, many of them trips and slips when moving around or using steps, and eight were
cases of respondents sliding off chairs or the bed. A further 11 of the respondents described falls in the
garden or outside the house, while hedge-trimming or watering plants, shovelling coal, putting the bins
out, and so on. The remainder of the falls happened while the respondent was out and about. A minority
of respondents described injuries resulting from the fall, ranging from fractures and being knocked
unconscious to cuts and bruises.
Some falls were described as having a clear mechanical cause, such as 2–6H missing his footing on a
stepladder while cutting the hedge. However, for many more, both inside and outside the home, the
cause seemed unclear, as in the case of one respondent who fell in her kitchen:
All of a sudden, I never felt it, it just . . . just . . . like it just . . . my mind went blank. I just felt myself
falling and when I looked around I was on the floor. So I thought to myself ‘silly bugger’.
3–21N
Many of the respondents explicitly stated that they did not know why they fell, while for a striking number
the fall was something which ‘just’ happened: ‘my leg just gave way’ (1–1H); ‘I just dropped’ (1–7F); ‘I just
slid down’ (1–2N), and so on.
TABLE 36 Number of patients participating in the qualitative interviews
Site
Transported to
hospital
Referred to falls
service
Neither transported
nor referred Total
Site 1 9 4 4 17
Site 2 15 2 2 19
Site 3 12 6 4 22
Total 36 12 10 58
QUALITATIVE RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
76
Others seemed to be seeking an explanation for why they fell:
But you know being in the middle of the night, waking up out of a sleep, you’re not very steady, are
you? I mean in the best of times.
3–9F
The falls happen like somebody’s switching off the light switch according to the doctor. It’s not a
stumble or a trip, it–, this is just a fall which happens [clicks fingers], which is related to probably blood
pressure or whatever. They are looking at the fact an epileptic fit may be involved here.
2–7H
TABLE 37 Summary of paramedic and stakeholder interviews
Site Data collection Participants
Site 1 Pretrial paramedic focus
group
Four paramedics
Pretrial paramedic
interviews
Two paramedics
Post-trial paramedic
focus group
Four paramedics
Post-trial stakeholder
focus group
Four stakeholders working for ambulance service: head of research and audit;
research project manager; operational support manager; and clinical quality manager
Post-trial stakeholder
interviews
Four stakeholders: ambulance service clinical team leader; and three falls team
leaders
Site 2 Pretrial paramedic focus
group
Four paramedics
Post-trial paramedic
focus group
Seven paramedics
Post-trial stakeholder
focus group 1
Three stakeholders working for ambulance service: R&D manager; clinical
effectiveness manager; and a research assistant
Post-trial stakeholder
focus group 2
13 stakeholders: community staff nurse; acute trust head of strategy; team leader;
community deputy team leader; team leader; district nurse team leader; district nurse;
team leader district nurse; district nurse; district nurse team leader; district nurse team
leader; district nurse team leader; and community sister
Site 3 Pretrial paramedic focus
group 1
Six paramedics, one clinical tutor
Pretrial paramedic focus
group 2
Eight paramedics
Post-trial paramedic
focus group 1
Seven paramedics
Post-trial paramedic
focus group 2
Seven paramedics
Post-trial stakeholder
focus group 1
Three stakeholders working for ambulance service: research manager; deputy
information manager; and clinical tutor
Post-trial stakeholder
focus group 2
Three stakeholders: senior ED clinical research nurse; falls co-ordinator and interim
head of falls team; and falls lead physiotherapist
Post-trial stakeholder
interviews
Two stakeholders: ambulance service medical director and library housebound service
manager
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In some cases this was expressed in terms of wanting to find an external cause for the fall:
But as I say the fact that I fell was simply something mechanical. I took a step back and I’d got a
saucepan in one hand and a spoon in the other so I wasn’t holding onto things as I usually do. It’s the
sort of thing that can happen to anybody, I think.
3–20N
Forty-three of the respondents described having had one or more previous falls, before the index incident,
although not all of these incidents would have been attended by an ambulance. Some seemed habituated
to falling:
Cause I’ve fell loads of times before.
1–11N
I have falls . . . I’m a faller.
3–18F
I can fall over at a drop of a hat, can’t I?
1–5H
However, while some of those who had previously fallen had said that they had managed to do so
without damage, and without professional intervention to get back on their feet, for others there was past
history of significant damage sustained in falling:
I said, ‘Oh my goodness, not again [wife’s name],’ ‘cause she’d broke the other hip 12 months ago.
1–4Hc
Thirteen of the respondents described having fallen again between the index incident and the interview.
For the majority of them, this was a single fall, or a series of minor falls dismissed as ‘little trips’ (3–5H),
but three described having had two or even three more major falls for which an ambulance had been called.
Patient experience of the ambulance service
Care
Respondents were asked to describe what happened when the paramedics arrived following the fall.
In terms of immediate care or intervention, much of the largest group of responses (n = 29) concerned the
patient being physically lifted, simply by hand, with the help of inflating equipment (n = 7) or in one case
with the help of a towel. A small number of respondents compared the experience of being lifted by the
paramedics with previous occasions when family, friends or neighbours had lifted them, sometimes
resulting in hurt to themselves.
A minority of respondents described other forms of treatment administered by the paramedic, such as the
dressing of wounds and the administration of pain relief, including morphine. In some cases, paramedics
advised the patient to contact the GP for further care needs.
More generally, respondents talked about the way in which paramedics delivered care and built rapport with
their patients. These comments were entirely positive across all three sites, and across all patient groups. The
very process of examination and asking questions was described by some patients as having a positive effect:
I was very impressed, they gave me confidence, I felt safe with them, I felt they’d looked at what they
needed to look at . . . yes they said to take painkillers and yes it was perfectly all right to have a drink
because I might be a bit dehydrated by now and they said–, and I thought, yes now you’ve seen me
I can do what I need to do.
1–6N
QUALITATIVE RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
78
I thought they were very good. I mean they dealt with it efficiently, the questions gave me confidence
. . . It was the confidence, you know you’re going to get a bit of pain but it’s the confidence they give
you that you can work at it.
3–11H
Paramedics were described as treating respondents with respect, making them feel safe, and generally
removing anxiety:
They put me at my ease lovely. I relaxed, I thought they were wonderful.
2–18H
Others used the words ‘fantastic’, ‘marvellous’, ‘efficient’, ‘caring’, ‘kindly’, ‘respectful’, ‘kind’, ‘nice’,
‘brilliant and a good laugh’ and ‘the nicest of all the public services’. This respondent reflected the overall
tone of the interviews:
I can’t praise them enough.
2–16H
Assessment and examination
Respondents were asked to describe the processes of assessment and physical examination which they
underwent after their fall. Recall of the details was frequently imprecise, not surprisingly, as the interviews
were done some months after the incident, and stress or memory problems may have clouded their recall.
Almost all showed patience with the assessment process and were positive in their reporting of it.
Respondents described in detail the various checks which paramedics went through:
They took me downstairs onto the ambulance and I was there for about half an hour. They were checking
me over . . . and they were very very thorough and they were very good as well . . . Yes they checked my
heart, blood pressure, they looked me over where I hurt myself and they were writing it all down which
I suppose goes to the hospital. They written down all the drugs and they knew what they were.
3–16H
Thorough 100% medical . . . They phoned up the GP and checked my medication and took my blood
pressure. They gave me a walking test and helped me . . . I was surprised at the thoroughness of the
test. I just took it as the normal procedure.
3–7F
From what I can remember, she was as thorough as any doctor, with the things that she did, didn’t she?
1–14F
One respondent was pleased with the manner and confidence with which the paramedics went through
the assessment, without referring to a ‘crib sheet’:
Oh, they were natural with it. They weren’t reading it up as we went, no . . . That would’ve affected
my confidence if they had done.
1–10H
The only respondent who expressed reservations about the assessment and examination process was
1–6Hc, whose wife was attended after a fall:
Don’t get out to a patient’s house when everybody’s frustrated and uptight and everything about
somebody being–, being very, very poorly and then start playing about with computers and, you
know, this sort of this nonsense . . . Initially I get a little bit worked up about the fact that they ask so
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many what–, seems to me to be extraneous questions . . . But they seem to ask so many questions
and you seem to be there forever and you think well, is all this relevant to taking somebody into
hospital that’s sick? You ring an ambulance in the first place because you think it’s urgent that they
need hospital attention, how can they burn all this time up?
1–6Hc
Those with previous experience of being attended by paramedics after a fall were asked to compare this
experience (index incident) with any other falls. Three said they felt that the assessment as part of the
SAFER 2 trial was more thorough, but the majority (n = 11) of respondents who made a comparison did
not think there was a difference.
It was pretty much the same . . . Pretty consistent and they always use the same sort of procedures.
2–17H
Well I didn’t know they were following a new process, it seemed exactly the same as the last time
they came.
3–19N
Decision-making
A minority of respondents described the process of decision-making which was informed by the
assessment and examination. These descriptions were almost exclusively in terms of the decision about
whether or not to attend hospital, rather than about referral to the falls team. One respondent, describing
how a decision was reached by the lead paramedic, seemed very positive about the use of a decision-
making tool:
And then eventually the young lady said, ‘I think you should go into hospital’, and . . . they took her
by ambulance to the hospital. It was a very straight cut simple sort of uncomplicated affair. Much
different to a lot of previous times we’ve called the ambulance.
1–4Hc
Not all the respondents were so clear about the process of reasoning which took place:
I didn’t know, they knew I had to get into hospital but I don’t think they knew what I had done, I’m
not sure about this, not that they missed anything, but I’m not sure, but they certainly were very sure
that I had to go to hospital.
3–9H
A few respondents described how the paramedics drew them into the decision-making process, offering
them the choice of whether or not to go to hospital: some decided to stay home, while others chose to go
in for additional examinations:
They gave me an option to go for a check-up in the hospital and I didn’t think it was necessary
because the hospital would have just done the same treatment I received from the paramedics.
3–7F
I wanted to go, I wanted to make sure if there was anything broken they would fix it.
3–16H
A small number, although advised by paramedics to attend hospital, exercised their right to refuse,
one of them in fairly strong terms:
They said it’s not just that we want you to go to hospital; we don’t know if a thorough enough
examination has been done. We want to feel sure that everything has been done and we haven’t
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done it. PLEASE go. And I said ‘On my head be it, I won’t go and if anyone wants to know – you
begged me to go . . . I don’t want to go to that bloody awful hospital.’
3–18F
But more common was a sense that the respondent put their confidence in the clinical skills and
decision-making of paramedics:
I mean, you rely on their judgement, don’t you?
2–11H
Patient experience: those referred to a falls service
Twelve of the respondents had been identified as having been referred to a falls service by the attending
ambulance crew. Respondents described being contacted within 2 weeks of referral at most, some within
a week, and receiving a range of interventions, such as 6-week courses in falls avoidance at a day centre,
home visits with exercise training, the installation of grab rails in the home, and equipment such as bed
levers and perching stools.
Among the respondents who had been referred to the falls service and had received input, satisfaction
was generally high:
Oh it’s the best thing that’s ever happened in my life.
1–8F
They’re tops. They really are. Not one of them you could fault. Very, very helpful . . . They’re
marvellous people. And so patient with you.
1–12F
I had wonderful care from [local authority]. Absolutely remarkable.
3–4F
Being identified as suitable for a falls service did not necessarily equate to receiving the intervention.
One respondent felt that the falls service offered nothing helpful, for another the intervention was stopped
for medical reasons and a third was identified as suitable for referral to a falls service, but refused it
altogether because:
I thought it was a waste of time really.
3–21N
Three respondents recorded as having been referred could not recall any contact, which may reveal a fault
with the recording system or with the referral system.
Although respondents were forthcoming about their views on the falls services themselves, it was hard to
disentangle any opinion on the process of being referred to the falls service as part of the SAFER 2 trial
intervention. One respondent was unusual in commenting on this, indicating that she felt some confusion
about the referral process:
Well, they just said to me when we–, ‘You know we have to refer you now to the falls team’ and so I
said, ‘Right’. But I wondered what’s the falls team? What it was all about.
1–12F
More generally, it was not always clear whether the intervention the respondent was talking about was
one which was delivered by a falls service associated with the SAFER 2 trial, or was actually a similar service
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delivered by another team or accessed through a different route. Respondents themselves were in some
cases unclear about this:
Well, I feel as though, yes, I mean I got this appointment at the falls, although the doctor, obviously,
did it, but I think it was through the SAFER 2 that they did it.
1–7F
Oh, sorry . . . I don’t know who arranged that then.
1–14F
Patient experience: those who attended hospital
Thirty-six of the respondents had been taken to hospital as part of the SAFER 2 trial. The care they received
in hospital varied greatly, from being ‘sent home with some paracetamol’ (1–1H), to being admitted for
surgery. Others were radiographed, stitched or were put in a cast, and a small number ended up with a
lengthy stay in hospital.
The majority of respondents had a positive evaluation of their visit to hospital. Generally, this was
expressed in terms of praise for the care provided by individual clinicians:
[The nurse] did fill me with confidence, you know, he was very, very good.
1–10H
The hospital staff, they were all absolutely wonderful, can’t rate them enough.
1–15H
They were very comforting, you know, they gave me confidence in them and they were thoughtful
and kind and helpful. I can’t praise them enough, nor the nurse that did the stitching.
2–16H
But, yeah, the doctor was marvellous, the people who done the X-ray, great. No problems.
2–6H
Two respondents stated explicitly that the decision to go in to hospital had been the right one, the wife of
3–6Hc suggesting that it ‘saved your life’.
However, for some the experience of attending hospital proved to be very frustrating. 2–6H was radiographed
for suspected broken ribs, although even after the radiograph, ‘they couldn’t say for sure if there was a break
or not’. Another respondent was reported by a carer as receiving even less in the way of an intervention:
We went into [ED] in the [hospital], we were there till quarter to three when a doctor eventually came
to see her. She had a quick look at her, asked me to get her off the bed and walk her, and because
she walked, to take her home . . . not even an X-ray to see whether she had broken her leg.
2–3Hc
Other negative aspects of attending hospital reported by respondents included delays in handover
and admission:
We were all lined up, it was like a production line, waiting to be handed over to the doctor.
2–10H
Another respondent mentioned the difficulty of getting only a one-way journey in the ambulance:
But, the only thing I have against all that, they’ll get you to the hospital but they don’t see about you
getting home again.
1–1H
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Patient health and quality of life since fall
Respondents were asked how their health had been since the fall, leading to extensive discussions not just
of health, but also of mobility and quality of life. Some patients made a comparison between their current
state and their prefall status, while others compared how they were at the time of the interview with their
immediate post-fall status; a few talked through the whole sequence of fall and recovery. A great range
of experience was described, across all three outcome groups, and all three study sites. It was not possible
to discern a clear pattern of difference between the three outcome groups, except that the group of
patients who had been taken to hospital, as might be expected, included some people with more
significant injuries.
A minority of respondents had very positive stories of recovery after the fall. These were most striking in
the case of people who had sustained fractures or other significant injury in the fall:
Getting better all the time.
2–10H
Mum is amazingly better. She walks around the whole house on her own. When she came back from
hospital she was actually moved with a hoist, she had no movement whatsoever and that has
changed dramatically.
2–17Hc
Among those who had been referred to a falls service, a minority described very clearly how the
intervention they were receiving was supporting an improvement in their well-being:
And now with the exercises . . . they show you to do, which I keep doing. I mean I couldn’t have
walked from here to the table at one time, now I can walk to the table . . . Walk round the house with
confidence, you know . . . not frightened of falling.
1–12F
Well I’m walking better and I’m feeling better in myself because I’ve gotten over the fall. And I try to do little
things. I haven’t quite got enough balance at the moment . . . and that’s what they’re trying to work on.
3–9F
Although there were positive stories of recovery, a larger number of respondents talked about the
increased limitations they experienced since the fall. This was a case of adapting what they did, taking
more care and keeping clear of risky places such as the garden:
I’ve been very careful . . . No I haven’t fallen since, I haven’t done any gardening though you see and
I’ve only done very little housework so I’ve tended not to do anything where I might fall.
1–6N
For some, having to accept these limitations was distressing:
I haven’t been up that road on my own since that happened . . . I used to go out once a week.
Yeah, I loved it. One leg wasn’t like 100% but I could do it. I can’t do it now, it breaks my heart . . .
I definitely can’t walk like I used to.
2–4H
For many of the respondents, it was a loss of confidence and a fear of falling that prevented them from
going out and about:
So I’ll freeze for fear of falling . . . Hoping to tell me legs where I want to go.
2–13H
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No but I won’t go out in the street on my own. I can’t, I just can’t, I just freeze. I go to that door,
I can’t even go out to the street door . . . Oh yeah. I used to go shopping and everything. I am
frightened I am gonna fall.
3–7H
Some expanded on this theme, talking about the fall as something which had pushed them a little further
along the inevitable journey into old age:
I have a loss of confidence, I am old but suddenly I feel much older. I feel a great sense of loss of
freedom, of a loss of independence . . . Somebody said to me what do I most miss and I said ‘being
out in the air’ I do stand at the back door, but I’m frightened of the stairs.
3–9H
I don’t get up around quite so much as I did. And it’s hard ‘cause I now, which I now, which I never
felt before, feel old. I am a bit nervous about doing physical things and where I’m going and should
I take my walking stick and things like that.
3–15H
I’m walking now and I start crying. Then they say why and I say all this things I don’t feel it before and
it’s my age.
3–1N
A large proportion of the respondents described their health, following the fall, as much the same as
before. However, many of these then went on to report pain, reduced mobility or lack of confidence since
the fall, presumably because they were thinking of these as being distinct from health. For example,
2–15H reported his health as being ‘just the same’ since the fall but went on to describe having to take
tablets for pain relief and now finding it hard to get up after sitting on the settee.
The patient in context: other health and social care provision
Nearly half of the respondents described the networks of health and social care provision which supported
their lives, much of which had direct relevance to preventing falls or managing their impact.
The most commonly reported form of support was an emergency alarm (also known as a Lifeline or
Linkline), mentioned by 12 respondents across all three study sites. These alarms feature a pendant carried
around the neck, which the user presses to call for help after a fall. For some respondents, they featured as
part of the story of the index incident; for others, they were mentioned more as a source of reassurance.
In all three areas, many respondents reported having previously been provided, through different routes,
with the type of support offered by the falls services associated with the SAFER 2 trial intervention.
This provision included the fitting of grab rails and other adaptations to the home, equipment such as
commodes and walking frames, and physiotherapy. Routes to accessing services varied; for one
respondent, the GP functioned as an effective gateway:
Well apparently if you fall more than a certain number of times in a year, it has to be reported which
my GP did, so I had a occupational therapist came out to see me and a physiotherapist. And they
sorted out all the things, the aids that they thought I would need, namely a trolley and the second
hand rail on the stairs, and grip rails everywhere, which I’m thankful for.
1–5H
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One respondent described how previous falls had acted as a trigger to push her up the waiting list:
Then when I had that fall, she got a bit worried so it moved up a bit to the next one, I moved up, and
that’s how it’s been going on, moving up and moving up to the next one ‘til they found time to come
down and assess me.
3–9F
An alternative route to provision was on hospital discharge, which was cited as a way of accessing both
practical home care for a limited period, rehabilitation (described by one as ‘walking stick instructions’
3–13H) and a range of useful equipment such as trolleys which contributes to falls prevention. These
routes to access were not always straightforward, with two respondents describing having gone through
the assessment process but then being found not eligible for support.
They did send an [occupational therapist] out to me, but she wasn’t very good, I didn’t end up getting
anything . . . But my husband has–, well, we’ve been trying to get a rail for the bath for years, each
time he’s had an assessment, but we never get it.
1–8F
Other respondents described other forms of health or social care that contributed to their well-being at
home, including specialist falls clinic, foot clinic, pain clinic and visits from the district nurse. A small
number of respondents described support which they paid for themselves, outside the range of public
sector or third-sector provision. In two cases this was people employed to help with cleaning, laundry and
gardening; in another three cases it was privately purchased equipment, such as a specialist bed, while two
reported paying privately for physiotherapy.
How the intervention was delivered in practice: paramedic and
stakeholder views
Paramedic and stakeholder expectations of the new intervention (pre trial)
Both paramedics and stakeholders expected significant usage of the new referral pathway. Paramedics
thought that the new referral protocol would be utilised widely if it was simple to complete.
I do think it can’t be too difficult to do that referral, that’s going to be the biggy. It’s whether it takes
an hour to sort something out. It needs to be a 5/10-minute phone call and ‘yeah, no problem’.
Site 1 paramedic
If you make it a 20-page document people are not going to go with it.
Site 3 paramedic
Paramedics believed that patient care would be improved through the intervention, through avoidance of
ED and through referral to a falls prevention service.
Once they can determine why the patient’s having the falls, it could be just poor housing, rugs, things
like that, slippers, could be medical, could be down to their medicines what they’re taking, . . . it’s got
to build their confidence, it’s got to do.
Site 1 paramedic
Paramedics from all three study sites expected personal gains, including an increase in job satisfaction
resulting from offering a more complete care intervention:
You feel like you’re finishing a job. You’re not leaving it half done. You know, it’s ‘Doris has fallen
again, we’ll go back to her tomorrow’ [but] ‘Oh Doris is fallen, she’s being referred, someone is
looking after her’.
Site 1 paramedic
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You’ll feel like you’ve actually achieved something for the patient because you’re not actually just
moving them along on a conveyer belt to hospital. You’ll feel that you’re actually benefiting them.
Site 3 paramedic
With the exception of one, paramedics believed that the intervention would increase time on-scene.
Paramedics from sites 2 and 3 expressed anxiety on how the control room would respond to an increase in
the time on-scene.
If you’re leaving people at home you need to do the checks to make sure they’re safe to stay, that’s
the thing isn’t it, you can’t just do a quick blood pressure, a quick pulse . . . then go. You know, in the
real world of course it isn’t like that and I think a lot of people up in like control, they think it is like
that and it’s not . . .
Site 3 paramedic
The referral bit will take time. I don’t know how control will feel about that.
Site 2 paramedic
Despite paramedics’ worries, ambulance service managers in sites 1 and 3 did not feel that increases in
time on-scene would be an issue.
I have no problem with paramedics spending an extra half an hour, three-quarters of an hour
on-scene doing a thorough assessment that’s appropriate for the patient. And at the end of the day,
the call cycle time will still be quicker than going into ED.
Site 1 stakeholder
I don’t necessarily think that time constraints on-scene would be a problem, I mean most paramedics
are quite adamant that time on-scene is my time, I’m not going to get any pressure from, you know,
control, if I’m with a patient then that’s the time that I need so I don’t think that that would have any
impact on them referring or not referring.
Site 3 stakeholder
Concern was raised by falls team leaders at the number of referrals that would be received the trial, and
the capacity of the services to deal with this, although one spoke of plans to bring in locum staff in order
to cover increases in demand for their service.
Paramedics’ and other stakeholders’ experiences and views on context and
existing practice
The majority of paramedics felt that current practice does not provide appropriate care to elderly patients
who fall. Paramedics from all three of the ambulance services stated that current practice involved
assessing patients for injuries, and depending on the outcome of the assessment and patient preference,
conveying the patient to an ED, leaving the patient at home with no onward referral, or leaving the
patient at home and referring to their GP. In two of the three sites (sites 1 and 3), there had been previous
attempts to set up alternative pathways for elderly patients who had fallen, referring them to, for example,
intermediate care teams, rapid response teams, district nurses and physiotherapy services, although these
pathways had fallen out of use.
Overall, paramedics felt that they are able to make decisions regarding leaving patients at home and
onward referrals, but they lack the referral pathways to properly undertake this. This was stated explicitly
by a paramedic within site 1, with paramedics from sites 2 and 3 stating that they routinely make decisions
regarding patient conveyance.
But this has been happening for years hasn’t it. We’ve never had anything put in place. I’d say we‘ve
got more access to more places now than we’ve ever had, and it’s still not enough . . . because nine
times out of 10 we know exactly what that patient needs, and we just can’t access it.
Site 1 paramedic
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The process of deciding whether a patient stays at home or is referred to hospital is not always a
straightforward one, and paramedics gave examples from existing practice where patients and paramedics
disagreed. These were most striking in cases in which a patient wished to stay at home, but the paramedic
felt, based on clinical assessment, that they should go to hospital; in these reported cases the paramedic’s
view prevailed, in part because of anxieties about risk:
I had a lady the other day, she clearly needed to go in and she was arguing with us for half an hour.
I think we just wore her down in the end, but she had to go.
Site 2 paramedic
You bully them, you do. You bully them to some extent ‘cause you think, I’m not risking it.
Site 2 paramedic
A number of paramedics discussed their anxieties about the risks of leaving a patient at home following a
fall, worrying both about the patient, and about any comeback on the paramedic if it were to turn out to
be the wrong decision:
I always think back at the end of the shift, oh God, I hope they’re all right.
Site 2 paramedic
At the back of our minds, it’s always gonna be . . . ‘am I gonna be wrong, am I gonna get in trouble’,
you know, not that anybody wants to do anything wrong, not that we’d purposely do it. We’re always
trying to do the right thing, but if you miss something for whatever reason, and we’re only human, . . .
what are the ramifications gonna be?
Site 1 paramedic
Paramedics within sites 1 and 3 discussed the concept of ‘covering their backs’ when attending an elderly
patient at home following a fall, in order to mitigate the risk of action against them if something were to
go wrong. In some cases, this resulted in the patient being conveyed to hospital even if the paramedic
could not see a clear clinical need:
Sometimes we convey the patient when quite clearly they didn’t need to go in. In essence you feel like
you need to cover your own backside because nobody else will.
Site 3 paramedic
Referrals to GPs were seen as problematic in all three sites: paramedics were not confident that the GP
would respond to a referral (owing to not realising the urgency or simply not receiving the referral) or that
they would make an onward referral if appropriate:
They [GPs] just don’t seem to understand they have options as well, that they can refer people on.
I just don’t trust the GP to make that choice, to know that there are more choices. It’s alright for us,
we know we can refer onto social services . . .
Site 3 paramedic
Paramedics’ professional status was seen as an important factor in the ability of paramedics to consider
alternatives to conveying patients to the ED. One paramedic appeared to express frustration that the
potential of paramedics to act as the gateway to a range of care services was untapped:
I went to a fall, and there was a district nurse who turned up just after I got there, . . . and the questions
she got asked, and the ease of [the district nurse] getting that person respite – I was just gobsmacked at
how easy it was. All those questions I could have just easily done . . . I think that paramedics have
generally been seen as just take them to hospital, they haven’t been seen as having any clue.
Site 1 paramedic
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Pay, and the responsibilities attached to it, were mentioned by paramedics (although not managers) as an
issue in sites 1 and 2:
Yeah, people are like, ‘Well I don’t get paid to [undertake additional decision-making to leave patients
at home] so why should I do it?’ So then everybody goes to hospital, so then you’ve got an A&E then
that is absolutely chocca full of people who could possibly have been treated elsewhere by a
different pathway.
Site 2 paramedic
Experience of implementing the Support and Assessment for Fall Emergency
Referrals 2 trial intervention
Post trial, paramedics and stakeholders reflected on the process of implementing SAFER 2 trial as part of
the research study. Paramedics stated three main reasons for volunteering to take part in the study:
persuasion by a colleague; opportunity for personal development and learning new skills; and
dissatisfaction with existing practice, in terms of both the lack of referral options available and the
frustration of multiple attendances to patients for falls.
And you’re taking somebody in and you know you’re going to be straight back out because, you
know, so if there’s something that you can stop from going in so it’s not a . . . waste of resources.
Site 2 paramedic
In sites 2 and 3, parallel developments of other pathways, while the SAFER 2 trial was under development,
were felt to have led to confusing messages for paramedics:
It made it quite complicated from a local point of view, so I had 30 paramedics who were trained as
intervention paramedics and 60 who weren’t and trying to tell them, ‘No, you can’t choose the
[SAFER 2] one yet,’ ‘Oh but we have seen adverts everywhere and we’re getting letters from operations
directors saying we must refer patients,’ ‘Well no you can’t.’ So it was quite complicated getting the
right message out to the right staff, I think we got there but it was quite challenging to do that.
Site 3 ambulance manager
In all three ambulance services, the majority of managers felt that implementation of the SAFER 2 trial
intervention had an impact on their role and workload during the initial phases of the study, when
paramedic training was being carried out, but less so in the latter parts of the study:
[My involvement] all seemed to be very front loaded and then I think I lost my way, if I’m perfectly
honest with it, during the latter–, I’d still come to the meetings and stuff, but once the training was
there and everything was set up, it was almost like, right, sort of sit back and watch what happens.
Site 1 manager
Factors which enabled/encouraged the use of the Support and Assessment
for Fall Emergency Referrals 2 trial intervention
According to the paramedics, usage of the new referral pathway was encouraged by its simplicity.
Overall, paramedics were positive regarding the suitability of the training they received. One paramedic
compared the benefits of the SAFER 2 trial training to previous training for novel ambulance service
interventions, which (as at the other two sites as well) seemed to be limited to e-mail or notice
board updates.
Well, there hasn’t been any training apart from this [the SAFER 2 trial training], . . . I mean this has
been superb really, you know. You get to sit and relax and get trained on it but the new pathways are
reading a piece of paper and acting on it. So, we’re not trained on it [previous pathways].
Site 1 paramedic
QUALITATIVE RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
88
Only one stakeholder commented on the value of the SAFER 2 trial training, and in positive terms:
The [paramedics] have now had some training that’s been approved by some specialists so they feel
very confident now at making those decisions with the backing of this triage tool.
Site 3 stakeholder
Paramedics in all three trial sites stated that they were aware of the clinical support available to them
throughout the trial, although the majority did not actively seek clinical support at any point during the
trial. Paramedics in all sites thought newsletters and e-mail updates were important to provide feedback
and so maintain the motivation to refer:
[The newsletters were] a kind of confirmation that you are doing the right thing. I can’t remember any
specific points but I remember one and I don’t know what it was, I can remember reading it and
thinking, oh yeah, OK, I’m doing that so I’m doing the right thing.
Site 3 paramedic
Factors which hindered the use of the Support and Assessment for Fall
Emergency Referrals 2 trial intervention
Both stakeholders and paramedics reported aspects of paramedic practice and the organisation of the
ambulance service which hindered use of the SAFER 2 trial intervention. Paramedics from all three sites
stated that taking a patient to the ED was often the easier option, especially when nearing the end of
a shift.
You’ve got a lot of paramedics who, anything for an easy life – ‘I’ll go back take them to [ED] . . .
Some of them want to do the best so they get off on time, or don’t have a late finish, or least path
of resistance.
Site 1 paramedic
Time of day, coupled with the patient’s social situation, was mentioned by paramedics as affecting their
ability to make a referral. Paramedics from all sites stated that they would feel uncomfortable leaving an
elderly patient at home late at night without support, even if they were not injured. A small number of
paramedics stated that a more immediate intervention than SAFER 2 trial was required by paramedics in
order to assure confidence when leaving a patient at home.
I think if we had, as you said earlier, a direct phone number to a person that we knew was going to
come out here in 2 or 3 hours, we’d maybe feel a little bit more confident to leave her there.
Site 2 paramedic
Paramedics said they often forgot to refer when on-scene, this being influenced by the time of day and
the amount of time they had already been on the road.
At different times of the day . . . you’re more tired, so you do occasionally leave the scene and then
think, ah, I haven’t done that [the SAFER 2 trial decision tool].
Site 2 paramedic
Ambulance service managers were aware of this, one suggesting that the use of the SAFER 2 trial declined
over time:
I just feel that–, possibly ‘cause it’s over 12 months they did it– and . . . there wasn’t any other trigger
mechanism to trigger them to participate actively, participate. And bit by bit, they started just
to forget.
Site 1 clinical tutor
DOI: 10.3310/hta21130 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 13
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Snooks et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
89
In contrast to examples described in Paramedics’ and other stakeholders’ experiences and views on context
and existing practice of paramedics persuading patients that they needed to go to hospital, they also
described examples of patients, or those who cared for them, putting pressure on paramedics for a
hospital transfer, even where paramedics might propose that a patient be left at home with a referral to a
falls team. Even though the SAFER 2 trial decision tool had been used, paramedics were frustrated in
taking the recommended step to refer to a falls service:
You feel pressure. When you attend elderly fallers, you face pressure from the families, their next door
neighbours, . . . generally speaking that patient will take the advice of their next door neighbour and
they’ll go to the hospital. So we face a lot of pressures from around us to take them in. The family will
say, ‘Oh, I’d prefer her to go in and see a doctor. I’d rather she went in and had an X-ray,’ even if you
explain that they don’t X-ray people routinely. So there’s a lot of pressure around taking them in.
Site 2 paramedic
You’re dealing with a frail, elderly group and often with little support in the community . . . added to
which I think there is still the ‘you call, we haul’ mentality . . . call for an ambulance, you expect to go
to hospital, that’s what we’ll do then.
Site 3 stakeholder
Obtaining consent from patients to refer to the falls team was seen as an issue in all sites:
Patients didn’t want to be referred, we meet a lot of obstinate people who [laughs]–, ‘Get me off the
floor, get me bed, I don’t want anything else from you and I’ll be calling you back tomorrow night’.
Site 3 paramedic
Paramedics and managers also reported that it could be difficult to ascertain from patients if they already
have involvement from such a service, or from an equivalent service:
If you went to a couple of falls to the same person and in the meanwhile they’d had an intervention
of some description from a falls team, they might not immediately recognise that as being the
intervention . . . It’s really quite hard, I think.
Site 1 ambulance service manager
And we just feel, are you going on overkill almost, you know, if you start referring to another little
team, you know, and they’ve already got this, that and the other coming in? You feel you’re just
repeating things.
Site 1 paramedic
Paramedics reported particular issues to do with referrals of patients living in nursing homes, where the
referral to the falls service could be seen by nursing home staff as threatening:
If you referred somebody in their own private address, it was welcomed because you explained the
package . . . But in the nursing home environment, you felt as though you were actually putting them
on the spot . . . they were being scrutinised because they weren’t providing the care or the facilities as
what was available.
Site 2 paramedic
Paramedics in sites 1 and 2 saw lack of information regarding the role of the falls teams as an issue,
specifically the time frames for initial contact and the interventions provided. Paramedics suggested that
increased knowledge of the intervention would have positively influenced the number of referrals.
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Evident across all interviews with ambulance service managers were some gaps in communication between
them and the study paramedics. Although paramedics spoke of the importance of clinical support in the
initial stages of a new pathway, most managers stated that they had not spoken directly to paramedics
about the study and had not provided clinical support to study paramedics, with one manager in site 1
describing the difficulty of ‘catching’ a paramedic in order to discuss progress. Paramedics in all sites told a
similar story.
[Asked if management were supportive of paramedics being involved in the trial] No one ever
said anything.
Site 1 paramedic
I don’t think they [ambulance service managers] knew who was taking part and who wasn’t.
Site 2 paramedic
Impact of the Support and Assessment for Fall Emergency Referrals 2 trial
intervention on paramedic practice
The Clinical Decision Flow Chart, used by paramedics on-scene, was felt to be a useful aide-memoire, but
its impact on practice was variable. Paramedics from all three sites discussed a process of ‘settling in’ to the
new assessment and referral process after their training. Many paramedics stated that it took time to get
used to using the Clinical Decision Flow chart, but once they had, it was only used to remind them of
specific details on-scene.
The more you used it, the less you needed to refer to it, or only certain points or anything. And if you
weren’t sure about something then you’d–, oh, just let me go and check on that. So once you got
used to it, as I say, it was very straightforward to use.
Site 2 paramedic
I found it useful as a memory jogger.
Site 3 paramedic
For those based in sites 1 and 3, the flow chart did not contain any new procedures that were not already
undertaken on-scene, apart from the referral to the falls team:
I think it [the flow chart] just reinforced what we already know. I guess . . . we’re all used to dealing
with falls.
Site 1 paramedic
In site 2, by contrast, the flow chart was felt to bring new assessment techniques into practice, to which
paramedics responded positively:
I never did two blood pressures on people, when they were on the floor and when they got up. That
didn’t cross my mind. So you know that was definitely a learning curve, so that’s given us extra skills.
Site 2 paramedic
Paramedics from all three sites felt that the SAFER 2 trial did not bring about significant changes in
decision-making on-scene; paramedics felt that the decision to convey or leave a patient at home was a
decision that they often made with some confidence but the new referral protocol ‘reinforced what they
already knew’.
Paramedics in sites 1 and 2 stated that the SAFER 2 trial intervention increased their confidence to leave a
patient at home through two mechanisms: the reassurance that the falls team will contact the patient and
the confidence in the assessment of a patient who has fallen. Paramedics within site 3 only stated the
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former. Opinion of ambulance service managers was split between those who thought the confidence had
increased, and those that believed that confidence was still an issue.
People are very confident, they are happy making those decisions [not to convey a patient to A&E]
I’d say in general.
Site 3 manager
One of the things that we’ve highlighted as a possible reason [for not referring patients] is the lack of
confidence, which is meaning that people aren’t leaving patients at home that could be possibly left
at home.
Site 1 operational support manager
Paramedics from all three sites thought that the new pathway increased time on-scene, mainly through
three mechanisms: increased time undertaking patient assessment, increased time recording patients’
assessment on PRF, and time spent on-scene making the referral to the falls team. Paramedics within site 3
discussed ‘welfare checks’ (a call from the control room to ensure the welfare of the paramedic after a
certain period of non-communication), which the paramedics perceived as ‘hurry-up checks’. One
paramedic realised a benefit to spending more time on-scene with the patient:
I think for the length of time that we would have been there before SAFER 2–, ‘cause you know,
obviously when you actually do the referral it takes up to an hour, so then you get to see the patient
sort of in their own environment and possibly doing things that you wouldn’t normally because you’d
probably just take them down the hospital.
Site 3 paramedic
Impact of the new pathway on falls services
Falls service representatives from all three sites commented on the appropriateness of the referrals made
from paramedics; the majority of patients were thought to have been referred appropriately, although one
falls service representative suggested some were not:
. . . there were some who maybe should have gone into hospital and actually not being kept at home.
Site 3 stakeholder
Representatives stated that the referrals they received through the SAFER 2 trial were a mix of patients
already known to the falls services, and patients of whom the falls services had not previously been aware.
Falls service team leaders from sites 1 and 3 reported that the newly identified patients referred through
the SAFER 2 trial were often more frail than those normally receiving treatment from falls teams; a number
of patients referred had subsequent A&E attendances and emergency service calls between the referral
being made and contact with the falls teams.
The impact of paramedic referrals on the falls service differed between trial sites. In site 2, falls service
representatives reported the impact as substantial in terms of paperwork, time and difficulties with onward
referral, although the assessment and onward referral process was not thought to be very different from
normal practice.
It was a bit of a put off really, and I have to be honest, when the referral come through . . . you were
sort of like dreading it a little bit.
Site 2 falls service representative
Representatives from sites 1 and 3, however, felt that the new referral pathway did not impact significantly
upon the service, with representatives in site 3 commenting on the positive impact of the new pathway on
their falls service.
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I think the response time was quite interesting ‘cause ours was a community team, we had a response
time and within 1 to 10 days or quicker . . . What SAFER 2 did was . . . it made us firm up a few
systems in our single point of access to flag up these fallers, patients, with the SAFER 2 you know,
they go on the top, they need to be prioritised so we had to do a bit of work around that which was
I think good for the service to kick in a sort of more urgent response, which we hadn’t had before, we
weren’t an urgent sort of rapid response team. But after SAFER 2 we had that ability.
Site 3 falls service representative
A number of representatives discussed receiving repeat referrals for the same patient; this was generally
felt to be useful, helping to identify gaps in current patient care.
At a personal level, falls service representatives from sites 1 and 3 were positive about their involvement in
the study, stating that it was ‘worthwhile’ and ‘enjoyable’. Despite the difficulties, representatives within
site 2 were also positive regarding their involvement.
Keeping people well and healthy in their own homes for longer, so I’m glad we did take part. And I
think it is something that, you know, the health board will look to develop further in future, but you
know, we do need to make sure we get it right, and address some of the issues that you’ve all raised.
Site 2 falls service representative
Suggestions for modifications or developments of the Support and
Assessment for Fall Emergency Referrals 2 trial intervention
Participants suggested modifications in four categories: the project set-up, training, patient assessment and
referral processes/post referral. Suggested modifications differed by study site, reflecting the variety of
issues experienced across the sites.
In sites 1 and 3, ambulance service managers suggested that key ambulance service staff should be
involved as soon as possible in the set-up of a study, to make important decisions on behalf of the trust
and to have input into the study design and data collection methods.
Falls service representatives from site 1 identified training as an issue, although their equivalents in the
other two sites did not, perhaps reflecting the more limited involvement falls service representatives had in
training in site 1. A falls service representative from site 1 suggested that training in the SAFER 2 trial
should be carried out at regular intervals, in order to include and update more paramedics:
Going back to the training really and maybe just doing some supplementary training and . . . some
scenarios with them . . . a quick half hour would have been enough just to say, ‘Thank you for your
referrals, thank you for your interest’, . . . they could think of patients that they thought of, ‘oh yeah
well I maybe could have referred that lady but she seemed quite fit . . . she seemed quite able but
she’d had a couple of falls’.
Site 1 falls service representative
Paramedics in sites 2 and 3 felt that the clinical decision flow chart needed to be simplified, to include less
routine information, and more about the causes of falls:
I think on the flow chart if you’re looking at possibly improving it maybe something a bit more . . .
shorter version, maybe tick box type of thing.
Site 3 paramedic
On the flow chart, the current one, sometimes there was a bit too much information.
Site 2 paramedic
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One site 3 paramedic felt that a smaller A5-sized flow chart would be better as it would to fit into
paramedics’ pockets, to allow improved access on-scene. By contrast, other stakeholders across all sites did
not comment on the flow chart being an issue.
Paramedics within both sites 1 and 3 felt that the decision to convey a patient would be easier to make if
they had access to patients’ records on-scene.
A copy of what their blood pressure is normally like, their normal observations so then . . . we can see
it’s . . . abnormal and then it’s going to help our decision-making whether we’re going to leave them
or not.
Site 3 paramedic
In site 1, electronic patient report forms (ePRFs) were implemented during the study period, and
ambulance service managers suggested that patient assessment could be improved if the ePRF included
prompts to remind paramedics to consider a referral to the falls service. An assessment checklist on the
ePRF was also considered beneficial by stakeholders.
. . . putting something on to the electronic Toughbook[® Panasonic, Newark, NJ, USA], create some
sort of mandatory check. You know, . . . do not pass go unless you have notified the falls team, etc.,
whatever it might be, so there is some sort of check there built into the system and–, so it’s
programmed and you’ve identified there’s a fall . . . for me, that way there, you will ensure that you’ve
actually triggered the response that you want, to trigger it, it’s going to be referred.
Site 1 clinical trainer
Other suggested improvements included increasing the number of people on telephone lines receiving
referrals, increasing the capacity to refer (suggested by a site 2 paramedic), and providing an information
sheet to referred patients to help them understand ‘what will happen next’ (site 3 paramedic).
Improvements to the feedback process were suggested by paramedics from all three study sites, and by
stakeholders in site 1. Paramedics from sites 1 and 3 argued for prompt feedback following a falls service
referral, while a paramedic from site 2 explained that confirmation that the patient received the
intervention would increase their confidence in the referral process:
We weren’t sure what happened after we left. There was a presumption that they were going to be
seen. It would have been nice to have some feedback to say that Doris has been seen yesterday and
this has been done, so that you know it’s working rather than presuming it’s working.
Site 2 paramedic
Summary of qualitative findings
Patient experience
We used the qualitative phase of research to assess whether or not patients were satisfied with the new
intervention and whether or not, if relevant, the referral pathways by which we had hypothesised that the
SAFER 2 trial intervention would make a difference were effective.
Almost all the respondents were very satisfied with the processes of assessment and examination carried
out by paramedics and tended to see them as part of a relationship based on empathy and care. The
majority of those who were in a position to make a comparison between the SAFER 2 trial encounter with
the ambulance service and a previous contact after a fall could not see much difference in the assessment
and care delivered. When patients talked about having a say in decision-making, it was generally in terms
of whether or not they would travel to hospital, not in terms of whether or not they wished to have
contact with the falls service.
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Even when patients were referred to the falls service, this did not necessarily lead to them receiving an
intervention. Patients referred to falls services may in practice have come by many and various routes.
Many of the patients in the SAFER 2 study were already tapping into a complex, and potentially confusing,
network of community-based services, delivered by a range of providers (NHS, social services or
third sector).
Although some patients reported good recovery after their fall, many had lasting ill-effects, with loss of
confidence a major issue. Many worked out their own ways of reducing risk of a future fall, but at some
cost to their quality of life.
For the vast majority of patients, the index incident was not the first fall they had experienced, although
previous falls may not have resulted in contact with the ambulance service, and many went on to have a
subsequent fall. Some seemed quite habituated to falling. Many falls were reported by patients as having
an unspecified or unclear cause.
Paramedic and stakeholder experience
Through the qualitative component of the study, we aimed to examine the perspective of paramedics and
other clinical stakeholders on the hypothesised mechanisms by which the SAFER 2 trial intervention was
meant to work, that is, improving the decision-making of paramedics in terms of safe non-conveyance and
referral of older people who have had a fall to appropriate community-based services, and necessary
factors to allow this to happen.
The intervention was hypothesised to increase paramedics’ clinical knowledge of how to make appropriate
non-conveyance decisions and their knowledge of falls services and pathways for referral. In sites 1 and 2
(but not site 3), paramedics reported that a lack of knowledge around the role of the falls team and the
structure of their intervention limited their ability to refer.
It was also hypothesised that it would increase paramedics’ confidence about making a non-conveyance
decision and reducing anxiety about risk and would increase the likelihood that paramedics will consider
non-conveyance and referral pathways as an option in appropriate cases. There were mixed messages
about whether or not confidence had been increased from both paramedics and managers. Paramedics
emphasised that the decision-making process remained complex, with patients and carers having a voice
which might contradict the paramedic and the protocol.
We also examined the three factors that we felt needed to be in place: effective referral pathways and
sufficient capacity in falls teams; effective training and support for paramedics; and motivation on the part
of paramedics to use the intervention. Before introduction of the intervention, falls service stakeholders
also felt that the new pathway would impact upon their role greatly, although after the intervention
stakeholders from two of the three sites reported no significant change to workload. Falls team managers
in sites 1 and 2 stated that many referred patients declined the falls service intervention, although this was
not mentioned as an issue at site 3. Paramedics in all three sites described reasons for not referring to falls
services relating to patients’ social situation and patient autonomy.
After implementation, paramedics reported that support for implementing the new intervention
(i.e. paramedic training, flow chart and clinical support) had a positive effect on their ability to refer and
make decisions about patient conveyance. The structured training on the SAFER 2 trial was felt to be more
helpful than previous, more informal, approaches to introducing innovations, especially in sites 1 and 2.
In sites 1 and 2, the SAFER trial processes such as the get up and go test and taking sitting and standing
blood pressures were new to paramedics, while paramedics in site 3 already undertook these.
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In terms of motivation, before introduction of the intervention, paramedics generally saw it as an effective
way to deal with elderly patients who fall, and potentially an improvement on current practice. Current
practice was felt to be geared towards conveyance to hospital even when not appropriate for the patient,
although paramedics from all sites stated that they routinely make the decision to leave a patient at home
following a fall. Paramedics expected to make significant usage of the new referral pathway, resulting in
increased time on-scene, but also personal gains in terms of their skills and job satisfaction.
Throughout the transcripts, there was a lack of evidence of paramedics and managers having ‘useful’
contact with each other. Paramedics from all three study sites stated that they had limited contact with
their managers during the study period. This is reinforced by the fact that paramedics were ‘worried’ about
increased times on-scene, but managers did not see this as an issue.
Suggested modifications differed by study site, reflecting the variety of issues experienced across the sites.
Paramedics from all three sites agreed that a ‘simpler’ intervention would have sufficed, with a less
detailed flow chart. This was not commented on by ambulance service managers.
Limitations of qualitative methods
Patient experience
The sampling of patients for the interviews was heavily skewed (36 out of 58) towards those who had
been transported to hospital. This may have meant that the patients interviewed were more likely, on
average, to have had a major fall, and/or were more likely to have wanted to be transported to hospital.
Some patients found it difficult to recall details of the index incident many months after the event. When
patients had had a number of falls, it was not always entirely clear which fall they were recalling and
describing in response to the interviewer’s questions.
It was hard to disentangle patients’ views on the SAFER 2 trial assessment protocol specifically from their
views on the more general process of examination and assessment.
Paramedic and stakeholder experience
It proved difficult to interview an equivalent cross-section of ambulance service managers within each trust,
which led to a small variation in the set of questions asked in each site.
Focus groups and interviews were undertaken at different times between May 2011 (pretrial focus groups)
and March 2013 (post-trial focus groups). The time of year may have affected the responses provided by
both stakeholders and paramedics, as service delivery pressures and priorities might have differed;
therefore, it could possibly have affected the issues at the forefront of the interviewees’ minds.
Each site varied in the basic training provided to paramedics, the set-up of the service, service delivery
pressures and priorities at the time of the study.
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Chapter 7 Discussion, conclusions and
recommendations
Summary of key findings
There is a limited evidence base on prehospital alternatives to conveyance to hospital for older people who
fall. The systematic review included 12 papers, only two of which were RCTs. Studies were of variable
quality, with the majority being rated as low quality. The review identified limited and weak evidence
regarding the most effective ways to deliver alternative treatments to older people who fall. A minority of
the included studies reported benefits: reductions in subsequent emergency calls and hospital admissions
when patients who had been left at home by their attending ambulance crew were referred retrospectively
to a falls prevention service or when patients were attended by a paramedic with additional skills (ECP).
However, in the majority of studies such outcomes were not explored. The review concluded that
high-quality evidence from well-designed and rigorously conducted research is needed to inform
service delivery.
In our RCT, we did not find any differences between trial arms in the composite primary outcome.
However, we found consistent evidence of a small reduction in subsequent emergency service calls, from
21.8% of participants in the control arm to 18.5% in the intervention arm at 1 month, and from 46.2%
to 43.7% at 6 months. Six per cent of patients had died in each group by 1 month and 18% by 6 months.
Nearly one-third of patients had suffered a further emergency episode or death by 1 month, rising to over
two-thirds by 6 months. Referrals to falls services were low: 8% in the intervention group. Overall, and at
each site, fewer patients were left at the scene without any referral for further care in the intervention
group than in the control group. We did not find clear evidence of any differences in other secondary
outcomes related to processes of care, further injuries or self-reported quality of life, satisfaction or fear
of falling.
Uptake of the intervention was variable. Sixty per cent of intervention group paramedics made at least one
referral, but most of these made only one or two in total.
The intervention cost £17.30 per patient and generated some clinically important, statistically significant
differences in the number of subsequent emergency service calls (at 1 month) and ED attendances
(at 6 months), but no statistically significant difference in QALYs gained.
Although the SAFER 2 trial intervention is relatively low cost, this was not offset over 6 months by
reductions in health-care resource use, neither did it generate improved health-related quality of life
among patients allocated at random to the intervention relative to those controls allocated to usual care.
Retrieval of anonymised linked data outcomes was highly successful in this ‘e-trial’, with analysable
outcomes available for 80% of those eligible. Such a high rate of inclusion produces findings that are
generalisable to the whole-study population. Further investigation and analysis of these trial findings is
warranted to fully describe the benefits and risks of this new approach.
Through the qualitative component of the study, we examined the perspective of patients, paramedics and
other clinical stakeholders to help us better understand how the SAFER 2 trial intervention might work. In
terms of increasing paramedics’ clinical knowledge of how to make appropriate non-conveyance decisions,
and their knowledge of falls services and pathways for referral, there were mixed messages, with
paramedics in two sites reporting that a lack of knowledge around the role of the falls team and the
structure of their intervention limited their ability to refer. Similarly, there were mixed messages in relation
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to the intervention’s role in increasing confidence to make non-conveyance decision and reducing in
anxiety about risk. Paramedics emphasised that the decision-making process remained complex, with
patients and carers having a voice which might contradict the paramedic and the protocol. Paramedics in
all three sites described reasons for not referring to falls services relating to patients’ social situation and
patient autonomy.
Patients and carers in the intervention arm were highly satisfied with the care received, although generally
they did not notice differences in practice compared with previous contacts. Interviews with patients and
carers revealed that the scope for the intervention to make a measurable impact is limited by a number of
factors. For various reasons, the pathway may not have led to a falls service intervention. Many of the
patients in the SAFER 2 study were already tapping into a complex, and potentially confusing, network of
community-based services, delivered by a range of providers (NHS, social services or third sector). The index
fall is not necessarily an isolated incident, but more often part of a bigger and more complex pattern of
falling, so it may not be straightforward to restore confidence and mobility after a fall, even with
an intervention.
Strengths and limitations
The SAFER 2 study was a large-scale, multicentre randomised trial in the challenging setting of prehospital
emergency care. We met our recruitment target for this frail group and achieved, through retrieval of
anonymised linked routine data outcomes, a very high rate of inclusion: we reported our primary outcome
for 80% of eligible patients, a much higher proportion than usually achieved.125 Completion of ‘designed
data sets’ concerning compliance with treatment and trial protocols, including reasons for non-referral,
was low. This may reflect the context; we carried out this trial in the emergency care environment in which
crews are under pressure to not only meet the care needs of each patient they attend but also to meet
operational requirements which largely consist of time-based performance standards. As a general rule in
trials in this setting, including the SAFER 2 trial, we try to minimise the collection of any new data from
practitioners and rely instead on routinely collected information. In this way we maximise the inclusion of
patients and the completeness of key data items and minimise intrusion into the clinical and operational
context of the trial. In the SAFER 2 trial our primary and many secondary outcomes were based on
routinely collected clinical and operational information and the completeness of these data sets is very
high. Data that relied on additional paperwork by crews or patients had low completion rates and a higher
rate of missing data items.
With low ICC, there is little dilution from observed to effective sample sizes, so we can be confident in
findings reported. Statistical analyses have attempted to assess the effect of the intervention while
allowing for variations across the three sites; analyses with statistically significant interactions therefore
require careful interpretation.
The SAFER 2 trial tested a complex intervention. We were able to clearly define the components of that
intervention with our research and clinical partners across sites. We delineated each component, common
minimum standards, and aspects that could vary locally. This allows our trial results to be transparent and
repeatable, in a field in which interventions often lack clarity.126
Some aspects of the trial limit the usefulness of the results, in particular the fact that the trial took place in
a context of changing practice and competing service innovations to care for this patient group. At each
trial site we lost geographical areas, GP practices, stations, paramedics and patients because of the
changing environment in which the trial took place. In site 3, an alternative referral innovation was
introduced service-wide, incentivised by local commissioners. In site 1, only some GP practices were able to
access the falls service which was taking part in our study, and patients not registered to those practices
were ineligible for the emergency service call referral; in addition, many patients who had fallen were
diverted to a clinical desk in the ambulance control room for an alternative (non-paramedic) response.
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In site 2, a Frailty Programme was introduced in one of the initially participating health board areas, and,
as a result, stations in this area were withdrawn from the trial. Six of 31 stations and 49 of 264 paramedics
withdrew following randomisation, as presented in the CONSORT flow chart in Chapter 4. The withdrawal
of stations was similar across trial arms, but withdrawal of paramedics was higher in the intervention arm.
We do not know whether or not these withdrawals affected implementation of the intervention. Overall,
we overcame these challenges which are perhaps inevitable in a pragmatic trial in a dynamic service
environment. We completed the trial with balanced groups and achieved a sample size sufficient to detect
important effects related to the intervention.
Uptake of the intervention was low, at 8% of patients in the intervention group. We do not know what
the appropriate rate should be, as the protocol was intended to be applied across the spectrum of older
people who had fallen, and many may have had a clinical need to be taken to the ED. Approximately
one-quarter of patients were left at the scene of their call without a referral. Although this varied between
groups and across sites, it is probably the best indication of the ‘pool’ of patients who might benefit from
referral to a community-based service. The referral rate was variable between individual paramedics, with
over one-third never making a referral at all during the study period. Referral rates did not vary by age, sex
or distance to ED. Patients were less likely to be referred at site 1, although some patients were ineligible
for the referral pathway at that site; and patients were more likely to be referred out of hours, but we do
not have any further insight into why this was the case. In addition, we found no difference between trial
arms on conveyance rate, suggesting that practice did not change significantly during the trial.
We recruited volunteer paramedics to participate in the trial, with the agreement of the three collaborating
ambulance services. With slow recruitment we agreed to the introduction of £50.00 vouchers for each
participating ambulance service, although, in practice, services used the payments in different ways.
This reflects the practical considerations of carrying out multicentre experimental research in a live health
service delivery environment. It does mean that the trial paramedics may not be representative of all
paramedics and, therefore, we need to be cautious about interpretation of our findings.
It was not possible to undertake planned analyses of fall-related subsequent events, as data quality was
found to be poor, with different codes and levels of completeness between hospitals and sites. It is well
known that falls are poorly categorised, as, for example, slips, trips, stumbles or collapses, which is why we
made the decision to analyse all events. Any effects on falls-related events would have also been evident in
the all cause event proportions and rates, so this further exploration became less important once we had
completed analysis of the primary outcome.
Implications (practice, policy and research)
With three participating ambulance services, 25 stations, > 200 paramedics and > 10 community-based
falls services, and with outcomes available for 80% of eligible patients, we are confident that findings are
generalisable to the UK setting and other similar health systems.
The SAFER 2 trial intervention was associated with a small reduction in the proportion of patients making
further emergency service calls, and in the number of further calls made. However, this effect was not
carried through to other parts of the emergency care system. There were no clear effects in secondary
care, on ED attendances or emergency admissions. This finding is difficult to interpret, as we would have
expected any difference in one part of the system to be reflected in other parts. It may be that patients in
the intervention arm are more confident to self-manage if they fall again; however, the lack of impact at
ED suggests that the effect may be restricted to those who were not conveyed to ED. Even a modest
reduction in emergency service calls in this population is a success for the intervention in terms of
prehospital care in which operational pressures are so high. Ambulance services may wish to implement
this intervention in order to tackle rising demand but it will not make a huge difference to emergency
service workload.
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Uptake was lower than expected, with < 10% of trial eligible patients attended by intervention group
paramedics referred to falls services. There may be several reasons for this, including a reluctance to
change practice, a risk-averse climate within emergency prehospital care, patients who were unwilling
to be referred or a lower than expected number of eligible older people who were not already under the
care of a falls or similar frailty team. Some of these reasons reflect the population and context of the trial.
Within the trial, all reasonable efforts were made to support a change in clinical practice; however,
variability in referral rates suggests that uptake of the new referral pathway could have been higher.
We do not know if higher use of the falls referral pathway would further reduce emergency service calls.
The smaller than expected effect may be because the pool of people who might benefit is smaller than
previously expected, because preventative measures are more likely to be effective than an emergency
intervention once a fall has occurred, or it may be because with many initiatives in place to target this
group, there simply is little remaining scope for impact by emergency service paramedics. These results
contrast with previous findings,61 perhaps because of the larger sample size and increased number of
centres in the SAFER 2 trial.
Direct referral by ambulance crews to falls services is being implemented across the UK,78 alongside many
other new clinical pathways. In terms of tackling rising demand and managing workload, particularly of
patients who present repeatedly to the emergency service, we can be confident that direct referral is not
going to revolutionise care. We have not found evidence of harm and have found evidence of limited
benefit to patients and the NHS.
Conclusions and recommendations for research
The complex SAFER 2 trial intervention, with a protocol for paramedics to assess older people who had
fallen and refer those without need for immediate clinical care to community-based falls services, was
inexpensive and safe. We did not find any effect on our primary outcome, although, when broken down
into its components, there was a small reduction in the occurrence and rate of further emergency service
calls. We did not find any evidence of improved quality of life, although some aspects of satisfaction were
higher in the intervention group. Referral to falls services was lower than expected and variable between
paramedics, although fairly consistent between sites. Fewer patients were left at scene in the intervention
group by their attending ambulance crews without ongoing care than in the control group; however,
other processes of care were unaltered.
Retrieval of anonymised linked data outcomes was highly successful in this ‘e-trial’, with analysable
outcomes available for 80% of those eligible. Such a high rate of inclusion produces findings that are
generalisable to the whole study population.
In terms of research priorities:
l Understanding implementation issues further is a research priority in this area for older people who fall
and other groups for whom the default emergency service response is conveyance to hospital.
l Further investigation and analysis of outcomes retrieved through anonymised data linkage is warranted
to fully describe the benefits and risks of this new approach.
l Further research regarding the performance of the SF-12 and the mFES for older people who fall is
warranted, including:
¢ exploring whether or not any differences exist in the either of the two scales between baseline and
6 months
¢ comparing differences in outcomes between the intervention and the control sites at each
time point
¢ comparing the completion rates of the scales in the intervention and control sites
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¢ examining differences between scale scores in those patients who went on to have a further fall
(using routine ED data)
¢ examining whether or not either scale had any predictive ability in terms of predicting the
likelihood of future falls.
In conclusion, the SAFER 2 trial findings indicate that ambulance services may introduce this new clinical
pathway for patients without risk of harm, and with some limited impact on emergency service call
workload. We did not find evidence of improved health outcomes for patients or reductions in emergency
episodes across the NHS.
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Appendix 4 Support and Assessment for Fall
Emergency Referrals 2 organisational flow chart
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Appendix 5 Station location maps
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Appendix 6 Support and Assessment for Fall
Emergency Referrals 2 postal consent pack
Safer 2 Participant Invitation Letter    Version  5      May 2011 
         
 
  
  
 Date  
             
Dear      
      
      We are contacting you following your 
recent 999 call. The Welsh Ambulance Service is currently carrying out a 
study with Swansea University called SAFER 2, which is looking at how 
to improve the emergency care of older people.  
 
As part of the study, we would like to follow up any 999 calls and 
unplanned A&E or hospital visits you may make over the next six months. 
You would not need to do anything for this to happen, as the information 
can be collected routinely. Please can you tick the box on the Consent 
Form enclosed if you are happy for us to see your information. 
 
We have also included a questionnaire about your health and well-being 
for you (or someone who cares for you) to complete.  
 
The information sheet provided gives further details about the study. If we 
haven’t heard back from you after two weeks, we will telephone you to 
check whether you have received this letter and if you would like to talk to  
someone about it. 
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As a thank you for your time considering of these documents, we have 
enclosed a £5 voucher and a pen.  
 
 
Please note that participation is voluntary and your care will not be 
affected in any way. 
 
 
Yours sincerely, 
 
 
 
  
Practice Research & Development Manager  
Welsh Ambulance Services NHS Trust  
 
 
 
Contact Details for Study  
Helen Snooks       
Professor of Health Services Research    
SAFER 2 lead  
Swansea University.   
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Safer 2 Study Participant Information Sheet    Version 6.2   May 2011 
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Safer 2 Participation Form      Version 4      May 2011 
SAFER 2 Consent Form 
  
 
Please tick one of the boxes and sign the form below.         
 
(The care and treatment you receive will not be affected in any way                         
by your response.)                 
 
 
 
 I give consent for the study team to follow up any 999 calls, 
 A&E attendances or hospital visits I may make for 6 months. 
 
 
  
 I do not wish to participate in the SAFER 2 study.  
   
 
Signed_____________________  Date_______________________ 
 
 
If someone else has filled this form in for you: 
 
 
Form completed by_______________ Relationship______________ 
 
Signed__________________________ Date_______________________ 
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Please return the completed form in the FREEPOST envelope provided 
 
 
Name_____________________________       Study ID 
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Appendix 7 Support and Assessment for Fall
Emergency Referrals 2 1-month questionnaire
SAFER 2 one month questionnaire v4 May 2011 Study Number: 
 
SAFER 2 
 
 
ONE MONTH QUESTIONNAIRE 
CONFIDENTIAL 
d  d m m y y y y 
Date of questionnaire completion   
Is someone completing this survey on your behalf YES NO 
Please let us know their relationship to you    
  
 
 
If you would like help with this questionnaire, 
please telephone XXX
 
 
If there is no answer, please leave your details 
and a member of the SAFER 2 team will return 
your call as soon as possible. 
 
 
 
Please return the completed questionnaire in 
the FREEPOST envelope provided. 
 
 
THANK  
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Study Number 
 
PLEASE READ THESE INSTRUCTIONS CAREFULLY 
Please use a blue or black pen, not a pencil  
Please mark your answers with an X clearly inside the box  
  Please answer every question
  If you find it difficult to answer a question, do the best you can 
SECTION A:  999 Care d d m  m y y y  y 
This section asks about the care you received from the ambulance service on / / 
A1. Overall, how would you rate your general health before this call? 
Excellent Good Fair Poor Very Poor 
A2. Do you feel the medical condition that you called 999 for was... 
Extremely Serious Very Serious Moderately Serious Slightly Serious Not Serious 
Very 
Dissatisfied 
Dissatisfied Neutral Satisfied Very 
Satisfied 
A3. How do you rate the following: 
a) Waiting time for the ambulance to 
arrive? 
b)  Amount of time ambulance person 
spent with you? 
c) Decisions made by the person  who 
attended you? 
d) The ambulance persons' concern 
about you? 
e) Receiving satisfactory answers 
to your questions from the ambulance 
person? 
f) Explanation of any further referrals 
made by the ambulance person? 
  
     
     
     
     
     
     
     
     
2 0      
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Study Number: 
 
Very 
Dissatisfied
Dissatisfied Neutral Satisfied Very 
Satisfied 
g) The thoroughness of the care you 
received? 
h) The overall quality of the care you 
received from the ambulance service? 
i) The outcome of your 999 call? 
SECTION B: Care and help needed 
The next section asks questions about the care and help you may have needed following your 999 call 
B1. Please circle how many times have you had a fall during the past month? 
0 1 2 3 4 5 6 7 8 9 10 
B2. Please circle the number of times you have had contact with each service related to 
your fall and 999 call. Please mark all the answers. 
a) GP telephone advice 0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 b) GP surgery visit 
0 1 2 3 4 5 6 7 8 9 10 c) GP home visit 
d) NHS Direct 0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 e) Community nurse visit 
0 1 2 3 4 5 6 7 8 9 10 f) Out-Patient attendance 
g) Other Social Service 
provision (eg home help) 0 1 2 3 4 5 6 7 8 9 10 
Please state 
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Study Number: 
 
The next section asks questions about the care and help you may have needed following your fall 
and how this has affected you and those who care for you. 
B3. a. Please let us know your CURRENT place of residence (please tick) 
Own home Staying with relatives 
Residential Home Hospital in-patient 
Other Please state    
b. Is this different from your NORMAL place of residence YES NO 
c. If yes, please indicate your normal place of residence    
B4. Please let us know what (if any) special equipment or furniture Social Services have installed in 
your home to help you since your fall? 
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Study Number 
 
SECTION C: Your health now 
For this section exploring health-related quality of life we used version 2 of the Short Form 
questionnaire-12 items (SF-12).105
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Study Number 
 
SECTION D: Fear of falling 
This section is about how confident you are about being able to do things without falling. 
Please circle your answer for each of the activities below, with 0 meaning "not confident at all", 5 
meaning "fairly confident" and 10 meaning "completely confident" 
Not 
confident 
at all 
Fairly 
confident 
Completely 
confident 
How confident are you that you can 
D1. Get dressed and undressed 0 1 2 3 4 5 6 7 8 9 10 
D2. Prepare a simple meal 0 1 2 3 4 5 6 7 8 9 10 
D3. Take a bath or a shower 0 1 2 3 4 5 6 7 8 9 10 
D4. Get in/out of a chair 0 1 2 3 4 5 6 7 8 9 10 
D5. Get in/out of bed 0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 D6. Answer the door or telephone 
0 1 2 3 4 5 6 7 8 9 10 D7. Walk around the inside of your house 
D8. Reach into cupboards or wardrobes 0 1 2 3 4 5 6 7 8 9 10 
D9. Do light housekeeping 0 1 2 3 4 5 6 7 8 9 10 
D10. Do simple shopping 0 1 2 3 4 5 6 7 8 9 10 
D11. Use public transport 0 1 2 3 4 5 6 7 8 9 10 
D12. Cross roads 0 1 2 3 4 5 6 7 8 9 10 
D13. Do light gardening or hang out the 
washing (please rate whichever you 
do most frequently) 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 D14. Using front or rear steps at home 
  
     
           
      
    
APPENDIX 7
NIHR Journals Library www.journalslibrary.nihr.ac.uk
156
Study Number 
 
SAFER 2 
Please note - these details will be kept separately 
from the questionnaire 
I am happy to be sent a questionnaire in 6 months 
YES NO 
We would like to contact a small number of people to talk to them face 
to face about their experiences. If you do not mind being contacted by 
a member of the research team, please fill in your details below. 
Name    
    
Thank you very much for your time and  
in completing this  
  
  
     
           
      
  
 
 
 
 
 
 .    
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Appendix 8 Final definition of the intervention
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Appendix 9 Support and Assessment for Fall
Emergency Referrals 2 paramedic training
session programme
 
 
 
 
 
 
 
SAFER 2 
Support and Assessment for Fall Emergency Referrals 
 
                               Paramedic Training Session Programme 
 
 
 
 
 
 
 
11:00 a.m. – 11:15 a.m. 
 
 
 
Welcome and introduction   
Aims, scope, time-line, paramedic involvement. 
 
 
 
11:15 a.m. – 11:30 a.m. 
 
 
Teaching of clinical assessment tools 
 
Watching of SAFER 2 clinical assessment DVD with discussion. 
Includes social and falls history and clinical examination to rule out the need for 
referral to the Emergency Department. 
 
 
11:30 a.m. – 12:00 p.m. 
 
 
Falls service overview and protocol for referring to falls service 
 
Falls service make-up, falls prevention interventions, referral protocol. 
 
 
12.00 p.m. – 12:15 p.m. 
 
Clinical decision making and use of the paramedic clinical decision 
flow chart 
 
12:15 p.m. – 12:45 p.m. 
 
 Lunch 
 
12:45 p.m. – 1:15 p.m. 
 
 
SAFER 2 patient scenarios 
 
Teaching of clinical assessment tools through likely scenarios. 
 
 
1:15 p.m. – 2:00 p.m. 
 
 
Assessment of competence 
 
Assessed clinical scenario. 
 
 
2:00 p.m. – 2:15 p.m. 
 
 
Question and answer session. 
 
Summary and close. 
 
Including details of clinical support available during the trial. 
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Appendix 10 Support and Assessment for Fall
Emergency Referrals 2 6-month questionnaire
SAFER 2 six month questionnaire V1 Sep 2011 
Study Number: 
 
SAFER 2 
 
 
SIX MONTHS QUESTIONNAIRE 
CONFIDENTIAL 
d  d m m y y y y 
Date of questionnaire completion   
Is someone completing this survey on your behalf YES NO 
Please let us know their relationship to you    
  
 
 
If you would like help with this questionnaire, 
please telephone XXX
 
 
If there is no answer, please leave your details 
and a member of the SAFER 2 team will return 
your call as soon as possible. 
 
 
 
Please return the completed questionnaire in 
the FREEPOST envelope provided. 
 
 
THANK  
 
  
        
      
      
        
     
  
 
 
 
 
 
 
          
 
 
DOI: 10.3310/hta21130 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 13
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Snooks et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
167
Study Number 
 
PLEASE READ THESE INSTRUCTIONS CAREFULLY 
Please use a blue or black pen, not a pencil  
Please mark your answers with an X clearly inside the box  
  Please answer every question
  If you find it difficult to answer a question, do the best you can 
SECTION A:  999 Care 
This section asks about the care you received from the ambulance service on 
/ / 
d  d m  m y y y y 
A1. Overall, how would you rate your general health before this call? 
Excellent Good Fair Poor Very Poor 
A2. Do you feel the medical condition that you called 999 for was... 
Extremely Serious Very Serious Moderately Serious Slightly Serious Not Serious 
Very 
Dissatisfied 
Dissatisfied Neutral Satisfied Very 
Satisfied 
A3. How do you rate the following: 
a) Waiting time for the ambulance to 
arrive? 
b)  Amount of time ambulance person 
spent with you? 
c) Decisions made by the person who 
attended you? 
d) The ambulance persons' concern 
about you? 
e) Receiving satisfactory answers to 
your questions from the ambulance 
person? 
f) Explanation of any further referrals 
made by the ambulance person? 
  
     
     
     
     
     
     
     
     
2 0       
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Study Number: 
 
Very 
Dissatisfied
Dissatisfied Neutral Satisfied Very 
Satisfied 
g) The thoroughness of the care you 
received? 
h) The overall quality of the care you 
received from the ambulance service? 
i) The outcome of your 999 call? 
SECTION B: Care and help needed 
The next section asks questions about the care and help you may have needed after your 999 call 
and over the following six months. 
B1. Thinking back to the time after your 999 call, please circle the number of contacts you had with 
each service because of the condition you called for. Please answer all the quesitons. 
a) GP telephone advice 0 
 
12 
1
 
13 
2 
 
14 
3 
 
15 
4 
 
16 
5 
 
17 
6 
 
18 
7 
 
19 
8 
 
20 
9 10 11 
More than 20 
0 
 
12 
1
 
13 
2 
 
14 
3 
 
15 
4 
 
16 
5 
 
17 
6 
 
18 
7 
 
19 
8 
 
20 
9 10 11 b) GP surgery visit 
More than 20 
c) GP home visit 0 
 
12 
1
 
13 
2 
 
14 
3 
 
15 
4 
 
16 
5 
 
17 
6 
 
18 
7 
 
19 
8 
 
20 
9 10 11 
More than 20 
d) NHS Direct 0 
 
12 
1
 
13 
2 
 
14 
3 
 
15 
4 
 
16 
5 
 
17 
6 
 
18 
7 
 
19 
8 
 
20 
9 10 11 
More than 20 
e) Community nurse 
visit 
0 
 
12 
1
 
13 
2 
 
14 
3 
 
15 
4 
 
16 
5 
 
17 
6 
 
18 
7 
 
19 
8 
 
20 
9 10 11 
More than 20 
f) Out-Patient 
attendance 
0 
 
12 
1
 
13 
2 
 
14 
3 
 
15 
4 
 
16 
5 
 
17 
6 
 
18 
7 
 
19 
8 
 
20 
9 10 11 
More than 20 
0 
 
12 
1
 
13 
2 
 
14 
3 
 
15 
4 
 
16 
5 
 
17 
6 
 
18 
7 
 
19 
8 
 
20 
9 10 11 g) Other Social Service 
provision 
(eg home help) More than 20 
Please state:    
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Study Number: 
 
B2. a. Please let us know your CURRENT place of residence (please tick) 
Own home Staying with relatives 
Residential Home Hospital in-patient 
Please state    Other 
b. How long have you been resident here?    
YES NO c. Is this different from your NORMAL place of residence 
d. If yes, please indicate your normal place of residence 
B3. Please let us know what (if any) special equipment or furniture Social Services have installed in 
your home to help you since your fall? 
B4. Please circle how many times in total you have had a fall during the past SIX months? 
0 1 2 3 4 5 6 7 8 9 10 11 
more than 20 12 13 14 15 16 17 18 19 20 
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Study Number 
 
For this section exploring health-related quality of life we used version 2 of the Short Form 
questionnaire-12 items (SF-12).105
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Study Number 
 
SECTION D: Fear of falling 
This section is about how confident you are now about being able to do things without falling. 
Please circle your answer for each of the activities below, with 0 meaning "not confident at all", 5 
meaning "fairly confident" and 10 meaning "completely confident" 
Not 
confident 
at all 
Fairly 
confident 
Completely 
confident 
How confident are you that you can 
D1.  Get dressed and undressed 0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 D2. Prepare a simple meal 
0 1 2 3 4 5 6 7 8 9 10 D3. Take a bath or a shower 
0 1 2 3 4 5 6 7 8 9 10 D4. Get in/out of a chair 
D5. Get in/out of bed 0 1 2 3 4 5 6 7 8 9 10 
D6. Answer the door or telephone 0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 D7. Walk around the inside of your house 
0 1 2 3 4 5 6 7 8 9 10 D8. Reach into cupboards or wardrobes 
0 1 2 3 4 5 6 7 8 9 10 D9. Do light housekeeping 
0 1 2 3 4 5 6 7 8 9 10 
D10. Do simple shopping 
0 1 2 3 4 5 6 7 8 9 10 D11. Use public transport 
0 1 2 3 4 5 6 7 8 9 10 D12. Cross roads 
D13. Do light gardening or hang out the 
washing (please rate most frequent) 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 D14. Using front or rear steps at home 
THANK YOU 
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Appendix 11 Support and Assessment for Fall
Emergency Referrals 2 data analysis plan
SAFER 2 DATA ANALYSIS PLAN 
Trial Title 
SAFER 2: Support and Assessment for Fall Emergency Referrals 2 
 
Trial Summary  
Care of older people who fall: evaluation of the clinical and cost effectiveness of new 
protocols for emergency ambulance paramedics to assess and refer to appropriate 
community based care 
 
Trial Details 
Trial Registration: ISRCTN 60481756  
Chief Investigator:  H.A. Snooks, Swansea University 
 
Revision History     
 
Revision 
Date 
Release Summary of Changes Changes 
Made by 
09/2009 1.0 Initial version WYC 
03/2010 1.1 Revised to include economic analysis WYC 
04/2010 1.2 Revised to include qualitative analysis WYC 
05/2010 1.3 Revised with protocol  HS 
07/2010 1.4 Revised randomisation, PGI, non-consenter 
& non-respondent analyses 
WYC 
09/2010 0.4 Version numbers revised by DMEC 20/07/10 JP 
02/2012 0.5 Revised with protocol AJW 
03/2012 0.6 Revised with protocol SG 
05/2012 0.7 Revised economic & qualitative analyses  BA 
07/2012 0.8 Revised for DMEC meeting on 24/07/12 AJW & ITR 
05/2013 0.9 Further revisions SG, IH, AJW 
 
Approvals 
This document requires the following approvals.  A signed copy should be placed in the 
project files. 
Name Signature Title Date of 
Issue 
Version 
 
Distribution 
This document has been distributed to: 
Name Title Date  Version 
SAFER 2 DMEC  20-07-2010 1.4 
SAFER 2 DMEC  24-07-2012 0.8 
SAFER 2 DMEC/TSC  28-11-2013 0.9 
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Section 1: SUMMARY AND OVERVIEW 
SAFER 2 is a pragmatic cluster randomised controlled trial (CRT) with a qualitative 
component, involving 25 ambulance stations from three UK centres (namely, the East 
Midlands, London, and Wales)[1]. 223 paramedics taking part in the study have recruited 
approximately 6000 patients who call 999 following a fall.  Half of the participating stations 
have been randomly allocated to an intervention group, and paramedics based at these 
stations deliver care to older people who have fallen according to new protocols which allow 
emergency ambulance paramedics to assess and refer patients to appropriate community 
based care. The control group comprises the remaining stations, and paramedics based at 
these deliver normal care.  
 
Randomisation of stations to groups was carried out in accordance with the principles 
outlined in WWORTH SOP24 Randomisation[2]; specifically, randomisation was undertaken 
after paramedics in study stations had volunteered to participate (thus avoiding possible 
selection bias), and used centre and the number of eligible calls attended (based on data 
from 2009) as stratification variables. Clinical relevance is related to, but not determined by, 
the criterion of one event avoided (or incurred) in ten, which was the clinically significant 
effect size used in the sample size calculation. The calculated sample size for binary 
outcomes (whether an event occurred or not) is also adequate for a statistical assessment of 
the observed differences in times to the first event in the intervention and control group.   
 
This analysis plan for SAFER 2 has been developed using appropriate CONSORT 
statements and checklists, including those relating to cluster 
trials and patient-reported outcomes.  
 
Section 2: TRIAL OBJECTIVES 
The overall aim of this trial is to assess the benefits and costs to patients and the NHS of a 
complex intervention comprising education, clinical protocols and pathways enabling 
paramedics to assess older people who have fallen and refer them to community-based falls  
services when appropriate. Specific objectives are to: 
 
1 Compare outcomes, processes and costs of care between intervention and control 
groups: 
a patient outcomes: rate and pattern of subsequent emergency healthcare 
contacts or deaths, for any reason and for falls; health related quality of life 
(HRQoL); psychological status (especially fear of falling); and change in place 
of residence  
b processes of care: pathway of care at index fall; subsequent healthcare 
contacts; ambulance service operational indicators and protocol compliance 
including clinical documentation 
c costs of care: provided by NHS and personal social services; incurred by 
patients and carers in seeking care;  
2 Estimate wider system effects of the introduction of the intervention on ambulance 
service performance and costs; 
3 Understand how patients experience the new health technology;  
4 Identify factors which facilitate or hinder the use of the intervention;  
5  Inform the development of methods for falls research, especially outcome measures 
recommended for trials of interventions for older people who fall [3] 
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Section 3:  DATA COLLECTION & HANDLING 
 
3.1 Data Sources & Collection  
Our primary outcome is “further emergency healthcare contacts (999 call or Emergency 
Department (ED) attendance or hospital admission) or death for any reason and for falls per 
recruited faller, and time to first contact or death” for six months following the index call. This 
CRT does not approach participants at the point of treatment, because they may be in 
distress and unable to give informed consent, but seeks instead retrospective consent to 
follow up through routine medical records and by postal questionnaire. We planned to follow-
up all our patients anonymously in order to achieve the primary outcome for our target 
sample size. In Wales, arrangements for this process are already in place through the 
existing SAIL (Secure Anonymised Information Linkage) Database, and our application for 
permission through the Information Governance Review Panel has been granted. We 
applied to the NIGB Ethics and Confidentiality Committee for permission to follow-up our 
patients anonymously through the Information Centre in England and permission has been 
granted for this process. Conditional to this permission, people who have clearly dissented 
to identifiable follow-up must be excluded from the study. For clarity, if a patient has at any 
time declined to be part of the study (either in returning a consent form or orally on the 
telephone) they will be removed from the study. 
 
3.2 Sample Size and Statistical Power 
We made the conservative estimate that trial patients have about 50% chance of making 
another emergency contact within six months; in the absence of intra-cluster correlation 
(ICC), a sample of 4190 evaluable participants yields 90% power, when using two-sided 5% 
significance level, of detecting a change in this chance from 50% to <45% or to >55%. The 
analogous outcome in the SAFER 1[4] trial indicated an ICC of zero in clusters of participants 
seen by paramedics from the same ambulance station. To be conservative, we therefore 
allowed for an ICC of 0.002, and sought 251.6 (calculated from 0.998*4190/{25-
0.002*4190}) participants per ambulance station, making a total sample size target of 6290.  
 
However, actual recruitment is slightly lower, at 5939 participants, and we will lose 
approximately 1000 patients that decline to be part of the study. Furthermore, previous 
experience suggests that we shall also lose about 10% of the remaining patients from 
analysis because we shall not be able to match them with their routine electronic data on 
contacts with the NHS. Hence we expect the recruited sample of 5939 participants to yield 
only 4400 suitable for accurate information linkage. With an ICC of 0.002 and equal cluster 
sizes, this expected evaluable sample size corresponds to 3260 independent participants, 
which, in turn, equates to approximately 80% statistical power. In short, the cumulative loss 
in recruitment, and from dissenting and un-matched patients will reduce the statistical power 
of SAFER 2 from a conservative 90% to the traditional 80%, even allowing for more intra-
cluster correlation than observed in the SAFER 1[4] trial.
  
3.3 Missing Data  
General Principles  
As per WWORTH SOP28 Statistics[5], we shall adopt a consistent approach to missing data 
relating to both effectiveness and cost-effectiveness except where individual outcome 
measures require some variation in that approach. We shall exclude participants without 
follow-up data, and, for each variable, summarise the frequency of missing data, which 
directly influences the sample size in, and hence the statistical power of, some analyses. If 
there is reason to suspect that data are not Missing Completely At Random (MCAR), the trial 
statistician and chief investigator will discuss the findings. If there is no reason to suspect 
that data are not MCAR, we shall use appropriate imputation methods to mitigate the 
problem of missing data. 
Internal imputation of HRQoL data at a particular data collection point 
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None of the questionnaires (SF-12, derived SF-6D, or Modified Falls Efficacy Scale 
(mFES)[6]) has an official algorithm for imputing individually missing answers. Some patients 
may have particular reasons for missing some of the questionnaire items, and it is unlikely 
that a plausible model for conditional Missing At Random can be established even on a 
case-by-case basis. Nevertheless, to minimise missing values and use available information, 
any such missing values within patient interviews will be completed by imputation[7] within 
the reduced dataset of individual responses to questions in the three measures, using the 
regression or expectation maximization (EM) algorithms of the Missing Value Analysis 
module within SPSS. Scale scores will then be calculated according to the relevant 
instructions for the measure. The use of multiple imputation methods will be considered if 
the incidence of missing data is high.   
 
External imputation of HRQoL data scores 
If a participant is dead at the data collection point, the SF-6D score will be taken as zero.  To 
avoid outliers, SF-12 and mFES scores will be taken as the minimum value observed for that 
measure in the relevant treatment group  
 
Otherwise, missing summary scale and subscale scores will be imputed by regression from 
all available values of that score at other data points and the allocated treatment group. 
Further predictors (eg gender, age, current hospitalisation) may be included, unless they are 
already used as covariates in the main analysis 
 
If any potential predictor other than study group has an F value of less than 1 (that is, it 
increases the standard error of the prediction) it will be removed from the list of predictors 
and the prediction recalculated. 
 
Missing Health Economic data 
Addressing the problem of missing data may involve employing Mean Imputation (that is, 
assigning a mean value to the respondents with missing data) or Regression Imputation 
(that is, using regression models to provide estimates of missing data from complete data, 
when the missing data is part of a multivariate data set). The usual method for dealing with 
censored data relating to costs will be to employ the weighted cost method with known cost 
histories[8].  
3.4 Withdrawals  
Patients can withdraw from the study whenever they wish, and do not have to give a reason, 
although any reasons given must be documented.  Their subsequent treatment will not be 
affected in any way.  Patients may also withdraw from the questionnaire element of the 
study but be retained for other follow up.  Any patients lost must be traced and documented 
whenever possible. 
 
Wherever possible, data missing because of withdrawal will be imputed from available data. 
 
Section 4:  LINKS BETWEEN OBJECTIVES & 
OUTCOMES 
 
4.1 Trial Objective 1 ‘Compare costs, processes and outcomes of care between 
experimental and control groups’ 
 
Objective 1a Patient Outcomes 
1 Number of further reported contacts or deaths [primary outcome] 
2 Time to the first reported contact or death  [primary outcome] 
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Primary outcomes will be analysed using the hierarchy of outcomes (comprising 999 
calls, ED attendances, emergency admissions, and death) established in SAFER1[4].  
3 Injuries related to further falls    [secondary outcome] 
This will be summarised by cross-tabulation of the numbers and proportions in each 
study group, split by types of injuries.  
4 Health-related Quality of Life     [secondary outcome] 
This is measured by SF-12 and derived SF-6D, and will be assessed and 
summarised at one month and six months.  
5 Satisfaction       [secondary outcome] 
This is measured by the Quality of Care Monitor, and will be assessed and 
summarised at one month. 
6 Psychological status      [secondary outcome]  
This is measured by the mFES, and will be assessed and summarised at one month 
and six months.  
7 Change in place of residence at six months   [secondary outcome]  
 
Objective 1b Processes of Care 
1  Pathway of care      [secondary outcome] 
This is measured by health and social care contacts associated with the index fall 
and during follow-up period, split by types of contacts and adjusted by covariates.   
2 Ambulance service operational indicators   [secondary outcomes] 
These comprise episode of care and job cycle times, adjusted by covariates.    
3 Protocol compliance      [secondary outcome] 
This will be measured by a series of data items related to protocol compliance (such 
as the completion of clinical documentation; referral processes).   
 
Objective 1c Cost of Care [secondary outcome] 
This objective is addressed by estimating and comparing the resources utilised in both 
groups, adopting a ‘bottom-up approach’ from the perspective of the NHS, personal social 
services, and patients and their families.  Specifically: 
1 Estimation of costs of providing the intervention 
Data relating to direct costs to the NHS will be assessed using data logged as a part 
of routine practice and from resource utilisation recording sheets, together with 
reference to patient records and discussions with relevant finance staff. Resources 
used will be translated into costs using relevant published unit costs. 
The number of non-conveyances will be logged, and potential impact on costs to the 
ambulance service and hospital emergency departments estimated. 
Further, the additional costs to community services will be documented and
 costs using relevant published unit costs. 
2 Costs to patients and families 
Patients and their families will complete a self-administered questionnaire specifically 
designed for this study but based on other instruments catalogued within the 
Database of Instruments for Resource Use Management
 
Further, data on the use of the health service and social services resources will be 
collected for each patient using a combination of paramedic records and routine 
hospital records (for hospital events). Data relating to social services costs will be 
derived from discussion with relevant social services departments 
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4.2 Trial Objective 2 ‘Estimate wider system effects of the introduction of the 
intervention on ambulance service performance and costs’ 
 
We consider this objective two parts.  
 
Objective 2a Wider effect on operational indicators  
Ambulance service operational indicators   [secondary outcomes] 
Response times across the study catchment and surrounding areas during the trial 
period will be compared to pre-trial response times and ‘rest of service’ response 
times (adjusted for pre-trial differences) in order to identify any knock on or halo 
effects. 
 
Objective 2b Wider effect on Costs of Care [secondary outcome] 
Consequences of the scheme for the wider NHS and social services (eg ED 
attendances, inpatient admissions, GP consultations, out-of-hours GP contacts, NHS 
Direct contacts, social services utilisation) will be estimated using a combination of 
routine data sources, discussions with staff from relevant departments (eg social 
services) and from responses to patient completed questionnaires that highlight 
service contacts and utilisation.. 
 
Further, the time spent by ambulance staff with patients and the nature of their 
involvement will be documented so as to determine the direct cost of patient care, 
cost of patient transportation and other costs – reflecting travel, time spent at ED 
discharging patients and so on.  
 
4.3 Trial Objective 3 ‘Gain an in-depth understanding of how the intervention is 
experienced by patients’ 
 
This objective is addressed using face-to-face semi-structured interviews conducted in co-
operation with a carer or older person present at time of fall. Qualitative interviews to be 
undertaken with patients who: experienced a fall; were recruited to the trial; seen by an 
intervention paramedic and agreed to the interview. This will include patients: who were 
taken to ED; referred to a falls service; and  patients who were neither taken to the ED nor 
referred to a falls service. 
   
The aims of the interviews are to explore: 
• Patient experience of ambulance service 
• Patient experience of those seen by a falls service 
• Patient health since fall 
• Patient satisfaction with treatment  
 
4.4  Trial Objective 4 ‘Understand how the intervention is delivered in practice, 
identifying factors which enable or hinder its use’ 
 
This objective is addressed using focus groups carried out with intervention paramedics ‘pre’ 
and ‘post’ trial. Focus groups will be carried out by two researchers, one to lead discussions 
and one to take notes and enable the linkage of texts to speakers as well as concerning 
other details, such as points of consensus or disagreement, issues that drew strong 
emotional responses such as anger, fear or anxiety.   
 
The aims of the focus groups are to explore: 
• Paramedics views and attitudes toward the new intervention  
• Any preconceptions about the new way of working  
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• Factors which enable the use of the new referral pathway 
• Factors which hinder the use of the new referral pathway 
 
4.5 Trial Objective 5 ‘Inform the development of methods for falls research in 
relation to outcomes assessment’ 
 
We shall compare mFES scores with SF-12 component scores and derived SF-6D scores 
as recommended by Prevention of Falls Network Europe (ProFaNE)[9] group to establish 
construct validity. We shall assess predictive validity by comparing mFES scores with the 
mean number of further falls and time to first subsequent fall.  
Section 5:  MAIN ANALYSES  
 
5.1 Statistical Analysis  
This will conform to principles outlined in WWORTH SOP28 Statistics [5]; specifically, the 
primary analysis will be by ‘treatment allocated’, reflecting the pragmatic nature of the trial 
design where patients are cared for by paramedics based at ambulance stations randomly 
allocated to deliver intervention or control care.  
 
Primary outcomes comprise a hierarchy relating to further emergency healthcare contacts 
for falls, as measured by contacts with the 999 service, Emergency Department (ED) or 
emergency admission to hospital for a further fall, or deaths within six months of the index 
fall. Important predictors that may affect triage decisions and outcomes, including the 
distance between incidents and EDs at index fall, patient age and gender, patterns of 
presentation (eg, whether out-of-hours or not) will be considered as covariates, and included 
in statistical modelling. We shall also take account of potential confounders such as the 
sequence of base stations (and their trial allocation) from which paramedics attend patients 
who fall more than once. The principles used in analysing primary outcomes also apply to 
quantitative secondary outcomes.   
 
Required analyses include: logistic regression (for binary outcomes); cross-tabulations and 
risk ratios (for categorical outcomes); and survival analysis, including Cox’s proportional 
hazards models[10], (for measurement outcomes, such as times to events). Primary 
outcomes will also be jointly analysed using methods developed for recurrent event 
analysis[11-14]. Repeated observations will be analysed in two ways: as ‘repeated measures’; 
and summarised by “area under curve” of HRQoL measures per patient. 
 
Where appropriate, multilevel modelling will be used to estimate clustering effects for 
stations or centres. The exact number of levels in models will be determined using 
statistically significant changes in likelihood ratio tests according to the principle of 
parsimonious parameterisation. Potential covariates to be included in models will be tested; 
those with an F value of less than 1 (that is, they increase the standard error of the estimate) 
will be excluded and the analysis recalculated. Binary covariates where almost all cases 
(>90%) are in one category will also be excluded. 
  
Residual diagnostics will be used where analyses assume Normality; if the distributions of 
residuals are markedly non-normal, data transformation or bootstrapping will be considered. 
Residual analysis will be used to identify outliers; identified outliers will be excluded and the 
analysis updated. Wherever possible, outcome descriptions, summaries and comparisons 
will be expressed in accordance with appropriate CONSORT 
 estimates with 95% confidence intervals (allowing two-tailed tests at the 
5% significance level). 
  
5.2 Health Economic Analysis  
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This will estimate costs of providing the new intervention, and consequences for the NHS 
(for instance, ED attendances, inpatient admissions) and personal social services. Data on 
the use of the health service resources will be collected for each patient using routine 
ambulance service and hospital records. Costs will then be calculated using unit-costs 
estimated through a micro-costing study within the trial. Direct costs to the NHS will be 
assessed using data logged as a part of routine practice and from resource utilisation 
recording sheets, together with reference to patient records and discussions with relevant 
finance staff.  
 
SF6D scores (derived from SF12 scores) will also be used to estimate the quality adjusted 
life years (QALYs) gained from the intervention, and an incremental cost-per-QALY 
calculated. These ratios will be presented along with their associated Cost-effectiveness 
Acceptability Curves (CEAC). Sensitivity analyses will be undertaken to assess the 
robustness of results to changes in the configuration of the intervention and other health 
service costs. We aim to publish economic results alongside clinical results where possible 
(for instance, in the BMJ format of pairs of companion papers).   
 
The Senior Trial Economist is responsible for the health economic analysis, which will 
generally adopt approaches employed in the main analysis of clinical data. Specifically: .  
• Analysis will be by ‘treatment allocated’ when generating baseline findings, with inclusive 
analysis by treatment received or exclusive analysis of treatment per-protocol being used 
for sensitivity analysis when also undertaken in reporting clinical findings 
• Addressing uncertainty by applying bootstrapping for CEACs and confidence intervals[15-
17].   
• Using a range of time-horizons to estimate the effectiveness and cost-effectiveness of 
the intervention. 
• Applying appropriate discount rates to costs and benefits, as required by NICE; applying 
appropriate threshold Incremental Cost-effectiveness Ratios (ICER), such as the 
£20,000 and £30,000 thresholds used by NICE, in cost-per-QALY calculations. 
 
5.3 Qualitative Analysis  
All interviews and focus groups, with the permission of participants, will be recorded and 
transcribed. As this is a team-based project involving collection of data in multiple sites, 
maintaining consistency in data collection and transcription is crucial. The qualitative 
analysis co-ordinator will set up a data management system consisting of instructions on 
converting raw data to computer files (in the form of a transcription protocol), organising data 
storage, data archiving steps and a data management checklist. The transcription protocol 
will ensure that standard conventions are adopted throughout the transcription process, and 
that a standard presentation format is used. Each transcript will be quality assured by the 
relevant researcher. 
Following transcription, participants in the paramedic and service provider focus groups will 
be given the opportunity to review the anonymised transcripts and state whether they agree 
with the contents or wish to amend their quotes. 
 
The data will be analysed thematically using the framework analysis approach for applied 
policy research [18]. This is a systematic, dynamic and transparent method of analysis, which 
generates themes from the original accounts of participants [19]. In the analysis the data is 
sifted, charted and sorted in accordance with key issues and themes using five steps: 
familiarisation; identifying a thematic framework; indexing, charting; and mapping and 
interpretation.   
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All data analysis will be carried out independently by two researchers, who will then meet to 
discuss and agree final coding and interpretation. Analysis will be conducted using NVivo. 
When reporting the results, we will ensure that the anonymity of responders is preserved 
and that no quote can be attributed to a particular individual.                                                                
 
Section 6:  INTERIM & FURTHER ANALYSES 
Patients will be recruited over a 15 month period and followed up for six months.  The trial 
will end and be analysed after the last six month follow-up contact with any patient in the 
trial.  No formal interim analyses of the trial outcomes, and no subgroup analyses, are 
planned within the trial.   
 
6.1 Non-Consenter Analysis  
Study patients will be compared with eligible patients who have not consented to the study in 
terms of age, gender, date and time of index call, on-scene time, main condition code and 
disposition by appropriate significance tests. 
 
6.2 Non-Respondent Analysis  
Study patients who have returned the study questionnaire will be compared with those who 
have not return the questionnaire by the same parameters of the non-consenter analysis.  In 
addition, those responding to the questionnaire will also be compared to those not returning 
the questionnaire in terms of the primary outcomes. 
 
6.3 Sensitivity Analyses  
Subject to resources, we will carry out further appropriate sensitivity analyses, some 
identified as the main analyses proceed. These will include a comparison between 
identifiable data retrieved from hospitals and those retrieved through the anonymous data 
sources (where experience with SAFER1[4] indicates that a good or perfect match between 
anonymised records and study participants should be possible in 90% of cases); 
consideration of patterns of referral to falls services; and analyses based on further refined 
definitions of the intervention group – for instance, excluding participants ineligible for falls 
service referral. 
 
 
Section 7: REPORTING & RELATED ISSUES 
The SAFER 2 DMEC will receive immediate notification of all SUSARs, and summaries of 
current trial data. This will allow the DMEC to monitor trial progress, and request unblinded 
comparisons where they have cause for concern.  The DMEC may then make a final 
decision to modify or terminate the trial, as specified in its terms of reference. 
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Appendix 12 Patient semistructured interviews
schedule
Patient experience (of ambulance service)
1. Can you tell me what happened when you fell and an ambulance was called?
Prompt:
Where did you fall?
How did you fall?
Were you hurt?
2. What did the ambulance crew do when they arrived?
3. Were you informed of what would happen next (e.g. referral to a falls service or taken to hospital)?
Prompt:
Did you understand what this would mean?
4. What did you feel about what they did?
Prompt:
At the time of fall and on reflection.
5. Have you fallen before and were you seen by an ambulance crew? (If answer is yes go to question 5a)
5a. In what ways was the assessment and treatment you received different from previously?
6. How did you feel about this decision?
Prompt:
Was it right for you and were you part of the decision?
Patient experience (of those seen by a falls service)
1. How long was it before someone from the falls service contacted you?
2. How did you feel about the amount of time it took before you were contacted?
3. What did the Falls Service offer you?
Prompt:
How did you feel about what they did?
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Prompts:
Exercise Programme.
Prompt any of the following:
l Home exercise programme to improve strength and balance.
l One to one strength, balance and mobility training.
l Referral to a balance group or other group.
l Floor transfer practice.
Falls Prevention programme
Prompt:
Advice and education regarding how to reduce risk of falls, including pacing activity, sitting to put on
trousers and shoes and appropriate footwear, etc.
Environmental adaptations or assistive devices
Prompt any of the following:
l Walking aid provision such as walking frame, walking stick, wheelchair, etc. or any other devices such
as pendant alarm, grab rails or anything else.
l Advice on environmental adaptations and onward referrals to services to address issues such as loose
rugs, wires, etc.
Occupational therapist
Prompt:
Occupational Therapy assessment of home environment, bed and toilet transfers and wheelchair suitability/
or of ability to perform personal care (including dressing) and domestic tasks.
Physiotherapist
Prompt:
Physiotherapy assessment of strength, range of movement, balance and transfers.
Disability counsellor
Prompt:
To talk about feelings and problems in a supportive way.
Social services assessment
Prompt:
For a review of the adequacy of the care package or anything else.
Anything else
4. Could the service be improved in any way?
Prompt:
Were you happy with what they offered you and was there anything you were unhappy with?
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Patient health (post fall)
1. Have you had a fall since?
2. In terms of your health, how is it different since your fall?
3. Since the fall have any areas of your life been affected?
Prompt:
Have any areas of your life improved?
Prompt:
Have any areas of your life got worse?
Patient satisfaction
1. This project is looking at helping ambulance paramedics decide the best treatment for you if you fall.
At the time of your fall did you know they were following a new process for assessing elderly fallers
and what do you think about this?
2. What did you think of the overall process?
3. How would you feel about being treated by the ambulance crew in this way in the future?
4. Is there anything else you would like to tell us relating to your fall and the attention you received?
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Appendix 13 Support and Assessment for Fall
Emergency Referrals 2 paramedic pretrial focus group
interview schedule
Support and Assessment for Fall Emergency Referrals 2
paramedic pretrial focus group interview schedule
Thank you for taking part today. This session is to find out a bit more about your current practice and to
get your thoughts and views on the new referral pathways proposed for the SAFER 2 trial.
Check that we have got the consent and demographic info forms completed.
Questions
What motivated you to get involved in the study?
Have there been any other ‘pathways of care’ or new ways of working introduced while you’ve been
a paramedic?
Prompts:
l How have new practices been introduced? What’s worked, what hasn’t?
l Issues around changing practice – are there any pressures?
l What are the attitudes towards new developments in the health service.
l Differences between attitudes of paramedics and their managers.
l Barriers and motivations to new developments?
l Issues around using new developments.
l Support for using new pathways/ways of working.
l Operational impacts.
Do new pathways of care sometimes bring with them additional decision-making for paramedics?
Prompts:
l Adapting to this.
l Resistance?
l Time to adopt new processes?
l Levels/amount of training.
How do you deal with calls from older fallers at the moment?
Prompts:
l Options available to the paramedic.
l Links to other services to support older fallers.
l Explore issues around deciding to leave at home or convey.
l Any frustrations with the current system.
l Risks with the current system – to patient.
l Risks with the current system – to paramedic (confidence to leave patients at home).
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Do you think that having access to a falls pathway will make a difference?
Prompts:
l To the patient.
l To you.
l To the ambulance service.
l Suitability of this patient group for the new care pathway.
And similarly, what are your expectations for this new pathway?
We asked at the beginning about your motivations for getting involved. We wondered what you thought
your colleagues would make of you taking part in the study.
Prompts:
l What could encourage more people to become involved?
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Appendix 14 Support and Assessment for
Fall Emergency Referrals 2 paramedic trial-end
interview schedule
Thank you for taking part today. This session is to find out more about your involvement in the SAFER 2study and experience of using the new protocol and to understand how you made your decisions on
whether to convey patients to hospital, refer to a falls service or to leave the patient at home.
Your views, which will be kept confidential, will enable us to assess the benefit to patients of the
‘intervention’ and pathways to community-based falls services. We simply need to understand if it works
and if it can improve patient outcomes in relation to injury, death and quality of life.
1. How did you find using the SAFER 2 trial flow chart in practice?
Prompts:
l Which parts were useful and which were not, i.e. the ‘get up and go test’?
l Did you need to make any additional decisions because patients did not fit into the protocol?
l Did you keep a copy of the flow chart with you?
l Did it make you feel more or less confident in your decision-making?
2. What were your expectations of the new way of working and were they met?
Prompts:
l Increase your job satisfaction and/or confidence.
l Aid your decision-making and assessments.
3. The idea of the flow chart was to make it safe to leave a patient at home with a referral to a falls
service. We found this didn’t always happen and some patients were left at home without a referral –
we’d like to find out what influenced your decision?
Prompts:
l Meeting response times and/or last job or on-scene time.
l Decision-making/confidence.
l Patient preference.
l Clinical judgement.
l Familiarity with process.
l Advising patients they did not need to go to hospital.
l Patient already had a care package in place/or similar.
l Something else.
4. How satisfied were you with the amount training you received?
Prompts:
l Would you have liked to have received more or less training?
l Was it informative enough – did you feel ready and confident to use the flow chart?
l Did it enhance your clinical knowledge?
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5. Was there any support available to you while you were taking part in the study?
Prompts:
l Did anyone contact you by telephone or e-mail?
l Did you feel well supported by ambulance service management and trainers?
6. What would you think if the initiative was introduced across the service?
Prompts:
l Do you feel it would change your role at all or affect the way you work?
l What factors would make it difficult and what could help the process?
7. When comparing the SAFER 2 trial to other similar studies, involving older fallers, it seems a higher
proportion of patients were conveyed to hospital – we’d like to find out if the SAFER 2 trial changed
the way you normally work?
Prompts
l Did the intervention affect you decision-making?
l Difficult/easier to assess this group of patients?
l Did it make you convey patients more often or less often?
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Appendix 15 Stakeholder trial-end interview
schedules
Support and Assessment for Fall Emergency Referrals 2
ambulance personnel trial-end interview schedule
1. At the beginning of the study, what were your expectations of the SAFER 2 trial intervention and the
new way of working?
Prompts:
l Increase job satisfaction and/or confidence.
l Aid decision-making and assessments.
l Better patient care.
l Increase workload/increased demand on service.
l Increased efficiency/turnaround time.
l How aware were they of the SAFER 2 trial and what it was meant to achieve?
2. In what ways did your involvement in the SAFER 2 trial impact on your role?
Prompts:
l Time.
l Advantages/Improvements.
l Disadvantages/difficulties.
3. In what way do you think the SAFER 2 intervention has changed the way that colleagues within the
organisation (paramedics, dispatch personnel) conduct their work?
Prompts:
l Advantages.
l Disadvantages.
l More confident or less confident in decisions.
l Make decisions in a different way.
l Provides more protection.
l Undermines/supports autonomy and clinical judgement.
4. What factors do you think had an effect on the extent to which the SAFER 2 trial was adopted within
your organisation?
Prompts:
Factors within the organisation:
l Time pressures.
l Dispatch coding.
l Beliefs.
l Work habits.
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Factors outside the organisation:
l Other pathways or developments.
l Patient choice.
l Family of patients, etc.
l Contact between roles (university, ambulance, falls).
l Any other barriers.
5. We have found that some patients seen by an intervention paramedic were left at home without a
referral. Why do you think this might have been?
Prompts:
l Patient already had a care package in place/or similar.
l Paramedics meeting response times and/or last job or on-scene time.
l Paramedic decision-making/confidence.
l Patient preference.
l Clinical judgement.
l Familiarity with process.
l Advising patients they did not need to go to hospital.
l Something else.
6. What would you think if the SAFER 2 trial was rolled out across a wider service area?
Prompts:
l Good thing or not?
l Advantages to patients/paramedics/organisation.
l What factors would make it difficult and what could help the process?
l Differences between a small scale trial and a big service change.
l Boundary and equity issues i.e. thought it wasn’t fair that people living in some areas got the service
and others didn’t.
l Risk of duplication of initiatives.
l Changes in work practices such as following new protocols/flow charts are an inevitable process.
7. Do you have any recommendations for how the process could be improved for future use?
8. Describe the SAFER 2 trial intervention using only one word?
9. Is there anything else about the study that you would like to say?
Support and Assessment for Fall Emergency Referrals 2 wider
stakeholder trial-end focus group schedule
1. At the beginning of the study, what were your expectations of the SAFER 2 trial intervention and the
new way of working?
Prompts:
l Increase job satisfaction and/or confidence.
l Aid decision-making and assessments.
l Better patient care.
l Increased workload/increased demand on services.
l Increased efficiency/turnaround time.
l Were your expectations met?
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2. In what ways did your involvement in the SAFER 2 trial impact on your role?
Prompts:
l Time?
l Improvements/difficulties?
3. What factors do you think had an effect on the use of the SAFER 2 trial intervention within
your organisation?
Prompts:
l Internal communications/support.
l Time pressures.
l Problems referring patients onto further specialist assessment.
l Beliefs/attitudes.
l Expectations about role, clear or unclear.
l Processes to be followed, clear or unclear.
4. What factors do you think had an effect on the use of the SAFER 2 trial intervention outside
your organisation?
Prompts:
l Other pathways or developments.
l Other organisations/support.
l Patient choice.
l Family of patients, etc.
l Contact between roles (university, ambulance, falls).
5. Have you had any feedback from service users about the SAFER 2 trial intervention?
Prompts:
l Positive feedback.
l Negative feedback.
6. What would you think if the new way of working was introduced across the service?
Prompts:
l Good thing or not?
l Advantages to patients/paramedics/organisation.
l What factors would make it difficult and what could help the process?
l Differences between a small scale trial and a big service change.
l Boundary and equity issues i.e. thought it wasn’t fair that people living in some areas got the service
and others didn’t.
l Risk of duplication of initiatives.
l Changes in work practices such as following new protocols/flow charts are an inevitable process.
7. Do you have any recommendations for how the process could be improved for future use?
8. Describe the SAFER 2 trial using only one word?
9. Is there anything else about the study that you would like to say?
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Appendix 16 Support and Assessment for Fall
Emergency Referrals 2 framework for analysis of
interviews and focus groups
Support and Assessment for Fall Emergency Referrals 2 framework or
analysis of interviews and focus groups with staff: including paramedics
and staff of other relevant service areas
This analysis is of ‘before’ and ‘after’ data together.
1. Core coding.
i. Data source (code entire transcript to either subcode below).
– Interview.
– Focus group.
ii. Site (code entire transcript to one of the subcodes below).
– London Ambulance Service.
– East Midlands Ambulance Service .
– Welsh Ambulance Services NHS Trust.
iii. Role of speaker (each extract coded should also be crosscoded to one of the subcodes below).
– Paramedic.
– Other ambulance service staff.
– Falls service.
– Other.
2. Expectations of the SAFER 2 trial intervention (before).
i. Rate of referrals.
ii. Monitoring/performance management function.
iii. Better patient care.
iv. Anticipated impact on process (paperwork/time at scene).
v. Anticipated impact on other services (e.g. falls service).
vi. Unclear/uncertain expectations.
vii. Other.
3. Implementation process for the SAFER 2 trial intervention (after).
i. Impact on workload and role – ambulance service.
ii. Training and support.
iii. Teamwork/networking/communication.
iv. Other changes taking place at the same time.
v. Wider impact within ambulance service (e.g. raising awareness of falls as an issue).
vi. Impact on workload and role – falls service/other (including comments on appropriateness
of referrals).
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vii. Overall comments on the SAFER 2 trial intervention.
– Negative.
– Positive.
4. Referral practice post-implementation.
i. Reported reasons for not referring.
– Negative feedback.
– Taking easier option/embedded habits
– Difficulties with patient assessment.
– Time restrictions/end of shift.
ii. Confidence in/anxiety about pathways and outcomes.
iii. Suitability of patients for referral to falls service.
iv. Referral to other services (including GPs).
v. Role of patient and family in decision-making.
vi. Advice from/discussion with colleagues.
vii. Other.
5. Tension between research and real world practice.
i. Motivation for involvement in research study or new innovation.
– Persuasion by an individual.
– Desire to improve service quality.
– Personal development and skills.
ii. Factors discouraging involvement in research study.
iii. Perspective on study as a contained piece of work (bounded area, end date, etc. plus comments
about any problems with timetable).
iv. Drive to recruit patients to target numbers.
v. Confusion/ambiguity around status and nature of research study (including references to other
research studies in progress).
vi. Future rollout.
vii. Perceived benefits of study (e.g. evidence for commissioners).
viii. Other.
6. Suggestions.
i. Follow-up/feedback on individual patients.
ii. Adapting model (e.g. case finding of patients at lower risk levels, scaling up falls service, more
links to other services).
iii. Adapting the SAFER 2 trial process (e.g. putting a prompt on ePRF, devising flow chart,
better communication).
iv. Adapting implementation of trial (e.g. better communication about progress).
v. Other.
7. Existing practice re older fallers.
i. Decision-making.
ii. Outcomes.
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iii. Perceived problems with existing practice.
iv. Other.
8. Communication.
9. Previous experience of pathways and protocols.
10. Concerns, issues around pay, status, role, hours, breaks, etc.
Support and Assessment for Fall Emergency Referrals 2:
framework for analysis of interviews with patients
1. Case coding for patient (note that the entire transcript will be coded to each of the nodes which start
with 1).
i. Outcome of contact.
– Patient attended hospital as a result of index fall.
– Patient did not attend hospital as a result of index fall, referred to falls service.
– Patient did not attend hospital as a result of index fall, not referred to falls service.
ii. Gender.
– Female.
– Male.
iii. Site.
– London Ambulance Service.
– East Midlands Ambulance Service.
– Welsh Ambulance Services NHS Trust.
2. Other overall comments (these should be coded to specific points in the transcript).
i. Any evidence of/report of memory problems or confusion.
ii. Nature/cause of fall.
iii. Repeat falls.
– Previous fall(s) reported.
– Subsequent fall(s) reported.
iv. Other medical conditions.
v. Description and nature of injury.
3. Patient perspective on ambulance service based on their contact at time of index fall.
i. Perspective on paramedics/ambulance technicians.
– Overall evaluation.
– Personal qualities – kindness/calm, etc.
– Impact on patient – maintaining dignity/minimising embarrassment/reassuring/asking rather
than telling/explaining what’s going on, etc.
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ii. Perspective on other aspects of the ambulance service.
– Service overall – including waiting time.
– Despatch.
4. Process – when ambulance service attended patient for index fall.
i. Physical checks/examination.
ii. Questions.
iii. Lifting.
iv. Social aspects – ‘having a laugh’/cup of tea/making lunch, etc.
v. Presence/role of family members/carers/others.
vi. Patient’s reflection/comparison with any previous experience.
vii. Paperwork/notes/records/communication.
5. Decision-making about transfer to hospital – when ambulance service attended patient for index fall.
i. Negotiation/paramedics offering choice.
ii. Patients’ expressed will/autonomy.
iii. Influences on patient’s decision-making.
6. Hospital attendance.
i. Experience of/perspective on attending hospital for index fall.
ii. Experience of/perspective on past hospital attendance.
7. Experience of falls service.
i. Patient evaluation.
ii. Confusion/ambiguity about role and contact.
8. Experience of other relevant health or support services.
i. Social care services (including voluntary sector).
ii. Other health services.
iii. Other or unclear.
iv. Private health care/own resources.
9. Consequences of fall.
i. Overall impact on quality of life.
ii. Impact on confidence/fear of falling.
iii. Pain/other health consequences.
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Appendix 17 Support and Assessment for Fall
Emergency Referrals 2 Involving People case study
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Appendix 18 Site Consolidated Standards of
Reporting Trials flow charts
Site 1
Number of eligible stations
(N = 9)
En
ro
lm
en
t
A
llo
ca
ti
o
n
Fo
llo
w
-u
p
A
n
al
ys
is
Intervention
Paramedics
(N = 63)
Stations
(N = 5)
Stations delivering intervention
(N = 5)
• Stations withdrawn after randomisation, n = 0
• Paramedics withdrawn after 
   randomization, n = 5
• Paramedics who did not volunteer, n = 19
Paramedics delivering intervention
(N = 39)
• Did not meet eligibility criteria, n = 2042
• Unable to confirm eligibility, n = 224
• Dead on scene, n = 2
• Dissented, n = 352
Patients screened as potentially eligible 
attended by intervention paramedics
(N = 3949)
Number of stations, n = 5; average per station = 
7.8; range per station = 2–15
Eligible patients attended by 
intervention paramedics
(N = 1681)
Number of stations, n = 5; average per
station = 336.2
Stations available for follow-up
(N = 5)
Paramedics available for follow-up
(N = 39)
Number of stations, n = 5; average per station =
7.8; range per station = 2–15
Patients available for follow-up
(N = 1329)
Number of stations, n = 5; average per station =
265.8; range per station = 73–447
• Patients not matched at HSCIC/SAIL, n = 18
Station clusters analysed
(N = 5)
Paramedics analysed
(N = 39)
Number of stations, n = 5; average per station =
7.8; range per station = 2–15; coefficient of 
variation = 63.7%
Patients analysed for primary 
outcome at 1 and 6 months
(N = 1311)
Number of stations, n = 5; average per station =
262; range per station = 72–428; coefficient 
of variations = 63.2%
Number of stations, n = 5; average per station =
216; range per station = 54–378; coefficient 
of variations = 65.3%
• Patients not eligible for falls service 
   referral, n = 230
Patients eligible for falls service referral
(N = 1081)
Control
Paramedics
(N = 63)
Stations
(N = 4)
Stations delivering control
(N = 4)
• Stations withdrawn after randomisation, n = 0
• Paramedics withdrawn after 
   randomization, n = 0
• Paramedics who did not volunteer, n = 25
Paramedics delivering control
(N = 38)
• Did not meet eligibility criteria, n = 1468
• Unable to confirm eligibility, n = 173
• Dead on scene, n = 3
• Dissented, n = 349
Patients screened as potentially eligible 
attended by control paramedics
(N = 3345)
Number of stations, n = 4; average per station =
9.50; range per station = 5–14
Eligible patients attended by 
control paramedics
(N = 1701)
Number of stations, n = 4; average per 
station = 425.25
Stations available for follow-up
(N = 4)
Paramedics follow-up
(N = 38)
Number of stations, n = 4; average per station =
9.5; range per station = 5–14
Patients available for follow-up
(N = 1352)
Number of stations, n = 4; average per station =
338; range per station = 131–518
• Patients not matched at HSCIC/SAIL, n = 15
Station clusters analysed
(N = 4)
Paramedics analysed
(N = 38)
Number of stations, n = 4; average per station =
9.5; range per station = 5–14; coefficient of 
variation = 44.2%
Patients analysed for primary 
outcome at 1 and 6 months
(N = 1337)
Number of stations, n = 4; average per station =
334; range per station = 131–457; coefficient 
of variation = 53.9%
Number of stations, n = 4; average per station = 
263.5; range per station = 123–383; coefficient 
of variations = 44.9%
• Patients not eligible for falls service 
   referral, n = 282
Patients eligible for falls service referral
(N = 1055)
Stations randomly allocated
(N = 9)
Paramedics available at 
randomly allocated stations
(N = 126)
• Stations which did not take part, n = 0
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Site 2
Number of eligible stations
(N = 15)
En
ro
lm
en
t
A
llo
ca
ti
o
n
Fo
llo
w
-u
p
A
n
al
ys
is
Intervention
Paramedics
(N = 86)
Stations
(N = 8)
Stations delivering intervention
(N = 5)
• Stations withdrawn after randomisation, n = 3
• Paramedics withdrawn after 
   randomisation, n = 20
• Paramedics who did not volunteer, n = 40
Paramedics delivering intervention
(N = 26)
• Did not meet eligibility criteria, n = 198
• Unable to confirm eligibility, n = 45
• Dead on scene, n = 0
• Dissented, n = 206
Patients screened as potentially eligible 
attended by intervention paramedics
(N = 993)
Number of stations, n = 5; average per station =
5.2; range per station = 1–7
Eligible patients attended by 
intervention paramedics
(N = 750)
Number of stations, n = 05; average per
station = 150
Stations available for follow-up
(N = 5)
Paramedics available for follow-up
(N = 26)
Number of stations, n = 5; average per station =
5.2; range per station = 1–7
Patients available for follow-up
(N = 544)
Number of stations, n = 5; average per station =
108.8; range per station = 14–196
• Patients not matched at HSCIC/SAIL, n = 4
Station clusters analysed
(N = 5)
Paramedics analysed
(N = 26)
Number of stations, n = 5; average per station =
5.2; range per station = 1–7; coefficient of 
variation = 58.3%
Patients analysed for primary outcome 
at 1 and 6 months (anonymised route)
(N = 540)
Number of stations, n = 5; average per station =
100.4; range per station = 14–194; coefficient 
of variation = 82.3%
• Patients not eligible for falls service 
   referral, n = 0
Patients eligible for falls service referral
(N = 540)
Control
Paramedics
(N = 65)
Stations
(N = 7)
Stations delivering control
(N = 4)
• Stations withdrawn after randomisation, n = 3
• Paramedics withdrawn after 
   randomisation, n = 16
• Paramedics who did not volunteer, n = 23
Paramedics delivering control
(N = 26)
• Did not meet eligibility criteria, n = 182
• Unable to confirm eligibility, n = 65
• Dead on scene, n = 0
• Dissented, n = 133
Patients screened as potentially eligible 
attended by control paramedics
(N = 816)
Number of stations, n = 4; average per station =
6.5; range per station = 4–9
Eligible patients attended by 
control paramedics
(N = 569)
Number of stations, n = 04; average per 
station = 144
Stations available for follow-up
(N = 4)
Paramedics follow-up
(N = 26)
Number of stations, n = 4; average per station =
6.5; range per station = 4–9
Patients available for follow-up
(N = 436)
Number of stations, n = 4; average per station =
110.75; range per station = 14–141
• Patients not matched at HSCIC/SAIL, n = 3
Station clusters analysed
(N = 4)
Paramedics analysed
(N = 26)
Number of stations, n = 4; average per station =
6.5; range per station = 4–9; coefficient of 
variation = 32.0%
Patients analysed for primary outcome 
at 1 and 6 months (anonymised route)
(N = 433)
Number of stations, n = 4; average per station =
99.3; range per station = 12–141; coefficient 
of variation = 59.3%
• Patients not eligible for falls service 
   referral, n = 0
Patients eligible for falls service referral
(N = 433)
Stations randomly allocated
(N = 15)
Paramedics available at 
randomly allocated stations
(N = 151)
• Stations which did not take part, n = 0
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Site 3
Number of eligible stations
(N = 7)
En
ro
lm
en
t
A
llo
ca
ti
o
n
Fo
llo
w
-u
p
A
n
al
ys
is
Intervention
Paramedics
(N = 100)
Stations
(N = 4)
Stations delivering intervention
(N = 4)
• Stations withdrawn after randomisation, n = 0
• Paramedics withdrawn after 
   randomisation, n = 8
• Paramedics who did not volunteer, n = 52
Paramedics delivering intervention
(N = 40)
• Did not meet eligibility criteria, n = 257
• Unable to confirm eligibility, n = 31
• Dead on scene, n = 0
• Dissented, n = 95
Patients screened as potentially eligible 
attended by intervention paramedics
(N = 930)
Number of stations, n = 4; average per station, 
10; range per station = 4–19
Eligible patients attended by 
intervention paramedics
(N = 642)
Number of stations, n = 4; average per
station = 160.5
Stations available for follow-up
(N = 4)
Paramedics available for follow-up
(N = 40)
Number of stations, n = 4; average per station,
10; range per station = 4–19
Patients available for follow-up
(N = 547)
Number of stations, n = 4; average per station,
136.75; range per station = 64–223
• Patients not matched at HSCIC/SAIL, n = 7
Station clusters analysed
(N = 4)
Paramedics analysed
(N = 40)
Number of stations, n = 4; average per station,
10; range per station = 4–9; coefficient of 
variation = 73.5%
Patients analysed at 1 and 6 months
 (anonymised route)
(N = 540)
Number of stations, n = 4; average per station, 
135; range per station = 63–221; coefficient 
of variation = 60.0%
• Patients not eligible for Falls Service 
   referral, n = 0
Patients eligible for Falls Service referral
(N = 540)
Control
Paramedics
(N = 74)
Stations
(N = 3)
Stations delivering control
(N = 3)
• Stations withdrawn after randomisation, n = 0
• Paramedics withdrawn after 
   randomisation, n = 0
• Paramedics who did not volunteer, n = 28
Paramedics delivering control
(N = 46)
• Did not meet eligibility criteria, n = 264
• Unable to confirm eligibility, n = 37
• Dead on scene, n = 0
• Dissented, n = 75
Patients screened as potentially eligible 
attended by control paramedics
(N = 872)
Number of stations, n = 3; average per station,
15.3; range per station = 7–28
Eligible patients attended by 
control paramedics
(N = 571)
Number of stations, n = 3; average per 
station = 187
Stations available for follow-up
(N = 3)
Paramedics follow-up
(N = 46)
Number of stations, n = 3; average per station,
15.3; range per station = 7–28
Patients available for follow-up
(N = 496)
Number of stations, n = 3; average per station,
162; range per station = 79–330
• Patients not matched at HSCIC, n = 2
Station clusters analysed
(N = 3)
Paramedics analysed
(N = 46)
Number of stations, n = 3; average per station, 
15.3; range per station = 7–28; coefficient of 
variation = 72.7%
Patients analysed at 1 and 6 months
 (anonymised route)
(N = 494)
Number of stations, n = 3; average per station, 
163; range per station = 79–328; coefficient 
of variation = 87.7%
• Patients not eligible for Falls Service 
   referral, n = 0
Patients eligible for Falls Service referral
(N = 494)
Stations randomly allocated
(N = 7)
Paramedics available at 
randomly allocated stations
(N = 174)
• Stations which did not take part, n = 0
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Appendix 19 Further clinical effectiveness results
Participant numbers and subgroups flow
As outlined in Chapter 4, a total of 5914 eligible patients were attended by 215 paramedics based at
31 ambulance stations across the three study sites. After dissenting patients were excluded, 80%
(n = 4704) were available for follow-up: 2420 in the intervention group and 2284 in the control group.
Various analyses in Chapter 4 exclude n = 49 participants not matched anonymously, as data on key
components in the primary outcome were unavailable. A further subgroup of participants in site 1 were
registered at a GP practice unable to refer patients to the falls referral service. In this appendix, we present
the main results tables for the subgroup which also excludes these participants ineligible for a falls referral.
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